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Variation in growth conditions is an inevitable consequence of the 
environment’s dynamism and, as such, organisms are subjected to adverse 
living conditions including non-optimal temperature. Exposure to elevated 
temperature and other proteotoxic stresses disrupts structural integrity of 
cellular machineries and results in cytotoxic unfolded-protein-aggregates. To 
cope with proteotoxic stresses, organisms are equipped with an evolutionarily 
conserved defense mechanism known as heat shock response (HSR). 
Despite the significance of HSR in protein homeostasis and survival, it’s 
scope, extent, and the molecular mechanism of regulation are poorly 
understood.  
Our work shows that the genome-wide transcriptional response to heat-
stress in mammals is rapid, dynamic, and results in induction of several 
hundred and repression of several thousand genes. Heat shock factor 1 
(HSF1), ‘the master regulator’ of the HSR, controls only a fraction of the heat-
stress induced genes, and does so by increasing RNA polymerase II (Pol II) 
	
release from its promoter-proximal pause. The pervasive repression of 
transcription is predominantly HSF1-independent, and is mediated through 
reduction of Pol II pause-release. The up- and down-regulated genes during 
HSR are accompanied by concomitant increase and decrease respectively in 
promoter occupancy of pause-release factor positive transcription elongation 
factor b (P-TEFb). HSF2, the ubiquitously expressed paralog of HSF1, has a 
broader repressive role during stress, likely mediated through other factors, 
and its promoter-binding activity is dependent on HSF1. Our work also 
demonstrates the unprecedented role of serum response factor (SRF) in 
transient induction of cytoskeletal genes during the early phase of HSR. 
Overall, mammalian cells orchestrate rapid, dynamic, and extensive changes 
in transcription upon heat-stress that are largely modulated at pause-release, 
and HSF1 plays a limited and specialized role.  
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CHAPTER 1 
 
MECHANISM AND MACHINERY OF TRANSCRIPTIONAL REGULATION 
OF HEAT SHOCK RESPONSE 
 
Summary 
 The dynamic nature of environment has a profound effect on evolution 
of life. Variation in the growth environment is an inevitable consequence of 
environment’s dynamism, and as such, organisms are subjected to adverse 
living conditions including non-optimal temperature. Exposure to high-
temperature disrupts the structural integrity of cellular proteins leading to 
formation of cytotoxic unfolded protein aggregates. To cope with elevated 
temperature, organisms have developed a cellular response mechanism 
known as heat shock response (HSR). This adaptive defense mechanism is 
evolutionarily conserved across the domains of life. The focus of this chapter 
is to provide an evolutionary context for the emergence of HSR, elaborate the 
roles of heat shock proteins in restoration of protein homeostasis, and the 
mechanisms of heat shock transcription factor-1 activation and its role in 
transcription regulation. Understanding the mechanism and machinery of HSR 
is critical in biology and diseases. The relentless pursuit of how major faculties 
of gene regulation contribute in its orchestration from studies in various 
species has unveiled the enormity and complexity of the HSR. 
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Introduction 
 Heat shock response (HSR) was first observed more than five decades 
ago as chromosomal puffs in Drosophila salivary glands (Ritossa, 1962). The 
discovery was considered a cellular artifact and struggled for some time to be 
embraced as a manifestation of a gene regulatory mechanism (De Maio et al., 
2012). However, the detection of heat shock proteins (HSPs) in 1974 
(Tissiéres et al., 1974) and the subsequent volumes of work in 80’s and 90’s 
on HSPs established the HSR as a critical and universal cellular defense 
mechanism. The stress response field has exploded ever since and the 
discovery of HSR in virtually every organism has catapulted it to be accepted 
as a general feature of cells. Similarity in the HSR among various organisms 
spans from instigating cues to activating molecules, and from mechanistic 
steps to synthesis of final products. Although HSR was discovered as a 
protective mechanism against heat stress, it is evoked by various stresses 
including toxins (Aït-Aïssa et al., 2000; Hensler et al., 1991; Liu et al., 1996; 
Löw-Friedrich and Schoeppe, 1991; Wirth et al., 2002), heavy metals (Boone 
and Vijayan, 2002; Deane and Woo, 2006; Singer et al., 2005; Warchałowska-
Sliwa et al., 2005), oxidants (Moraitis and Curran, 2004; Trott et al., 2008; 
Wallen et al., 1997), radiations (Lin et al., 1997; Trautinger et al., 1996), 
metabolites (Abe et al., 1998; Chang et al., 2001), and pathogens (Kantengwa 
and Polla, 1993; Ramaglia et al., 2004). Furthermore, HSR can also be 
triggered by exercise (Fehrenbach and Niess, 1999; Leon, 2016; Yamada et 
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al., 2008), and nutrients (Mahat and Lis, 2016). As such, HSR is now regarded 
as the integrated cellular response for its ability to sense and respond to 
various stresses.  
 The defining features of HSR are well established. Despite the diversity 
in origin of stresses, they generate non-native proteins in cells and disrupt 
protein homeostasis (proteostasis) (Morimoto, 1998a). Disruption in 
proteostasis affects several aspects of cellular structure and function (Figure 
1.1) and subsequently results in activation of the heat shock transcription 
factor 1 (HSF1) (Parker and Topol, 1984). Vertebrates have four HSF genes, 
HSF1–4. HSF1 is considered the ‘master regulator’ of HSR and is the ortholog 
of the sole HSF gene in invertebrates. Upon stress, the dormant monomeric-
HSF1 trimerizes, binds to heat shock element (HSE, inverted repeats of 
nGAAn pentamers) in the promoters of heat shock protein genes (HSPs), and 
increases their transcription considerably (Perisic et al., 1989; Westwood et 
al., 1991; Xiao and Lis, 1988). Subsequent post-transcriptional and 
translational regulatory steps further accentuate HSPs’ expression, whereas 
non-critical genes’ expression is suppressed by coordination of the 
transcriptional, post-transcriptional, and translational regulatory steps.  
 Despite the flood of information on several aspects of the HSR, 
including various nature of activating cues and the stress-specific synthesis of 
HSPs (Roccheri et al., 2004), many features of this response mechanism 
remain poorly understood. How cells sense heat and other kinds of stresses?  
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Figure 1.1. Deformation of cellular structures induced by heat stress 
Heat stress damages cytoskeleton, including the reorganization of actin 
filaments (blue) into stress fibers and the aggregation of other filaments. 
Organelles such as Golgi and endoplasmic reticulum (white) become 
fragmented the number and integrity of mitochondria (green) and lysosomes 
(yellow-white gradient) decreases. Large depositions of the stress granula 
(yellow), resulting from assemblies of proteins and RNA, are found in the 
cytosol. Changes in the membrane morphology, aggregation of membrane 
proteins, and an increase in membrane fluidity also occur. Figure and 
description adapter from (Richter et al., 2010). 
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What triggers the activation of HSF1? What are the genes regulated by 
HSF1and what factors and mechanisms induce non-HSPs? How is global 
repression of non-essential genes achieved? After decades of research, some 
models and hypotheses have emerged that explain key observations in the 
HSR. However, advent and application of new tools routinely challenge the 
established models and new technologies continue to broaden our 
understanding of the causes and consequences of proteotoxic stress. The 
enduring exploration of mechanism and machinery of HSR is more important 
than ever because of its direct involvement in various diseases. This chapter 
focuses on the evolutionary context and functions of HSPs, the regulation of 
HSR with an emphasis on transcriptional regulation and the role of HSF1, and 
the implications of HSR in health and diseases. 
 
Evolution of protein folding machinery 
The foundation for the evolution of protein folding machinery is 
multifaceted. Many small cellular proteins have the ability to refold into their 
native three-dimensional structure with sub-second kinetics (Kubelka et al., 
2004), indicating the structural information of a protein is encoded in its DNA 
(Dobson et al., 1998). However, folding of larger proteins may take from 
minutes to even hours (Herbst et al., 1997).The longer folding kinetics and a 
high in vivo protein concentration (300-400 ng/ul) (Dobson et al., 1998) makes 
larger proteins vulnerable for misfolding and thus requires assisting machinery 
		
	
	
6	
for proper folding. Furthermore, chaperone machinery serves as a capacitor of 
change in protein structure that arise from nonsynomous substitution of amino 
acids and mediates protein evolution by temporarily masking the phenotype of 
altered protein structure (Rutherford and Lindquist, 1998). Lastly, extracellular 
and intracellular cytotoxic agents can potentially alter the free-energy 
landscape of cellular proteins, which makes proteostasis restoration 
mechanism a critical requisite for continued cellular functions (Morimoto, 
1998a). These scenarios that were likely encountered at the dawn of evolution 
are responsible for the ubiquity of protein folding machinery.  
 
Heat shock proteins in proteostasis 
The objective of HSR from sensing ectopic stress to synthesizing HSPs 
by employing multiple layers of regulatory events from transcription to 
translation is to restore proteostasis. If HSR is an emergency response, HSPs 
are the paramedics, and there seems to be a variety of paramedics with 
unique specializations. Some HSPs serve as the hub of protein refolding 
machinery whereas others recognize and deliver the “injured” proteins to the 
refolding machinery. In general, HSPs utilize ATP molecules to restore the 
native conformation of unfolded and folding-intermediate proteins with the help 
of co-chaperones. Moreover, different HSPs characterize different diseases 
invoking the concept of HSP barcoded diseases (Kakkar et al., 2014).  
		
	
	
7	
HSP110 family members are close relatives of HSP70 with a longer 
linker region between the N-teminal ATPase domain and the C-terminal 
peptide-binding domain resulting in their larger size (Easton et al., 2000). 
These proteins associate with and assist the protein folding activity of HSP70 
by serving as a nucleotide exchange factor during ATP hydrolysis in 
chaperoning cycle (Andréasson et al., 2008; Dragovic et al., 2006; Raviol et 
al., 2006). This auxiliary role of HSP110s in HSP70-mediated protein folding 
and their high efficiency and differential preference in substrate holding have 
led some scientists to argue that they lack chaperoning activity (Zuo et al., 
2016), however, studies using heat-denatured luciferase (Yamagishi et al., 
2011) and misfolded and aggregated polypeptides (Mattoo et al., 2013) as 
substrates have provided evidence for the direct role of HSP110s in protein 
folding and established them as bona fide chaperones. In yeast, HSP110 is 
also critical for acquired thermotolerance (Sanchez and Lindquist, 1990). 
HSP110s have implications beyond the protein-folding space. They 
mitigate oxidative stress-induced apoptosis through p38 MAPK-dependent 
mitochondrial pathway (Yamagishi et al., 2008). Targeting of HSP110 by small 
synthetic interfering RNA induces apoptosis of various cancer cells indicating 
addiction of cancer cells to HSP110s (Hosaka et al., 2006). Interestingly, they 
also play a critical role in innate immunity by delivering antigens to the 
endogenous antigen-presenting pathway for cross-presentation and thus are 
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being considered for cancer immunotherapy (Bolhassani and Rafati, 2008; 
Murshid et al., 2008).  
 Hsp90s are another major class of HSPs. They are highly abundant 
dimeric protein constituting 1-2% of total cellular protein content. Eukaryotic 
genomes encode multiple compartment-specific HSP90 proteins and their 
conservation across species indicate that they likely arose early in evolution 
(Taipale et al., 2010). Despite the high intrinsic flexibility of HSP90, its 
structural properties in bacteria, yeast, and mammals have been resolved, 
which indicate that the HSP90s share structural homology with other ATPases 
(Ali et al., 2006; Dollins et al., 2007; Shiau et al., 2006). The highly conserved 
amino-terminal domain binds ATP and the carboxy-terminal domain mediates 
dimerization (Csermely et al., 1993). ATP binding triggers a conformational 
change in HSP90 causing a transition from an open (ADP-bound) to a closed 
(ATP-bound) form (Grenert et al., 1997), and induces structural readjustments 
necessary for client protein’s conformational change (Chadli et al., 2000). 
However, recognition of client proteins by HSP90 is still a mystery. Its diverse 
clientele lack structural or sequence similarity, prompting the model where 
client proteins are delivered to HSP90 by other chaperones and co-
chaperones. Indeed, HSP70 interacts with HSP40 to recognize short 
hydrophobic exposed segment of nascent polypeptides or partially unfolded 
proteins, which are brought to HSP90 for refolding (Genevaux et al., 2007; 
Rüdiger et al., 1997).  
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 Besides assisting in the folding of nascent polypeptide and partially-
unfolded proteins, HSP90, in association with other chaperones and co-
chaperones, sequesters HSF1 in a repressive complex (Zou et al., 1998). 
HSP90 also cooperates with HSP70 to transport a subset of mitochondrial 
preproteins for subsequent membrane translocation (Young et al., 2003). It 
capacitates alteration in protein structure and facilitates evolution by 
temporarily masking cryptic variation (Jarosz and Lindquist, 2010). Because of 
its role in proteostasis, cancer cells heavily rely on HSP90 to stabilize mutant 
proteins that would otherwise be degraded (Li et al., 2011; Trepel et al., 2010). 
Predictably, several HSP90 inhibitors designed for cancer therapeutics are at 
different phases of clinical trial (Neckers and Workman, 2012). 
  
Regulation of heat shock response 
The regulation of HSR is an intricate process accomplished by 
engaging various faculties of regulation. Cells deploy transcriptional (Duarte et 
al., 2016; Mahat et al., 2016; Solís et al., 2016), post-transcriptional (Meyer et 
al., 2015; Shalgi et al., 2014; Zhou et al., 2015) , translational (Shalgi et al., 
2013) , and post-translational (Raychaudhuri et al., 2014) programs to regulate 
the HSR. Feedback regulation between translational and transcriptional 
processes further complicates the regulatory cycle (Santagata et al., 2013). 
The evolution of checks and balances ensures optimal expression of 
chaperone proteins and temporal control of their expression, whereas, the 
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tight coordination between various regulatory steps underlies the significance 
of this cellular response mechanism in survival. 
 So why do cells conjure such concerted effort from all major regulatory 
branches of gene expression in response to stress? The answer is rather 
simple – stress is harmful, even lethal in case of increased severity or 
duration, and cells do everything to promote their survival. In order to survive, 
cells halt non-critical functions, conserve energy, and selectively mobilize pro-
survival programs. The rapid and robust expression of pro-survival genes and 
suppression of non-critical functions is a keenly regulated process - it begins 
with instantaneous sensing of heat stress by cells and continues all the way to 
recovery from heat stress. 
 
Mechanisms to sense heat stress and activation of HSF1  
The field of stress response has taken significant strides in identifying 
the events downstream of HSF1 activation and the subsequent changes in 
transcriptional and translational programs caused by proteotoxic stress. 
However, after more than five decades since the discovery of HSR, the 
primary mechanism and factors responsible to sense heat stress remain 
elusive. The quest to identify the pioneering events in incitation of the HSR is 
further complicated by the discovery of several distinct models of heat sensing 
and HSF1 activation. The three predominant models in the field of HSR are 
discussed below. 
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Chaperone titration  
Release of inert monomeric HSF1 from chaperone-associated complex 
is the predominant model of HSF1 activation. The influx of protein folding 
intermediates due to heat stress is sensed by HSP90, HSP70, and their co-
chaperones and the chaperones dissociate from the HSF1-interacting complex 
liberating HSF1 to trimerize and activate (Morimoto, 1998b; Neef et al., 2014). 
This model is supported by the activation of HSF1 and subsequent expression 
of HSPs triggered by the injection of denatured proteins into Xenopus oocytes 
but not by native proteins (Ananthan et al., 1986). Furthermore, multiple 
observations of interaction between the chaperones and HSF1 (Abravaya et 
al., 1992; Duina et al., 1998; Nadeau et al., 1993; Neef et al., 2014; Ohama et 
al., 2016) indicate the presence of such repressive complex. This interaction is 
reduced during proteotoxic stress (Guo et al., 2001), and pharmacological 
inhibition of HSP90 releases HSF1 to trimerize and bind to HSE in vitro (Zou et 
al., 1998). A more recent study using experimental and theoretical approaches 
tested this model and found that the dynamic interaction of HSP70 with HSF1 
forms the basis of HSF1 activation switch (Zheng et al., 2016). The influx of 
unfolded proteins caused by stress titrates away HSP70 enabling HSF1 to 
trimerize and activate. To this date, this is the most compelling evidence for 
the activation of HSF1 via titration of chaperones from the inactive complex. 
Nevertheless, the existing models of HSF1 activation are not necessarily 
mutually exclusive and other models could still contribute in heat sensing. 
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Post-translational modification of HSF1 
Post-translational modifications of HSF1 serve as another putative 
mechanism for cell’s ability to sense heat stress and activate HSF1. This 
model emerged from two sets of observations. First, the release of latent 
monomeric HSF1 from repressive chaperone complex and subsequent 
trimerization and binding to HSEs is not sufficient to induce transcription, 
suggesting the requirement of further activating cues in HSF1-mediated 
transcription induction (Cotto et al., 1996; Jurivich et al., 1995; Petesch and 
Lis, 2008). Second, HSF1 is heavily phosphorylated during heat stress 
suggesting that the post-translational modifications may serve as the ultimate 
activating cue that renders HSE-bound HSF1active (Guettouche et al., 2005; 
Holmberg et al., 2001; Lee et al., 2008; Soncin et al., 2003; Sorger and 
Pelham, 1988). However, phosphorylation of some serine residues are 
associated with HSF1 repression (Høj and Jakobsen, 1994; Kline and 
Morimoto, 1997; Knauf et al., 1996) and phosphorylation-dependent 
sumoylation also has an inhibitory role on HSF1 function (Hietakangas et al., 
2003). Furthermore, acetylation of the lysine residues of HSF1 by p300 serves 
as a negative regulator of HSF1’s DNA binding ability, whereas SIRT1-
mediated deacetylation maintains HSF1 in a DNA-binding competent state 
(Westerheide et al., 2009). 
 The surprising finding regarding the post-translational modifications of 
HSF1 emerged when the mutagenesis of all known phosphoacceptor residues 
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of HSF1 did not hamper its transcription activation potential (Guettouche et al., 
2005). Simultaneous mutagenesis of 15 phosphorylation sites had no effect on 
HSF1’s activation (Budzyński et al., 2015) and genome-wide RNAi screens 
failed to identify kinases as modulators of HSF1 activity (Raychaudhuri et al., 
2014). Nevertheless, quantitative examination of the contribution of 
phosphorylation revealed its dispensability on HSF1 activation and revealed its 
role as a ‘fine tuning’ knob on HSF1 activity (Zheng et al., 2016). 
 
Intrinsic ability of HSF1 to sense stress 
HSF1’s intrinsic ability to sense heat adds another dimension to the 
heat sensing landscape during stress. Monomeric HSF1 can trimerize in vitro 
by heat stress, oxidative stress, low pH, and higher calcium concentration 
(Goodson and Sarge, 1995; Mosser et al., 1990; Zhong et al., 1998). HSF1’s 
thermosensory ability is manifested by temperature-dependent unfolding of the 
heptad region in its regulatory domain (HR-C) and concomitant stabilization of 
oligomerization domain (HR-A/B) (Hentze et al., 2016). Substitution of three 
hydrophobic residues in the HR-C domain renders HSF1 constitutively 
trimerized and competent for DNA binding (Rabindran et al., 1993; Zuo et al., 
1994). The trimerized state of human HSF1 achieved through this genetic 
manipulation is capable of translocating into the nucleus when expressed in 
yeast cells, while native human HSF1 localizes throughout the yeast cell, and 
complements the viability defect associated with the deletion of yeast HSF 
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gene (Liu et al., 1997). Besides the aforementioned evidence of temperature-
dependent unfolding of HSF1, the inherent ability of HSF1 in heat-sensing is 
poorly understood. Nevertheless, the built-in sensory capability of HSF1 
provides a plausible explanation for the promptness of the HSR activation, 
which is difficult to reconcile with the first two models that require separate 
molecular events to occur prior to HSF1 activation. 
 Beyond the three leading models of HSF1 activation, anecdotal 
evidences indicate the existence of two additional mechanisms of HSF1 
activation. First, a ribonuclear protein complex that consist heat shock RNA-1 
(HSR-1) facilitates HSF1 activation (Shamovsky et al., 2006). This model 
suggests that the HSR-1 serves as a thermosensor by undergoing heat-
induced conformational change (Kugel and Goodrich, 2006). Second, a heat-
stress dedicated neuronal circuit controls the HSR in C. elegans (Prahlad et 
al., 2008). Such neuronal network is yet to be identified in mammals, 
nevertheless, the finding in C. elegans indicates a likely organismal level 
control in stress response. Overall, organisms deploy several mechanisms 
that are not necessarily mutually exclusive to transduce stress signal to HSF1, 
which in turn activates highly coordinated transcriptional programs. 
  
Transcriptional regulation of heat shock response 
Once HSF1 is activated by heat stress, it orchestrates a transcriptional 
program designed to maximize cell’s survival, the molecular details of which 
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are just beginning to emerge. Historically, study of the HSR was limited to the 
focused gene studies of HSPs. The confined window of HSF1 and HSPs and 
the lack of genome-wide tools masked the extent and diversity of the 
transcriptional program regulated during HSR for a long time. As a result, 
HSF1 has been considered the ‘master regulator’ of HSR. However, 
development of highly sensitive genome-wide methods has enabled the 
discovery of the diversity of transcriptional programs regulated during HSR.  
 
HSF1 in HSR 
It is well-known that HSF1 transcriptionally induces HSPs in all model 
organisms (Clos et al., 1990; Lindquist, 1986; McMillan et al., 1998). Much of 
what we know today about the basic mechanism of transcription regulation of 
HSPs by HSF1 comes from the focused gene studies in yeast (Gallo et al., 
1993; Lindquist, 1986; Lindquist and Kim, 1996; Sorger and Pelham, 1988; 
Verghese et al., 2012; Wiederrecht et al., 1988) and Drosphila Hsp70 gene 
(Giardina and Lis, 1995a; Jedlicka et al., 1997; Lis et al., 1983; Perisic et al., 
1989; Rougvie and Lis, 1988; Zobeck et al., 2010).  
 
Essentiality of HSF1 
Acute inactivation of HSF1 through the “anchor-away” approach even 
during normal growth condition triggers toxic protein aggregates in yeast (Solís 
et al., 2016). This observation indicates the requirement of HSF1 in 
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maintaining protein homeostasis and corroborates the essentiality of yeast 
HSF1 for cell growth and viability (Gallo et al., 1993; Sorger and Pelham, 
1988; Wiederrecht et al., 1988). Mutations disrupting DNA binding domain or 
activation domain of yeast HSF1 is lethal even in the unstressed condition 
(Jakobsen and Pelham, 1991; Torres and Bonner, 1995). In contrast, HSF1 is 
not essential for normal growth and viability in Drosophila but is required 
during larval development (Jedlicka et al., 1997). Similarly, mammalian cells 
can survive without HSF1 as long as they don’t encounter stress and their 
lifespan is uncompromised (McMillan et al., 1998). However, lack of HSF1 can 
severely reduce their survival likelihood in event of stress (Luft et al., 2009). 
The reliance of mammalian cells on HSF1 only during stress indicates an 
alternative mechanism exists for basal expression of HSPs. It further suggests 
the adaptation of HSF1 as a stress-specialist transcription factor in 
mammalian cells.  
 
Structure of HSF1 
Structure of a biological molecule can convey vital information on its 
functional characteristics. HSF1 protein ranges from ~50-90 kDa in different 
species and is composed of structurally distinct domains. The winged helix-
turn-helix DNA binding domain (DBD) lies in the N-terminal, followed by coiled-
coil trimerization domain - a largely unstructured regulatory domain that 
consists a short heptad repeat, and a transactivation domain that is also 
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generally unstructured (Wu, 1995). Molecular structure of the DBD (Harrison et 
al., 1994) and DBD-HSE complex (Littlefield and Nelson, 1999) of yeast, DBD 
of Drosophila (Vuister et al., 1994), DBD (Liu et al., 2011) and DBD-HSE 
(Neudegger et al., 2016) of human HSF1 have been resolved so far. The most 
recent and comprehensive analysis of HSF1 structure yet showed the DBD of 
HSF1 completely embracing the DNA (Neudegger et al., 2016), providing an 
ample opportunity for other factors to interact with DNA-bound HSF1. It also 
revealed the conspicuous lack of deep pockets for small molecule drug to bind 
and interfere HSF1’s DNA binding ability (Neudegger et al., 2016).  
 
DNA binding ability of HSF1 
Another critical feature in HSF1-mediated transcription regulation is its 
ability to bind DNA. Long stretches of DNA are condensed into chromatin 
using nucleosomes. Some transcription factors, known as ‘pioneer factors’, 
are able to bind condensed chromatin, recruit co-factors and chromatin 
remodelers to open local chromatin to create conducive environment for 
transcription initiation (Zaret and Carroll, 2011). Non-pioneer transcription 
factors bind to already accessible chromatin sites only. Some studies have 
suggested a likely pioneering transcriptional activity of HSF1. HSF1 opens the 
chromatin structure of Interleukin-6 promoter (Inouye et al., 2007) and 
stimulates demethylation of the promoter to facilitate p65 and c-Jun binding 
(Rokavec et al., 2012). Association with replication protein A (RPA) and 
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subsequent recruitment of histone Chaperone FACT allows HSF1 to access 
nucleosomal DNA (Fujimoto et al., 2012). However, conclusive experiment 
showing pioneering activity of HSF1 in more than few genomic loci remains to 
be conducted. Meanwhile, observations of active chromatin marks such as 
histone acetylation and H3K4 trimethylation dictating the heat-inducible 
binding of HSF1 to DNA (Guertin and Lis, 2010) underminess the hypothesis 
of HSF1 being a pioneer factor. Alteration of chromatin landscape from 
inactive to active state permits inducible HSF1 binding (Guertin and Lis, 2010), 
further indicating HSF1’s inability to overcome inactive chromatin landscape. 
While HSF1’s ability to access chromatin remains to be fully known, its 
DNA binding mechanics is fairly understood. HSF1 binds DNA mostly as a 
trimer with multiple dyad symmetries and the trimerization is stabilized through 
coil-coin interaction (Perisic et al., 1989). DNA bound HSF1 trimer is further 
stabilized by intermolecular disulfide bond between individual monomers (Ahn 
and Thiele, 2003). Interference of the disulfide bond by reducing agents 
minimizes trimerization and stress-responsive gene transcription (Neef et al., 
2010a). Once bound, it stably associates with DNA and facilitates multiple 
cycles of transcription (Yao et al., 2006). 
 
Interacting partners and recruited factors 
 HSF1 binding to promoters is not sufficient to induce transcription 
suggesting the requirement of additional events (Cotto et al., 1996; Giardina 
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and Lis, 1995b; Jurivich et al., 1995; 1992; Petesch and Lis, 2008). One 
possible additional event is the modification of DNA-bound HSF1 by 
interacting partners or recruited factors that confers competency for 
transcription activation. Upon stress, P-TEFb kinase is recruited to heat shock 
loci in HSF1-dependent manner as shown by polytene spreads (Lis et al., 
2000) and live cell imaging (Zobeck et al., 2010). Small molecule mediated 
inhibition of HSF1’s ability to recruit P-TEFb results in lack of HSPs induction 
(Yoon et al., 2011). Similarly, a direct interaction between HSF1 and a 
mediator subunit recruits co-activating mediator complex to heat shock loci 
(Kim and Gross, 2013; Park et al., 2001). Genome-wide screens of HSF1 
interacting partners through co-immunoprecipitation assay have identified 
more than 30 proteins that play a role in DNA repair, splicing, signaling, and 
protein degradation among others (Fujimoto et al., 2012; Kang et al., 2015). 
Given the promiscuous nature of co-immunoprecipitation assay, whether these 
interactions are functional remains to be shown. 
HSF1 also modifies chromatin landscape to facilitate transcription. 
Stimulation of histone acetyl transferase Tip60 by HSF1 and consequent 
histone H2A lysine 5 acetylation boosts transcription activation of Drosophila 
Hsp70 gene (Petesch and Lis, 2012). HSF1 recruits histone actetyltransferase 
p300/CBP to HSF1 bound sites (Hong et al., 2004; Smith et al., 2004), which 
in-turn acetylates HSF1 (Raychaudhuri et al., 2014). However, HSF1 
acetylation is a dynamic process and the modulation of this mark has a 
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potential to alter HSF1’s function. As discussed earlier, SIRT1 mediated 
deacetylation of HSF1 is required for its ability to bind DNA and inhibition of 
SIRT1 catalytic activity attenuates HSF1-DNA interaction and the HSR 
(Westerheide et al., 2009). 
 
Mechanism of HSF1-mediated transcription induction 
Transcription cycle consists of multiple rate-limiting steps (Fuda et al., 
2009). Transcription factors often control either one or both of the two early 
steps in transcription cycle - Pol II recruitment and release of Pol II from the 
promoter-proximal pause (Adelman and Lis, 2012). The contribution of HSF1 
in recruitment and/or release of Pol II was unclear until the development of 
genome-wide nuclear run-on assays. Precision run-on and sequencing (PRO-
seq) is a highly sensitive genome-wide assay that maps RNA polymerase at 
base-pair resolution and thus provides quantitative transcriptional status. Use 
of PRO-seq in HSF1 knock out mouse embryonic fibroblasts revealed that the 
HSF1 induces transcription by increasing the release of Pol II from promoter-
proximal pause (Duarte et al., 2016; Mahat et al., 2016). The recruitment of 
Pol II also increases during HS resulting in net increase in paused Pol II; 
however, the increase in Pol II recruitment and pausing is independent of 
HSF1 (Mahat et al., 2016). The primary candidate factor in mediating HSF1-
induced pause release is P-TEFb kinase. Earlier observations of HSF1-
dependent P-TEFb recruitment to heat shock loci indicate cooperation 
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between the two factors (Lis et al., 2000; Zobeck et al., 2010). Quantitative 
assessment of the occupancy of Cyclin dependent kinase 9 (Cdk9), the kinase 
subunit of P-TEFb, show that the P-TEFb is significantly enriched in the 
promoters and proximal gene body regions of HSF1-dependent genes during 
HSR (unpublished data, see Chapter 2). It further supports the existing model 
of HSF1 inducing transcription by accelerating the release of Pol II from 
promoter-proximal paused state (Figure 1.2). 
 Another defining feature of the HSR is the global downregulation of 
genes. More than 50% of actively transcribing genes are significantly 
downregulated during HSR (Mahat et al., 2016). The global repression of 
transcription is attained by the inhibition of Pol II release form promoter-
proximal pause (Mahat et al., 2016). The reduction in P-TEFb occupancy in 
the promoters of repressed genes (unpublished data, see Chapter 2) provides 
a likely mechanism where reduction in P-TEFb availability impedes the 
maturation of paused Pol II into productive elongation complex (Figure 1.3). 
Together, the dependence of upregulated genes on P-TEFb and the deficit of 
P-TEFb in downregulated genes support a comprehensive model of gene 
regulation during HSR. At HSF1 induced genes, HSF1 recruits P-TEFb to 
increase the rate of Pol II release from the promoter-proximal pause. The 
shuttling of P-TEFb to HS-induced genes by HSF1 and possibly other 
transcription factors titrates P-TEFb away from genes that will eventually be 
repressed. Fluorescent recovery after photobleaching (FRAP) analysis 
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Figure 1.2. Mechanism of HSF1-mediated transcription induction during 
HSR 
HSF1 binds and recruits the pause release factor P-TEFb, which accelerates 
the release of paused Pol II from the promoter-proximal paused state. The 
recruitment of Pol II, however, occurs independent of HSF1. 
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Figure 1.3. Mechanism of transcription repression during HSR 
Global repression of transcription is caused by the inhibition of paused Pol II 
release from the promoter-proximal paused state. This inhibition and 
subsequent increase in paused Pol II is accompanied by decrease in P-TEFb 
occupancy at the promoters and it is independent of HSF1. The recruitment of 
Pol II is unaffected and independent of HSF1. 
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indicated that the P-TEFb binding at heat shock loci is dynamic (Zobeck et al., 
2010), which supports the titration model in which HSF1 shuttles P-TEFb as it 
comes off the genes that will eventually be repressed. Alternatively, global P-
TEFb may disengage at the onset of HSR requiring active recruitment by 
transcription factors such as HSF1 to the genes that are destined for 
upregulation. The failure to deliver P-TEFb to the remaining genes likely due to 
the lack of transcription factor binding results in their repression. It is also 
possible for P-TEFb to be limiting either by reduction in its kinase activity 
(Fujinaga et al., 1998), which is required for Pol II pause release, or due to its 
depletion from nucleus (Raychaudhuri et al., 2014) and likely sequestration in 
cytoplasmic stress granules. 
 Another interesting aspect of transcription regulation during HSR is the 
increase in paused Pol II density at both upregulated and downregulated 
genes. While it is theoretically possible that another transcription factor binds 
to all genes and recruits Pol II in HSF1-independent manner, the more 
plausible hypothesis is the mass action loading of Pol II that are liberated by 
global repression.  
 
HSF1-regulated genes in stress  
 HSF1 regulated genes during stress are characterized in several model 
species (Brown et al., 2014; Duarte et al., 2016; Hahn et al., 2004; Mahat et 
al., 2016; Solís et al., 2016; Trinklein et al., 2004). The major constituents in 
		
	
	
25	
the repertoire of selectively induced genes are canonical HSPs that play a 
central role in chaperone machinery. But not all genes in the HSP family, as 
defined by a recent attempt to streamline the nomenclature of HSPs and 
auxiliary chaperone proteins (Kampinga et al., 2009), are stress-inducible at 
transcriptional level (Duarte et al., 2016; Mahat et al., 2016; Solís et al., 2016). 
While some of the uninduced HSPs could be induced in other type of stress, 
the general lack of HSF1 binding and HSE in their promoters indicate that they 
likely are not a transcriptional target of HSF1 (Mahat et al., 2016). Comparable 
expression of HSPs in wild type and HSF1-/- cells in unstressed condition 
indicates that the HSF1 does not play a role in basal expression of HSPs in 
mammalian cells. However, this observation also raises a critical question on 
the mechanism underlying basal expression of HSPs. 
 
HSF1-regulated genes in absence of stress  
 The study of HSF1’s role in unstressed cells is complicated by few 
factors. First, mammals have multiple paralogs of HSF1 and they bind to 
identical HSEs as homo- or hetero-trimers (Sandqvist et al., 2009). The lack of 
complete map of binding landscapes of different HSFs and their relative 
enrichment in different promoters confounds the contribution of each paralog 
in basal transcription regulation. Second, tools that can instantaneously and 
completely inhibit HSF1 function are yet to be developed. Conventional 
knockout (McMillan et al., 1998), CRISPR/Cas9 mediated genetic 
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manipulation (Solís et al., 2016), or RNAi based (Duarte et al., 2016) approach 
takes days to manifest their effect, which provides sufficient time for secondary 
effects to kick in. Tools that can instantaneously and almost completely inhibit 
HSF1 function such as inducible RNA aptamer (Salamanca et al., 2014) or 
small molecule inhibitors (Au et al., 2009; Whitesell and Lindquist, 2009; Yoon 
et al., 2011) are yet to be used to identify HSF1 regulated genes under basal 
conditions. A recent study using ‘anchor-away’ approach identified 18 genes 
that are constitutively regulated by HSF1 in yeast (Solís et al., 2016). 
However, CRISPR/Cas9 mediated genetic manipulation of HSF1 in the same 
study identified no genes under HSF1 control under basal conditions in 
mammals. There is a chance that this failure to find affected genes could have 
been a result of the cellular mechanisms to compensate for the loss of HSF1, 
because the CRISPR/Cas9 approach is not instantaneous. Moreover, previous 
studies have identified at least a few genes under HSF1’s control in 
unstressed cells (Hayashida et al., 2010; Inouye et al., 2007). In the future, 
highly efficient tools that can be employed instantaneously, such as inducible 
RNA aptamers, potent small molecule inhibitors, or the mammalian ‘anchor 
away’ approach, can be used in conjunction with highly sensitive assays to 
decipher the transcriptional role of HSF1 in unstressed cells. 
 
HSF1’s role in cold shock 
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 While much of the temperature-dependent stress is centered on a 
temperature increase, organisms are also exposed to cold environments. 
Seasonal cold acclimation trigger deep phenotypic transfiguration mediated by 
changes in global gene expression patterns and metabolome composition 
(Ragland et al., 2010). Rapid cold hardening (RCH) protects insects from cold 
injuries, which is primarily mediated by signaling cascade and protein 
phosphorylation (Kelty and Lee, 2001; Teets and Denlinger, 2013). Robust 
induction of Hsp genes mediated by HSF activation characterize both cases of 
long-term cold-acclimation and during recovery from cold shocks (Liu et al., 
1994; Štětina et al., 2015). Understanding the mechanism of HSF1 in sensing 
a temperature decrease and the comparison of genome-wide transcriptional 
profiles in heat shock response and cold shock response can decipher the 
basic transcriptional program required for survival during stress. 
 
HSF2 in HSR 
Vertebrates have multiple paralogs of HSF1. HSF2 shares the highest 
degree of sequence homology (Ahn et al., 2001) and structural similarity 
(Jaeger et al., 2016; Neudegger et al., 2016) with HSF1. HSF1 and HSF2 are 
ubiquitously expressed unlike other HSFs (Akerfelt et al., 2010) and they bind 
to identical DNA sequences as homo- or hetero-trimers (Manuel et al., 2002; 
Sandqvist et al., 2009). This apparent redundancy has promoted the 
speculation of HSF2 being an insurance policy in evocation of the HSR. In 
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support of this hypothesis, HSF2 heterotrimerizes with HSF1 during HS and 
binds to the promoter of Hsp70 gene (Ostling et al., 2007). It also binds to the 
promoters of selected HSPs constitutively and modulates their expression 
(Wilkerson et al., 2007). Surprisingly, human HSF2 but not HSF1 
complements the viability defect associated with the deletion of yeast HSF 
gene (Liu et al., 1997), raising the debate whether HSF2 emerged by 
duplication of HSF1 or vice versa. 
On the other hand, HSF2 plays distinct roles from HSF1 in development 
and non-stressed conditions. HSF2 is dispensable for HSPs induction during 
stress response (Jin et al., 2011; Kallio et al., 2002; Wang et al., 2003). A 
constitutive role of HSF2 is implicated in brain development (Kallio et al., 
2002) and fetal alcohol syndrome (Fatimy et al., 2014). HSF2 is also known to 
play a role in diseases – it mitigates prostate cancer invasion (Björk et al., 
2016) and mutations in HSF2 are associated with idiopathic azoospermia 
(Mou et al., 2013; Wilkerson et al., 2008). Proteotoxic stress induced by 
proteasome inhibition reduces the viability of both HSF1-knockout and HSF2-
knockout MEFs but through different underlying mechanisms (Mou et al., 
2013; Wilkerson et al., 2008). 
 The limited role of HSF2 during stress as inferred from a handful of 
studies on a few selected HSPs have defined the current view on HSF2 
function during stress. In order to assess the genome-wide role of HSF2, our 
recent study examined the HSF2-dependent global transcriptional changes in 
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HSF1’s presence or absence (Mahat et al., 2016). The lack of HSF2’s role in 
stress-mediated induction of HSPs was confirmed by direct and quantitative 
measurement of transcription. Besides the complete reliance of HSPs and 
other chaperone assisting factors on HSF1 for their transcription induction 
during stress, the rest of the heat-induced genes were similarly regulated 
irrespective of HSF1, HSF2, or both. However, the pool of downregulated 
genes was significantly smaller in absence of HSF2 (Mahat et al., 2016), 
indicating the role of HSF2 in stress-mediated transcription repression. HSF2 
is known to repress HSR in mitotic cells (Elsing et al., 2014), but the HSF2-
dependent repression in freely cycling cells and the scale of repression was 
not observed before. The lack of HSF2 binding to the promoters of repressed 
genes (only ~4% of the HSF2-dependent repressed genes exhibit detectable 
HSF2 binding) indicate an indirect role of HSF2 in repression (unpublished 
data). One caveat however is that these observations were made using 
knockout cell lines, which could harbor compensatory or secondary effects. In 
order to discern the direct role of HSF2 in repression, instantaneous inhibition 
of HSF2 is required, likely through small molecule drugs or very rapid 
expression of domain-specific RNA aptamers. 
 
HSR and HSF1 in therapeutics 
 Understanding the molecular events that occur immediately after 
exposure of cells to stress can unlock therapeutic potential in protein-folding 
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disorders and cancers. Cancer cells heavily depend on molecular chaperones 
to support imbalance in protein homeostasis (Dai et al., 2007) (Figure 1.4) and 
the increased expression and activity of chaperone machinery is directly 
controlled by HSF1 (Mendillo et al., 2012; Santagata et al., 2011; Scherz-
Shouval et al., 2014). These findings have prompted the use of small molecule 
inhibitor of HSF1 as anti-cancer drug (Salamanca et al., 2014; Whitesell and 
Lindquist, 2009; Yoon et al., 2011). In contrast, neurological disorders such as 
Alzheimer, Parkinson, and Huntington, which are characterized by 
accumulation of protein-aggregates (Figure 1.4), have diminished molecular 
chaperone activity (Neef et al., 2011). Pharmaceutical companies are 
exploring therapeutic approaches to activate HSF1 in order to increase HSPs 
expression and enhance protein refolding (Neef et al., 2010b). This dichotomy 
in the roles of HSF1 in cancer and neurological diseases requires a deeper 
understanding of the precise molecular mechanism of HSF1-driven gene 
regulation before HSF1-based therapeutic tools can be clinically applied. 
Besides cancer and neurological disorders, HSF1 is implicated in aging and 
longevity (Morley and Morimoto, 2004), obesity (Ma et al., 2015), and 
cardiovascular diseases (Locke and Tanguay, 1996). Because of its 
widespread implication in biology and diseases, understanding the molecular 
mechanism of HSF1 function and identifying the genes regulated by HSF1 
under different circumstances are more critical than ever. 
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Figure 1.4. Opposing roles of HSF1 in cancer and neurological disorders 
Cancer cells rely on HSF1 for tumorigenesis, prompting the use of small 
molecule inhibitor of HSF1 in cancer therapeutics. In contrast, Neurological 
disorders are characterized by diminished chaperone activity resulting in 
misfolded proteins, making pharmacological activation of HSF1 a promising 
therapeutics for neurological diseases. Adapted from (Dai et al., 2007; Neef et 
al., 2011). 
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CHAPTER 2a 
 
MAMMALIAN HEAT SHOCK RESPONSE AND MECHANISMS 
UNDERLYING ITS GENOME-WIDE TRANSCRIPTIONAL REGULATION 
 
Summary 
 The heat shock response (HSR) is critical for the survival of all 
organisms. However, it’s scope, extent, and the molecular mechanism of 
regulation is poorly understood. Here we show that the genome-wide 
transcriptional response to heat-shock in mammals is rapid, dynamic, and 
results in induction of several hundred and repression of several thousand 
genes. Heat shock factor 1 (HSF1), ‘the master regulator’ of the HSR, controls 
only a fraction of the heat-shock induced genes, and does so by increasing 
RNA polymerase II (Pol II) release from promoter-proximal pause. The 
pervasive repression of transcription is predominantly HSF1-independent, and 
is mediated through reduction of Pol II pause-release. Moreover, the up- and 
down-regulated genes during HSR exhibit concomitant increase and decrease 
respectively in occupancy of pause-release factor positive transcription 
elongation factor b (P-TEFb). Interestingly, serum response factor (SRF) is 
																																																						
a Partially adapted from Mahat, D. B., Salamanca, H. H., Duarte, F. M., Danko, 
C. G., & Lis, J. T. (2016). Mammalian Heat Shock Response and Mechanisms 
Underlying Its Genome-wide Transcriptional Regulation. Molecular Cell, 62(1), 
63–78. Reprinted with permission from Elsevier. 
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transiently activated during the early phase of HSR, binds promoters of several 
cytoskeletal genes, and transiently induces their transcription in SRF-
dependent manner. Overall, mammalian cells orchestrate rapid, dynamic, and 
extensive changes in transcription upon heat-shock that are largely modulated 
at pause-release, and HSF1 plays a limited and specialized role.  
 
Introduction 
 Organisms have to cope with various kinds of stresses for survival, and 
one of the major repercussions of stress is the disruption of protein 
homeostasis. Without a proper rescue mechanism, accumulation of unfolded 
proteins and failure to properly fold newly synthesized polypeptides result in 
protein aggregates that interfere with cellular functions and ultimately leads to 
apoptosis (Milleron and Bratton, 2006). To protect cells from proteotoxic 
environment caused by heat stress, organisms deploy an evolutionarily 
conserved mechanism known as heat shock response (HSR). Exposure to 
elevated temperature, as well as many other stresses, triggers HSR, which is 
characterized by rapid and robust induction of heat shock protein genes 
(Hsps) (Berendes, 1968). HSPs are molecular chaperones responsible for 
maintaining protein homeostasis and are critical for survival during stress 
(Lindquist and Craig, 1988).  
The HSR is orchestrated at the level of transcription by heat shock 
transcription factor (HSF) (Parker and Topol, 1984; Wu, 1984). Vertebrates 
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have four HSF genes, Hsf1-4. HSF1 is considered the master regulator of the 
HSR and is the ortholog of the sole HSF gene in invertebrates. HSF2 is the 
ubiquitously expressed HSF1 paralog that interplays with HSF1 during HSR 
and is involved in developmental pathways (Akerfelt et al., 2010; Rallu et al., 
1997; Sarge et al., 1991). HSF3 and HSF4 show tissue-restricted expression 
and their roles in HSR remain to be explored (Akerfelt et al., 2010). 
 The current understanding of the mechanisms of transcription 
regulation during heat shock (HS) comes largely from in vitro and in vivo 
studies of the Hsp70 gene in invertebrates (Morimoto, 1998). HSF1 is 
constitutively expressed as an inactive monomer and upon HS, HSF1 
becomes active, trimerizes, (Westwood et al., 1991) and binds to the inverted 
repeats of nGAAn pentamers known as heat shock element (HSE) in the 
promoter of the Hsp70 (Perisic et al., 1989; Sorger et al., 1987; Westwood et 
al., 1991). Thereupon, HSF1 recruits co-factors that dramatically increases the 
transcription of Hsp70 (Anckar and Sistonen, 2011).  
In addition to the induction of Hsps, HSF1 is implicated in various 
aspects of human physiology (Anckar and Sistonen, 2011). HSF1 plays an 
important role in aging and longevity (Morley and Morimoto, 2004; Murshid et 
al., 2013), protects organisms from obesity by regulating energy expenditure 
(Ma et al., 2015), and reduces susceptibility to stress in elderly hearts (Locke 
and Tanguay, 1996). More importantly, cancer cells co-opt HSF1 to support 
malignancy (Dai et al., 2007; Mendillo et al., 2012; Salamanca et al., 2014), 
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making its reduction in level or activity a potentially better target for cancer 
therapy than the several small inhibitory molecules against HSPs that are in 
ongoing clinical trials (Whitesell and Lindquist, 2009). In contrast, enhanced 
chaperone expression through clinical activation of HSF1 can improve 
prognosis of age-related neurodegenerative disorders that are caused by 
protein aggregates (Neef et al., 2011; 2010). This dichotomy in the role of 
HSF1 in cancer and neurological diseases requires a deeper understanding of 
the precise molecular mechanism of HSF1 driven gene regulation before 
clinical application of HSF1-based therapeutic tools. 
Understanding networks of genes and cellular processes that are 
regulated during HSR is equally important to decipher how healthy cells 
survive acute stress and maintain proteostasis. Earlier genome-wide studies 
using microarray and RNA-sequencing indicated that additional genes besides 
Hsps are regulated during the HSR (Brown et al., 2014; Inouye et al., 2003; 
Page et al., 2006; Trinklein et al., 2004). These assays measure the 
cumulative effects of both transcriptional and post-transcriptional regulation, as 
they probe stable mRNA and lack the temporal resolution to reveal the first-
order regulatory mechanisms of transcription. Transcription regulation consists 
of several steps any one of which might regulate gene expression, including 
Pol II recruitment, assembly of the initiation complex, promoter-proximal 
pausing and release from the pause, and Pol II elongation rates (Fuda et al., 
2009). After more than 50 years since the discovery of HSR (Ritossa, 1962), 
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the breadth of transcriptional regulation during HSR, the precise step(s) 
modulated, and the kinetics and dynamics of the regulation remain to be fully 
understood.  
 In this study, we examined the HSR at transcriptional level - a primary 
and major point of regulation. To identify genome-wide changes in 
transcription, we used precision nuclear run-on sequencing (PRO-seq) (Kwak 
et al., 2013) - an assay that maps transcriptionally engaged Pol II at a 
nucleotide resolution by nascent RNA sequencing. We paired PRO-seq 
measurements in mouse embryonic fibroblasts (MEFs) derived from HSF1 
knockout (Hsf1-/-) mouse and its wild type (WT) littermate (McMillan et al., 
1998) with HSF1-bound chromatin immunoprecipitation sequencing (ChIP-
seq) to identify the genome-wide targets of HSF1 and its role in HSR. A time 
course of PRO-seq and HSF1 ChIP-seq prior to HS and immediately after HS 
extending up to an hour allowed us to observe the primary and secondary 
effects of heat-stress in transcription and decipher the roles of HSF1. We find 
HSF1 to be critical for induction of Hsps, other chaperones, and over 200 
additional genes; however, the transcriptional changes during HSR are 
remarkably extensive and the majority of these changes are HSF1-
independent. We identify different regulated classes of genes based on 
kinetics and dynamics of transcriptional regulation. We also decipher the 
mechanistic step in transcription where HSF1 exerts its regulation, as well as 
the mechanism of global repression. Together, these comprehensive and 
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highly sensitive analyses indicate that HSR is much more elaborate than 
previously understood, and regulators in addition to HSF1 are mobilized.  
 
Materials and methods 
Cell lines 
 Immortalized MEFs generated from Hsf1-/- and its wild type littermate 
mice (McMillan et al., 1998) were a gift from Ivor Benjamin. Hsf1&2-/- MEFs 
were generated by Christians ES and Le Dréan Y by crossing Hsf1-/- mouse 
and Hsf2-/- mice and the cells were immortalized by Valerie Mezger (Lecomte 
et al., 2010; 2013; McMillan et al., 1998; 2002). 
 
Cell culture, heat shock, and nuclei isolation 
 MEFs were grown in 150mm TC-treated and gamma irradiated cell 
culture dish in Dulbecco's Modified Eagle Medium supplemented with 10% 
heat inactivated fetal bovine serum (v/v) and 1% Penicillin Streptomycin (v/v) 
at 370C with 5% CO2 and 90% humidity.  
 Instantaneous HS was performed using ~80% confluent cells by adding 
pre-heated (420C) conditioned media collected from identically growing cells 
and by incubating the cell plates at 420C for the desired time. Heated media 
was used to ensure instantaneous HS as it takes more than 2.5 minutes for 
370C cell culture plates to reach 420C in 420C incubator. Also, use of 
conditioned media from another plate of same cells grown identically avoids 
		
	
	
60	
complications that could result from the use of fresh media that contains fresh 
serum and higher glucose concentration.  
 After the desired duration of HS, NHS cells grown at 370C and the heat 
shocked cells were harvested identically. Nuclei were isolated as described 
previously with minor modifications (Core et al., 2008). Cells were rinsed once 
with ice-cold PBS and incubated in cell membrane lysis buffer (10mM Tris-Cl 
pH 8.0, 300mM sucrose, 3mM CaCl2, 2mM MgAC2, 0.1% TritonX-100, 0.5mM 
DTT) for five minutes. After incubation, cells were dounced 25 times using a 
dounce homogenizer (wheaton # 357546, loose pestle with 114nm clearance) 
and nuclei were harvested by centrifugation at 1000g for 5 mins. The isolated 
nuclei were washed twice in lysis buffer and resuspended in storage buffer (10 
mM Tris-HCl pH 8.0, 25% glycerol, 5 mM MgAc2, 0.1 mM EDTA, 5 mM DTT). 
 
Nuclear run-on and PRO-seq library preparation 
 Nuclear run-on experiments were carried out as described previously 
with some modifications (Kwak et al., 2013). Briefly, 10 × 106 nuclei in 100µl of 
storage buffer were mixed with 100µl of 2x nuclear run-on buffer (10 mM Tris-
HCl pH 8.0, 5 mM MgCl2, 1 mM DTT, 300 mM KCl, 1% Sarkosyl, 50 uM biotin-
11-A/C/G/UTP, 0.2 units/µl RNase inhibitor) and incubated at 370C for three 
minutes. RNAs were isolated and base-hydrolyzed with 200 nM final 
concentration of NaOH to an average size between 100-150 nucleotides. 
Nascent RNAs were isolated with magnetic beads coated with streptavidin 
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followed by 3’ adapter ligation. After another round of biotin-streptavidin affinity 
purification, the mRNA cap was removed and the 5’ adapter was ligated. After 
the third biotin-streptavidin affinity purification, cDNA was generated by 
reverse transcription and PRO-seq libraries were prepared for sequencing 
using Illumina TruSeq small-RNA adaptors with nine cycles of PCR. 
 
Mapping of PRO-seq sequencing reads 
 Adapters from PRO-seq reads were clipped using cutadapt (Marcel, 
2011). Remaining reads were trimmed to a maximum length of either 30, 32, 
34, or 36bp. We found that 36bp reads result in the highest fraction mapping 
to the genome, and thus, the clipped reads were trimmed to 36bp for all 
downstream analysis. The filtered reads (>15bp and up to 36bp) were first 
mapped to a single copy of ribosomal DNA (45,309 bp long, TPA Accession 
No. BK0000964) to remove the contribution of nascent RNAs from ribosomal 
genes. The remaining reads were mapped to the mouse genome mm10 
(released on December 2011) using bowtie (Langmead et al., 2009) and were 
required to uniquely map to the genome allowing up to 2 mismatches. 
 
Normalization of PRO-seq libraries and validation of normalization 
 To account for the possibility of global change in transcription upon HS, 
we pursued different strategies to normalize data sets that are not based on 
using total reads. We tested the possibility of using histone genes and 
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ribosomal genes, but we found that transcription of many of these genes 
changes during HS. Ultimately, we discovered that the use of PRO-seq reads 
in the 3’end of long genes, where the advancing or receding wave of new 
pause-escaped Pol II upon HS would have not reached, is a robust, sensitive, 
and reliable strategy for normalization. This strategy also normalizes for all 
possible variations in sample handling and PRO-seq library preparation. 
 We selected 288 genes that are longer than 400kb for normalization 
(Figure 2.2C). Genes were further required to have at least 10x higher 
transcription than background regions, which are long gene-desert regions in 
different chromosomes, to avoid the inclusion of very lowly expressed genes in 
normalization. We reasoned that Pol II wave would not reach beyond 360 kb 
by 60 minutes of HS even at an exceptionally high rate of transcription 
(6kb/min). Thus, PRO-seq reads from 370kb downstream from the TSS to 
10kb upstream of PAS were used for normalization. This novel approach to 
normalization was validated in three independent ways:  
1. After normalization of libraries at all time points, we compared the change 
in PRO-seq density in the 5’ and 3’ end of significantly changed genes at 
12’HS that are longer than 96 kb. At this earlier time point, the changes in 
Pol II distribution does not progress as far as in the 60’HS time point, 
allowing us to examine more genes and also exclude genes that were used 
for normalization. The 5’ end (1 kb downstream of TSS up to 25 kb = 24 
kb) region of the genes showed expected change in PRO-seq density, and 
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the 3’ end (72 kb downstream of TSS to 96 kb = 24 kb, and as before, the 
rationale for avoiding the first 72 kb region is to avoid the newly released 
Pol II wave that could be present in this region - 12 minutes * very-high 
elongation rate of 6 kb/min = 72 kb) showed no change suggesting the 
normalization approach did not create any bias (Figure 2.2E). 
2. We further used 52 genes that were identified as unchanged upon HS in 
MEFs out of 437 genes that were tested using an independent microarray 
experiment (Trinklein et al., 2004). Expression level of these genes after 
normalization was unbiased across the HS time course. 
3. Finally, we examined the transcription level of 339 housekeeping genes not 
regulated following HS (la Grange et al., 2005) and found their normalized 
Pol II densities were unbiased across the HS time course. 
 Together, these analyses confirm that the normalization process was 
not biased and can be reliably used in PRO-seq time-course experiments in 
the future. 
 
Differential expression analysis 
 DESeq2 (Love et al., 2014) was used to identify genes with differential 
PRO-seq density between NHS and HS libraries. In order to only consider the 
regions that likely have change in PRO-seq density, we used the window from 
1 kb downstream of TSS up to 24 kb downstream of TSS or 1 kb upstream of 
PAS, whichever was shorter. The beginning of this 24 kb region started from 1 
		
	
	
64	
kb downstream of TSS in order to avoid the promoter-proximal paused Pol II, 
which is mostly in the first 100 bp but could appear to be further downstream 
due to some improperly annotated TSS. The 24 kb region was selected to 
ensure that Pol II had enough time to spread across most of the changed 
region at the conservative elongation rate of 2kb/min (Danko et al., 2013; 
Jonkers et al., 2014) * 12min = 24kb. To identify significantly changed genes at 
2.5’HS, PRO-seq density from 500 bp downstream of TSS up to 5 kb 
downstream of TSS or 1 kb upstream of PAS, whichever was shorter, was 
used. For a gene to be called significantly changed between NHS and HS 
conditions, we set the PRO-seq density fold change threshold at 1.25 and 
DESeq2 p-value threshold at 0.001. Because of the DESeq2 threshold, we 
were unable to assign the mode of regulation to some genes. For example, in 
Figure 2F, 13% of the genes (100 - 17 - 53 - 4 - 13 = 13) bound by HSF1 in 
promoter are unaccounted because these genes did not meet the statistical 
threshold set by the differential expression analysis package. 
 
Removing potential false positives  
 By visual inspection of genes in the genome browser, we discovered 
some genes that could be falsely identified to have differential PRO-seq 
density between NHS and HS conditions (Figure 2.3A). These false positives 
result from either run-over transcription from upstream genes (for example, 
Abca6 could be called by DESeq2 to have increase in PRO-seq density at 
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60’HS compared to NHS when, in fact, this was the result of run-over 
transcription from the upstream gene Abca5), or intronic enhancers and 
internal TSSs (Tmem88b is not expressed which is evident by the lack of 
PRO-seq signal at the TSS of the gene but has an internal TSS or intronic 
enhancer evident by divergent transcription and the PRO-seq reads in the 
anti-sense direction of this region is being counted as the gene body PRO-seq 
reads of Tmem88b). These false positive genes are on the range of 18% of all 
sampled genes. To filter these genes, we used discriminative Regulatory 
Element detection from GRO-seq (dREG), a machine learning method that 
uses support vector regression to identify active transcriptional regulatory 
elements (Danko et al., 2015). To be considered for downstream analysis, we 
required the genes that have differential PRO-seq density in their gene body 
according to DESeq2 to have a dREG peak in their TSS. This approach very 
effectively filtered genes that could be falsely identified as being differentially 
regulated upon HS. 
 
Western immunoblotting 
 Serial dilution of whole cell protein extract (20, 10, and 5 μg) from WT 
and Hsf1-/- MEFs was subjected to SDS-PAGE and transferred to 
nitrocellulose membrane. After blocking the membrane for 1 hour in 5% (w/v) 
bovine serum albumin (BSA), the membrane was probed with rabbit anti-HSF1 
antibody (Cell Signaling #4356) and mouse anti-actin (Millipore #MAB1501) 
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overnight according to the manufacturer’s instructions. Incubation with primary 
antibodies was followed by incubation in corresponding secondary antibodies 
(anti-rabbit conjugated to IRDye 800CW and anti-mouse conjugated to IRDye 
680RD) for one hour and imaged in LI-COR Odyssey® CLx imaging system. 
 
RNA-seq data and analysis 
 RNA-seq data in mouse 3T3 cells before and after HS that is used in 
Figures 2.3C and 2.3D was downloaded from NCBI Sequence Read Archive 
(accession number SRP035393). Sequences were aligned to the mouse 
genome using Tophat2 (Kim et al., 2013) and the mapped reads in each gene 
were quantified using HTSeq (Anders et al., 2015).  
 
HSF1 and SRF ChIP-seq library preparation 
 ChIP was performed as described previously with some modifications 
(Guertin and Lis, 2010). 2.4 x 107 cells for each IP were cross-linked using 2% 
paraformaldehyde for five minutes at room temperature. The cross-linking 
reaction was quenched with 250 mM Glycine and the cell membrane lysed 
using Farnham lysis buffer (5mM PIPES pH 8.0, 85mM KCl, 0.5% NP-40, 1 
tablet/50ml Protease Inhibitor). Nuclei were pelleted by centrifugation and 
incubated in RIPA buffer (1x PBS, 1% NP-40, 0.5% Sodium Deoxycholate, 
0.1% SDS, 1 tablet/50ml Protease Inhibitor) for 20 minutes and sonicated for 
45 minutes in the highest setting in a Bioruptor® (15s ON 30 sec OFF). 
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Primary antibodies (first HSF1 antibody (Ab1) from Cell Signaling #4356, 
second HSF1 antibody (Ab2) gift from Richard Morimoto Lab, and SRF 
antibody from Cell Signaling #5147) conjugated to magnetic beads were used 
to immunoprecipitate chromatin fragments and washed five times with Lithium 
Chloride (LiCl) wash buffer (100mM Tris pH 7.5, 500mM LiCl, 1% NP-40, 1% 
DOC). Samples were incubated overnight at 650C using elution buffer (1% 
SDS and 100mM NaHCO3) to reverse crosslinks. 
 The ends of purified DNA were repaired and dATP was ligated to the 3’ 
ends. Illumina TRUseq DNA adapters with dTTP overhang were ligated on 
both ends of the DNA and ChIP-seq libraries, and were PCR amplified for five 
initial cycles. The libraries were gel purified to remove adapter dimers and 
further PCR amplified for an additional four cycles. 
 
ChIP-seq peak calling and combining p-values of overlapping HSF1 
peaks from two different antibodies 
 HSF1 peaks in ChIP-seq libraries prepared with two HSF1 antibodies 
were called against library prepared with non-specific IgG using MACS (Zhang 
et al., 2008). In order to minimize the false positive peaks, we only considered 
HSF1 peaks that were identified with both antibodies at a threshold of 1e-03. 
We then combined the two p-values of a peak from two antibodies using 
Fisher method for combining two p-values for effects in the same direction 
([Fisher, 1958] Fisher, R. A. (1958). Statistical Methods for Research Workers, 
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13th Edition. Hafner Publishing). We selected HSF1 peaks that passed a 
combined p-value threshold of 1.0e-08, which is equivalent to two individual p-
values of 1e-05 (default p-value used by MACS). We further removed HSF1 
peaks that were present in Hsf1-/- MEFs as we assumed that peaks identified 
in Hsf1-/- ChIP-seq libraries were false positives. 
 
HSE motif 
 Empirically identified position weight matrix of HSE from HSF1 ChIP-
seq peaks was scanned over the entire mouse genome using FIMO from the 
MEME suite (Grant et al., 2011). Motifs that have p-values less than 1e-05 were 
used to score the presence of HSE in the genome. 
 
GO analysis 
 Molecular functions and biological processes enriched in HS regulated 
genes were identified using DAVID (the database for annotation, visualization 
and integrated discovery) (Huang et al., 2009). Highly enriched and non-
redundant GO terms from the PANTHER database were selected using the 
option provided in DAVID. 
 
Enrichment of TF binding motifs 
 Position weight matrices corresponding to known TFs curated from 
several repositories (Jolma et al., 2013; Mathelier et al., 2014; Neph et al., 
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2012; Trinklein et al., 2004; Weirauch et al., 2014) were first clustered based 
on DNA sequence recognition site similarity and scanned in the promoters of 
regulated genes using the RTFBSDB package (Kwak et al., 2013). The p-
value was calculated against the 3rd order Markov model background 
constructed from all active promoters in MEFs. 
 
ENCODE and non-ENCODE genomic data 
 ChIP-seq data for histone modifications and Pol II ser5P were 
downloaded from GEO. H3K4me1, H3K4me3, and H3k27ac were generated 
by ENCODE (ENCODE Project Consortium, 2012), H3K9me3 and H3K79me2 
were generated by the Richard Young lab and Pol II ser5P by Lee JT lab. 
 
Measurement of elongating Pol II wave 
 The Pol II wave was identified in upregulated genes at 2.5’HS and 
12’HS, and also in downregulated genes at 12’HS and 60’HS. A three-state 
hidden Markov model, with states representing the 5’ upstream region, the Pol 
II wave, and the 3’ end of the gene, were used to identify the start and end of 
the PRO-seq waves (Danko et al., 2013). Differences in PRO-seq read counts 
in 50bp windows between NHS and HS time points in upregulated genes at 
2.5’HS and 12’HS were used as input for HMM (Figures 3E-H), whereas 2 kb 
windows were used for downregulated genes at 12’HS and 60’HS (Figure 
S4G). 
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Results 
HS triggers rapid, robust, and diverse changes in transcription  
 To characterize the global changes in transcription associated with 
HSR and to understand the role of HSF1, we performed genome-wide PRO-
seq assays on WT and Hsf1-/- MEFs.  We prepared two biological replicates of 
PRO-seq libraries at 370C (NHS) and 2.5, 12, and 60 minutes after an 
instantaneous HS at 420C (Figure 2.1A). The libraries were sequenced to high  
depth (Table 2.1) and mapped to the mouse genome (mm10). The biological 
replicates correlated well (Figure 2.1B and Table 2.2), and as expected, the 
Hsf1-/- MEFs produced no HSF1 protein (Figure 2.1C), nor any PRO-seq reads 
in the deleted region of the Hsf1 gene (Figure 2.1D). 
 Normalization of genomic libraries by conventional methods such as 
total mapped reads or ribosomal RNA reads are inadequate when dealing with 
significant changes in total transcription. Therefore, we devised a novel 
approach for normalizing the PRO-seq libraries using PRO-seq reads from the 
3’ end of very long genes (>400 kb), the regions beyond the advancing or 
receding wave of Pol II even at the longest HS time point (60’HS) (Figures 
2.1E and 2.1F). This normalization approach was validated using three 
different tests. First, the PRO-seq density after normalization in the 3’ ends of 
significantly upregulated and downregulated genes after a 12’HS is 
unchanged, while the 5’ ends show expected change (Figures 2.2A – note this 
includes a larger collection of genes than used for the normalization and the 
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Figure 2.1. A novel and reliable normalization approach for PRO-seq 
 (A) Experimental set-up, PRO-seq assay was performed in nuclei isolated 
from WT and Hsf1-/- MEFs at NHS, 2.5’HS, 12’HS, and 60’HS. 
(B) A representative spearman correlation plot between the biological 
replicates of PRO-seq libraries in the pause region (left) and the gene-body 
region. Color of hex-bins represents the number of reads in each bin. 
Complete table of Pearson and Spearman correlation values are listed in 
Table 2.2. 
(C) Quantitative Western Blot analysis of HSF1 in WT and Hsf1-/- MEFs. Actin 
is used as the loading control.  
(D) Genome browser screenshot of Hsf1 gene. The 2 kb region devoid of 
PRO-seq reads (green box) represents half of the DNA binding domain and 
trimerization domain excised to create Hsf1-/- MEFs. 
(E) Graphical representation of the genes used for normalization of PRO-seq 
libraries. A region that is at least 20 kb covering an interval from 370 kb 
downstream of TSS to 10 kb upstream from PAS in the 3’ end of genes longer 
than 400 kb is used for normalization. 
(F) Screenshot of two long genes used for normalization. Zfpm2 is upregulated 
and Exoc6b is downregulated at 60’HS, which is evident by increase and 
decrease in PRO-seq density in the 5’end of genes respectively. The green 
box represents the 3’ end region of the genes used for normalization. 
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Figure 2.2. Validation of normalization and use of dREG to minimize 
potential false positives 
(A) PRO-seq density in the 5’ end (region 1 kb downstream of TSS up to 25 
kb) and the 3’ end (24 kb region after the first 72 kb) of the upregulated genes 
(left) and downregulated genes (right) at 12’HS. Genes used in this analysis 
does not include genes used for normalization and are longer than 96 kb. 
(B) Correlation of normalized PRO-seq density before and after HS in genes 
not bound by HSF1 as measured by ChIP-chip and not induced upon HS as 
measured by microarray (n=52) after HS (Trinklein et al., 2004). The red line 
represents the linear fit of all data points. A complete list of spearman 
correlation values for these genes between NHS and HS in WT and Hsf1-/- 
MEFs are listed in Table 2.3. 
(C) Correlation of normalized PRO-seq density before and after HS in house-
keeping genes (n=339). The red line represents the linear fit of all data points. 
A complete list of spearman correlation values for these genes between NHS 
and HS in WT and Hsf1-/- MEFs are listed in Table 2.3. 
(D) Fraction of genes that are true positive and have clean transcription units 
with dREG peak overlapping the TSS region of the genes, run-over 
transcription from the upstream genes, and the genes with internal TSS or 
intronic enhancer. For instance, Abca6 is a result of run-over transcription from 
upstream Abca5 gene in the same strand. This gene would be called 
significantly upregulated in 60’HS compared to NHS. Similarly, Tmem88b has 
an internal TSS or intronic enhancer that contributes to gene-body PRO-seq 
density and would also be called significantly downregulated at 12’HS 
compared to NHS. 
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Table 2.1. Sequencing depth and alignment statistics of PRO-seq in WT 
and Hsf1-/- MEFs. Significant fraction of reads were not uniquely mapped to 
the genome because of the deliberate inclusion of short fragments in the final 
library for sequencing in order to optimize the detection of promoter-proximal 
paused Pol II. Libraries were sequenced in Illumina HiSeq-2000. 
 
Library Sequenced 
Ribo-
somal 
(%) 
Un-
aligned 
(%) 
Non-
unique 
(%) 
Aligned 
(mm10) 
WT_NHS_BR1 116,597,845 11.80 21.48 16.22 21,942,702 
WT_NHS_BR2 74,543,714 9.92 36.19 13.81 14,069,970 
WT_2.5’HS_BR1 124,769,718 14.33 7.06 21.53 16,889,583 
WT_2.5’HS_BR2 113,241,306 14.26 6.74 20.79 13,776,348 
WT_12’HS_BR1 154,121,332 19.25 8.69 19.26 23,254,910 
WT_12’HS_BR2 87,985,404 19.57 16.72 24.32 17,678,637 
WT_60’HS_BR1 153,916,793 6.61 20.11 23.39 30,211,715 
WT_60’HS_BR2 17,742,544 6.77 37.62 23.79 4,222,282 
      
Hsf1-/-_NHS_BR1 71,252,588 18.66 11.52 14.43 33,556,982 
Hsf1-/-_NHS_BR2 65,940,822 20.25 11.05 15.81 30,059,980 
Hsf1-/-_2.5’HS_BR1 37,020,268 13.57 4.16 26.76 6,442,517 
Hsf1-/-_2.5’HS_BR2 39,429,009 10.66 3.69 47.85 5,979,212 
Hsf1-/-_12’HS_BR1 55,063,106 20.03 7.44 20.26 18,035,093 
Hsf1-/-_12’HS_BR2 90,945,600 17.87 7.30 20.48 26,820,803 
Hsf1-/-_60’HS_BR1 28,318,086 9.13 5.74 23.60 11,497,974 
Hsf1-/-_60’HS_BR2 60,676,032 9.57 7.01 23.24 23,054,099 
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Table 2.2. PRO-seq biological replicates are highly correlated. PRO-seq 
reads for each gene were correlated for promoter region (100bp region in the 
5’ end of the genes) and gene body region (500 bp downstream of TSS to 
polyA site). 
 
 Pearson Correlation Spearman correlation 
 Promoter Gene body Promoter Gene body 
WT_NHS 0.93 0.99 0.97 0.97 
WT_2.5’HS 0.99 0.99 0.98 0.97 
WT_12’HS 0.96 0.99 0.97 0.97 
WT_60’HS 0.94 0.99 0.95 0.94 
     
Hsf1-/-_NHS 0.99 0.99 0.98 0.97 
Hsf1-/-_2.5’HS 0.91 0.99 0.97 0.97 
Hsf1-/-_12’HS 0.99 0.99 0.98 0.97 
Hsf1-/-_60’HS 0.99 0.99 0.97 0.96 
 
 
Table 2.3. Normalization of PRO-seq libraries using PRO-seq reads in the 
3’end of long genes show expected results. Spearman correlation for 
previously identified genes as not bound by HSF1 and not changed upon HS 
in microarray study from Richard Myers lab (Trinklein et al., 2004) (top), and 
housekeeping genes from previously published study (la Grange et al., 2005) 
(bottom) show absence of systematic bias in normalization scheme used in 
this study. We would expect to see a systematic bias if the normalization 
method was non-optimal. 
 
 2.5’HS vs NHS 12’HS vs NHS 60’HS vs NHS 
WT  0.97 0.97 0.72 
Hsf1-/- 0.96 0.96 0.84 
 
 2.5’HS vs NHS 12’HS vs NHS 60’HS vs NHS 
WT  0.97 0.97 0.81 
Hsf1-/- 0.96 0.96 0.84 
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genes used for normalization are excluded in this test). Second, a set of genes 
identified as unaffected during HSR in MEFs using microarrays (Trinklein et 
al., 2004) showed no changes in PRO-seq density between NHS and HS 
conditions after normalization (Figure 2.2B & Table 2.3). Third, a previously 
defined group of house-keeping genes (la Grange et al., 2005) also showed no 
systematic deviation between HS and NHS conditions (Figure 2.2C & Table 
2.3). After normalization, genes that could be falsely detected in differential 
expression analysis due to a) transcription running past the 3’ end of upstream 
genes and b) internal TSS or intronic enhancers were eliminated using dREG 
(Danko et al., 2015) (Figure 2.2D) (see methods). 
 To characterize the transcriptome regulated during HS, we used 
DESeq2 (Love et al., 2014) to identify differential PRO-seq density in the body 
of genes before and after HS. A substantial fraction of the transcriptome 
changes upon HS, and the number of genes and the level of change 
progressively increase with time (Figures 2.3A and 2.3B). Moreover, the 
kinetics and dynamics of change is remarkably diverse (Figure 2.3C). First, 
many Hsps are robustly and persistently induced in an HSF1-dependent 
manner (such as Hsph1 with ~ 60 fold induction). Second, many genes are 
immediately and transiently induced (like Vcl) where the advancing wave of 
newly transcribing Pol II is particularly noticeable, and this induction is 
independent of HSF1. Third, many genes show late induction (such as Ptprm), 
some of which could be targets of late-activated HSF1 or transcription factors 
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Figure 2.3. HS induces rapid, dynamic, and extensive changes in 
transcription in a mostly HSF1-independent manner 
(A) 'Minus-average' (MA) plots represent PRO-seq density change in the 
gene-body of all genes (n=23460) between NHS and 2.5’HS (left panel), 
12’HS (mid panel), and 60’HS (right panel) in WT MEFs. Significantly 
upregulated genes (p-value < 0.001 in DESeq2) are shown in gold and 
significantly downregulated genes are shown in blue. 
(B) MA plots represent PRO-seq density change in the gene-body of all genes 
(n=23460) between NHS and 2.5’HS (left panel), 12’HS (mid panel), and 
60’HS (right panel) in Hsf1-/- MEFs. Significantly upregulated genes are shown 
in gold and significantly downregulated genes are shown in blue. 
(C) Screenshots of four genes with different kinetics and dynamics of 
regulation. PRO-seq density in sense and antisense direction is shown in red 
and blue respectively. Small vertical black bars at the bottom of PRO-seq 
tracks represent the genomic regions that do not map uniquely at 36bp 
resolution. 
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(TFs) induced early during HS, and the majority of these are independent of 
HSF1. Fourth, a large fraction of the expressed genes (like Kif14) are 
significantly downregulated, and all or nearly all are independent of HSF1. 
Overall, DESeq2 identifies significant upregulation of 10% and downregulation 
of 55% of all active genes (Figure 2.4A). For the majority of these genes, the 
change in transcription measured by PRO-seq is recapitulated at the mRNA 
level measured by RNA-seq (Shalgi et al., 2014), despite the fundamental 
difference between the two assays and the additional regulation of mRNA 
stability being a part of RNA-seq measurement (Figure 2.4B). Fold change in 
RNA-seq requires higher change in transcription than required for PRO-seq 
due to the higher level of steady-state mRNA level compared to the nascent 
transcription in a cell, which is reflected here by the lower magnitude of 
change in RNA-seq than in PRO-seq for the HS regulated genes (Figures 2.4B 
and 2.4C). Thus, our results indicate that the RNA regulation in response to 
HS is manifested directly at the level of transcription and consists of multiple 
distinct regulatory programs that are captured here with high spatiotemporal 
resolution and sensitivity afforded by the PRO-seq assay.    
 
Majority of the HS-regulated genes are HSF1-independent 
 In addition to the unexpectedly higher number of changed genes, the 
similar numbers of regulated genes in WT and Hsf1-/- MEFs (Figure 2.4A) and 
the extent of their overlap are uncanny (Figures 2.4D). The overlap reported  
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Figure 2.4. Majority of the HS-regulated genes are HSF1-independent 
(A) Number of significantly changed genes upon HS. Upregulated genes are 
shown in gold and downregulated genes are shown in blue. 
(B) Comparison of PRO-seq density fold change and RNA-seq fold change in 
genes that are significantly upregulated (left) and downregulated (right) at 
12’HS and 60’HS by PRO-seq measurement. 
(C) Screenshot of Hsph1 gene showing the PRO-seq and RNA-seq reads. The 
scale on y-axis is shown in the top left corner. 
(D) Venn diagram of significantly upregulated and downregulated genes 
between WT and Hsf1-/- MEFs. 
(E) PRO-seq density fold change in WT and Hsf1-/- MEFs at 60’HS in genes 
that are called significantly upregulated only in WT 60’HS (left) and only in 
Hsf1-/- 60’HS (right) by DESeq2.  
(F) GO analysis of the three classes of genes upregulated at 60’HS. The GO 
terms in each gene class are further categorized into three groups of biological 
processes, molecular functions, and signaling pathways. The length of the bar 
(x-axis) denotes the p-value. 
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here in upregulated genes is likely an underestimation as many of the uniquely 
upregulated genes in WT MEFs are upregulated in Hsf1-/- MEFs and vice 
versa, but don’t meet the DESeq2 threshold. For example, 21% of the 465 
genes identified by DESeq2 as upregulated only in WT 60’HS also show 
upregulation in Hsf1-/- (Figure 2.4E), and similarly, 22% of the 232 genes 
identified by DESeq2 as upregulated only in Hsf1-/- 60’HS are also upregulated 
in WT, but they don’t meet the statistical threshold of DESeq2. Compared to 
the upregulated genes, the downregulated genes show even more overlap 
between WT and Hsf1-/- MEFs indicating that transcriptional repression occurs 
by mechanisms that are largely HSF1-independent. 
 To examine the biological functions related to the genes that are 
differentially expressed in WT and Hsf1-/- MEFs, we performed gene ontology 
(GO) analysis using DAVID (Huang et al., 2009). As expected, genes 
upregulated only in WT MEFs are enriched for chaperones involved in protein 
folding and stress response (Figure 2.4F). Genes upregulated only in Hsf1-/- 
MEFs are enriched for ATPase and protein kinases. Genes that are 
upregulated in both cell types, which is a significant fraction of the upregulated 
genes, are enriched for transcription factors (TFs) and protein kinases 
involved in developmental processes. Overall, more than 87% of genes 
regulated at 60’HS in WT are similarly regulated in Hsf1-/- MEFs, and these 
observations suggest that alternative HSF1-independent mechanisms mediate 
widespread changes in transcription upon HS. 
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HSF1 binds to the promoters of a small fraction of HS-induced genes 
 Despite being called the master regulator of HSR, the majority of HS 
regulated genes appear to be HSF1-independent (Figures 2.4A & 2.4D). 
Therefore, to understand the role of HSF1 binding during HSR, we performed 
HSF1 ChIP-seq in WT and Hsf1-/- MEFs at NHS, 12’HS, and 60’HS (Figure 
2.5A). We optimized various parameters like sonication (Figure 2.5B), 
crosslinkers and cross-linking duration (Figure 2.5C), and antibody 
concentrations (Figure 2.5D). To minimize false-positive peaks in ChIP-seq 
(Bailey et al., 2013; Chen et al., 2012; Pickrell et al., 2011), we used two 
different antibodies for ChIP that recognize different parts of HSF1 and 
prepared two biological replicates of ChIP-seq libraries for each antibody. As 
negative controls, we made ChIP-seq libraries from Input DNA, chromatin 
immuno-precipitated with non-specific antibody (IgG) in WT MEFs, and 
chromatin immuno-precipitated with both HSF1 antibodies in Hsf1-/- MEFs 
(Table 2.4). Biological replicates correlated well (Figure 2.5E) and were 
combined, and ChIP-seq peaks were called using MACS (Zhang et al., 2008).  
 As expected, we find prominent HSF1 peaks in the promoters of 
classical Hsps, and the two antibodies generated similar ChIP-seq profile 
(Figure 2.6A). HSF1 peaks identified here are highly specific, 89% of the HSF1 
bound sites contain canonical HSE (p-value < 0.00001) (Figures 2.6B and 
2.6C), and the fold enrichment of HSF1 correlates with the motif match score  
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Figure 2.5. Optimization of various parameters for HSF1 ChIP-seq 
(A) Experimental set-up, ChIP-seq libraries in WT MEFs were made in 
duplicates with Input DNA, chromatin immunoprecipitated with non-specific 
IgG and two different HSF1 specific antibodies – Ab1 and Ab2 - at NHS, 
12’HS, and 60’HS. Additionally, ChIP-seq libraries were also made with both 
HSF1 specific antibodies in Hsf1-/- MEFs. 
(B) Distribution of DNA fragments size as a function of sonication time. 
Sonicated DNA was ran in agarose gel (left) and also assessed by automated 
sizing and quantitation using Agilent bioanalyzer kit (right). 
(C) HSF1 ChIP-qPCR at Hsph1 (positive) and Hbb (negative) gene before and 
after HS in order to test the efficiency of two crosslinking reagents 
(paraformaldehyde - PFA and formaldehyde - FA) and crosslinking time. Y-
axis represents percentage input and standard deviation is calculated from 
three independent experiments. 
(D) HSF1 ChIP-qPCR at Hsph1 (positive) and Hbb (negative) gene before and 
after HS in order to optimize different amounts of antibody for optimal result in 
ChIP-seq experiment. Y-axis represents percentage input and standard 
deviation is calculated from three experiments. 
(E) Correlation of the intensity of overlapping HSF1 peaks between two 
biological replicates in WT 60’HS for Ab1 (left) and Ab2 (right). 
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Figure 2.6. Use of two HSF1 antibodies yield high-quality ChIP-seq 
libraries 
(A) Screenshot of Hsph1 gene shows ChIP-seq read density in WT and Hsf1-/- 
MEFs. The scale on the y-axis represents the number of ChIP-seq tags under 
the peaks. 
(B) Sequence logo of the most represented motif in HSF1 peaks identified by 
de novo motif search using MEME. 
(C) Barplot showing the fraction of all HSF1 peaks that contains highly 
significant HSE (p < 0.00001) in the DNA sequence occupied by the peaks. 
Actual number of peaks in each case is shown on top. 
(D) Fold enrichment of HSF1 peaks in the four quartiles classified by low to 
high match score to HSE (n=36, 36, 36, 35 respectively for the lowest, lower, 
higher, and highest). 
 
		
	
	
88	
Table 2.4. Sequencing depth and alignment statistics of HSF1 ChIP-seq 
libraries. ChIP-seq reads that pass the Illumina quality filter were retained, 
adapters were clipped and the reads longer than 15 bp were mapped to the 
mouse genome. 
 
Library Sequenced Adaptor dimers Unaligned 
Uniquely 
aligned 
WT_NHS_Input 8,015,869 997,080 309,635 6,709,154 
WT_NHS_IgG_BR1 8,206,235 2,676,621 232,390 5,297,224 
WT_NHS_IgG_BR2 9,721,219 3,562,286 654,125 5,504,808 
WT_NHS_HSF1_CS_BR1 28,188,028 5,766,142 1,006,461 21,415,425 
WT_NHS_HSF1_CS_BR2 11,366,384 2,911,272 1,781,586 6,673,526 
WT-NHS_HSF1_MM_BR1 16,692,201 5,319,869 577,680 10,794,652 
WT_NHS_HSF1_MM_BR2 11,242,250 3,977,681 699,178 6,565,391 
Hsf1-/-_NHS_HSF1_CS 20,796,807 7,107,929 2,630,784 11,058,094 
Hsf1-/-_NHS_HSF1_MM 29,863,811 14,022,020 2,229,073 13,612,718 
      
WT_12’HS_Input 6,300,333 1,255,474 169,101 4,875,758 
WT_12’HS_IgG_BR1 8,147,506 1,851,801 251,080 6,044,625 
WT_12’HS_IgG_BR2 11,837,162 3,874,032 768,462 7,194,668 
WT_12’HS_HSF1_CS_BR1 31,309,203 8,191,568 893,657 22,223,978 
WT_12’HS_HSF1_CS_BR2 11,403,588 3,996,282 812,367 6,594,939 
WT_12’HS_HSF1_MM_BR1 15,261,069 3,797,256 497,576 10,966,237 
WT_12’HS_HSF1_MM_BR2 12,920,837 3,598,854 906,175 8,415,808 
Hsf1-/-_12’HS_HSF1_CS 19,473,435 12,442,371 1,366,285 5,664,779 
Hsf1-/-_12’HS_HSF1_MM 27,597,714 8,353,866 2,014,259 17,229,589 
      
WT_60’HS_Input 7,767,992 1,139,060 223,600 6,405,332 
WT_60’HS_IgG_BR1 14,785,033 10,619,596 224,501 3,940,936 
WT_60’HS_IgG_BR2 9,523,443 2,934,886 727,287 5,861,270 
WT_60’HS_HSF1_CS_BR1 13,472,052 2,369,949 427,637 10,674,466 
WT_60’HS_HSF1_CS_BR2 14,863,043 3,094,488 1,093,241 10,675,314 
WT_60’HS_HSF1_MM_BR1 31,268,936 23,110,624 802,871 7,355,441 
WT_60’HS_HSF1_MM_BR2 12,236,596 4,055,221 636,281 7,545,094 
Hsf1-/-_60’HS_HSF1_CS 23,749,525 11,390,017 2,405,648 9,953,860 
Hsf1-/-_60’HS_HSF1_MM 19,278,068 9,530,952 1,604,941 8,142,175 
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of the HSE underneath the peaks (Figure 2.6D). While HSF1 occupies some 
sites prior to HS, most sites are detectably bound only after HS (Figure 2.7A) 
and many of these binding events appear only at 60’HS (Figure 2.7B). In 
terms of the genome-wide binding landscape, majority of the HSF1 peaks are 
located far from the nearest TSSs (Figure 2.7C). However, all the classical 
inducible Hsps have HSF1 binding within 1 kb upstream of their TSS (Figure 
2.7D). Therefore, we defined a region 1kb upstream and 500 bp downstream 
of TSS as the promoter and examined the distribution of HSF1 binding on 
promoter, intragenic, and intergenic regions. The density of HSF1 peaks is 
highest in promoters; however, higher incidences of absolute binding events 
occur in intragenic and intergenic regions (Figure 2.7E).  
 To understand the significance of HSF1 binding in the promoter, we 
examined the changes in PRO-seq density in HSF1-promoter-bound genes 
(Figure 2.8A). 22% of HSF1-promoter-bound genes show HSF1-dependent 
transcription induction upon HS (magenta bars). However, 53% of HSF1-
promoter-bound genes are repressed upon HS (blue bars), demonstrating that 
promoter bound HSF1 does not always induce transcription. Moreover, nearly 
all of these repressed genes are also repressed in the Hsf1-/- MEFs, indicating 
that promoter-bound HSF1 is not responsible for repression. Intriguingly, 13% 
of the HSF1-promoter-bound genes induced upon HS are also induced in 
Hsf1-/- MEFs (purple bar) indicating that some HSF1-bound genes do not 
require HSF1 for their induction.   
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Figure 2.7. HSF1 binding progressively increases with HS duration 
(A) Venn diagram of the number of HSF1 peaks identified by MACS at 
different time points. 
(B) Screenshot of Des gene, which is bound by HSF1 only after 12 min of HS, 
shows ChIP-seq read density in WT and Hsf1-/- MEFs. The scale on the y-axis 
represents the number of ChIP-seq tags under the peaks. 
(C) Cumulative fraction of HSF1 peaks from the nearest annotated TSS. 
Colors of the cumulative distribution functions correspond to the different 
classes represented in the venn diagram in panel A. The dotted line 
represents 1 kb and the x-axis is in log10 scale. 
(D) Cumulative fraction of the Hsps bound by HSF1 in the promoter and the 
distance of HSF1 peaks from their TSS. 
(E) Density of HSF1 peaks in discrete genomic regions. The absolute numbers 
of HSF1 peaks are shown over the bars. Colors below the sets of three 
genomic regions correspond to the different classes represented in the venn 
diagram in panel A. 
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Figure 2.8 HSF1 binds and regulates a small fraction of HS induced 
genes 
(A) Heatmap of HSF1 binding by ChIP-seq (left, grey to brown) and change in 
PRO-seq density (right, blue to red) before and after HS in all HSF1-promoter-
bound genes. Green bar represents genes induced in both cell types, magenta 
bars represent HSF1-dependent induced genes, blue bars represent HSF1-
independent repressed genes, and purple bar represents unchanged genes in 
both cell types. 
(B) Cumulative fraction of HSF1-dependent upregulated genes in WT MEFs 
from the nearest HSF1 peaks. The dotted line represents 1 kb and x-axis is in 
log10 scale. 
(C) Heatmap of HSF1 binding by ChIP-seq (left, grey to brown) and change in 
PRO-seq density (right, blue to red) before and after HS in all genes bound by 
HSF1 in the body of genes.  
 (D) PRO-seq density (with 95% confidence interval in light shades) at 60’HS 
around the center of intragenic-bound HSF1 sites. Upstream region of the 
intragenic-bound HSF1 sites lack HSF1-dependent accumulation of PRO-seq 
density. 
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We further tested whether promoter binding of HSF1 is a necessary condition 
for transcription induction. We probed the distance of the nearest HSF1 peak 
from genes that show HSF1-dependent transcription induction upon HS and 
found that only ~35% of these genes have HSF1 bound in their promoters 
(Figure 2.8B). This indicates that promoter binding of HSF1 is not entirely 
necessary for transcription induction during HS, and suggests that HSF1 can 
exert its influence from a distance, presumably from an enhancer. Together, 
these observations show that the promoter-bound HSF1 is not responsible for 
induction or repression of a majority of the HS-regulated genes. 
 
HSF1 binding to gene-body is not the mechanism of transcription 
repression  
 Past studies have suggested that HSF1 bound in the gene-body 
creates an obstacle to transcribing Pol II that leads to repression of 
transcription (Guertin and Lis, 2010; Westwood et al., 1991). Here, we find that 
transcription of genes that have HSF1- bound in the transcription unit are 
mostly regulated in an HSF1-independent manner (Figure 2.8C). 
Approximately 50% of these genes are repressed upon HS; however, this 
repression occurs in Hsf1-/- MEFs as well. To examine the gene-body bound 
HSF1 mediated steric hindrance to transcribing Pol II, we examined PRO-seq 
density around HSF1-intragenic-bound sites at 60’HS. We detect divergent 
transcription at these sites, a signature of enhancers (Core et al., 2014), which 
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is reduced in Hsf1-/- (Figure 2.8D). PRO-seq levels upstream of the HSF1 sites 
reveal no significant Pol II accumulation that would be expected by the steric 
hindrance of bound HSF1. Thus, the HSF1 bound in the body of a gene is not 
a strong obstacle to transcription and does not contribute appreciably to 
repression during HS. 
 
Cytoskeleton genes are induced extremely early in HSF1-independent 
manner 
 Some classical Hsps are known for rapid induction of transcription upon 
HS, for example, Drosophila Hsp70 is induced within 2 minutes following HS 
(O'Brien and Lis, 1991; Zobeck et al., 2010). However, the early kinetics of 
induction of genes beyond Hsps during HS has not been examined to date. 
Here, we find that many genes in MEFs are significantly induced by 2.5’HS 
(Figure 2.9A). Majority of these early-induced (EI) genes are HSF1-
independent (Figure 2.9B). Induction of these genes continues to 12’HS, after 
which transcription declines to below basal levels (Figure 2.9C). 
 Gene ontology analysis revealed that the many of these EI genes, 
especially the HSF1-independent ones, encode proteins with biological 
function related to cytoskeletal structure and function (Figure 2.9D). Dynamic 
rearrangement of cytoskeleton in the cells has been previously documented 
during HSR (Laszlo, 1992), and cytoskeleton proteins are critical for survival 
during heat-stress (Baird et al., 2014). Proteomics analysis also showed  
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Figure 2.9. Early and transiently induced genes are primarily 
cytoskeleton genes  
(A) Screenshot of rapidly and transiently induced Dstn gene showing PRO-seq 
density at various time points in WT and Hsf1-/- MEFs. 
(B) Heatmap of PRO-seq density fold change in significantly upregulated 
genes at 2.5’HS (EI genes) in WT only (green), common in both WT & Hsf1-/- 
(olive), and Hsf1-/- only (orange).  
(C) Change in PRO-seq density of EI genes at all time points. 
(D) GO analysis of the three classes of EI genes (same color scheme as in A). 
The heatmap denotes the number of genes in each GO class and the length of 
the bar (x-axis) denotes the p-value. 
(E) Significantly enriched TF motifs out of 1200 scanned in the promoter of 
genes in the three classes of EI genes (left panel) and the four classes of 
upregulated genes at 12’HS (right panel). P-value of motif enrichment over 3rd 
order Markov model is represented in the heatmap. Sequence logo of DNA 
binding motif of the most significantly enriched TF is shown. 
(F) Heatmap showing PRO-seq density change during HS on a subset of 
immediate-early genes that were found to be bound by SRF in a previous 
study (Esnault et al., 2014), and contain SRF motif in promoters from our 
analysis. 
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increase in the level of some cytoskeletal proteins in nuclear extract after two 
hours of HS (Raychaudhuri et al., 2014). However, the extremely rapid and 
transient induction of selective cytoskeleton genes during HS has not been 
detected before.  
 Because these genes are predominantly HSF1-independent, we 
searched for enriched TF-binding motifs in their promoters, and found serum 
response factor (SRF) to be the most highly enriched candidate (Figure 2.9E). 
SRF is known to induce a class of genes known as immediate-early genes 
(Schratt et al., 2001). These genes are rapidly and transiently induced in 
response to various extracellular stimuli (Sheng and Greenberg, 1990). SRF is 
also a known effector of MAP kinase pathway, which is often implicated in 
stress. Therefore, we examined the kinetics of induction of a subset of 
immediate-early genes that were found to be bound by SRF in a previous 
study (Esnault et al., 2014), and contain SRF motif in promoters from our 
analysis. Most of these genes are rapidly and transiently induced (Figure 2.9F) 
indicating that immediate-early genes, many of which belong to cytoskeleton 
family, are induced upon HS and are likely regulated by SRF. 
 
SRF is transiently activated by HS and binds and induces cytoskeletal 
genes 
 Enrichment of DNA element for TF binding implies a possibility for 
regulation, however, direct evidence of binding is required to conclusively 
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establish the connection. To verify SRF as a novel regulator of cytoskeletal 
genes during HS, we examined SRF binding in WT MEFs by ChIP-seq (Figure 
2.10A and Table 2.5). We found that the transiently induced genes upon HS 
that contain an SRF binding motif in their promoters are bound by SRF in a 
transient manner (Figure 2.10B). The composite profile of SRF occupancy 
around the TSS of all transiently induced genes also show a transient 
enrichment of SRF, mirroring the kinetics of transcription induction upon HS 
(Figure 2.10C). This finding strongly implicates SRF as a novel regulator of 
cytoskeletal genes during HSR. 
 To verify the dependence of cytoskeletal genes on SRF for transient 
induction during HS, we pharmacologically inhibited SRF using CCG-203971, 
a potent inhibitor of SRF (Bell et al., 2013; Haak et al., 2014), and made PRO-
seq libraries from SRF-inhibited WT MEFs during HS (Figure 2.10D and Table 
2.6). Inhibition of SRF attenuated the induction of cytoskeletal genes, as 
shown by the individual transcription profile of a gene (Figure 2.10E) and the 
metagene profile (Figure 2.10F). Together, for the first time, these finding 
establish SRF as a major regulator of a specific class of genes during HS. 
 
Measurements of Pol II elongation rates show similar kinetics of 
induction in cytoskeleton genes and Hsps   
 One striking feature of PRO-seq data in induced genes is a distinct 
wave of elongating Pol II that are in the midst of transcription (Figure 2.11A).  
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Figure 2.10 SRF transiently binds and regulates transiently induced 
genes during HS 
(A) Experimental set-up, ChIP-seq libraries in WT MEFs were made with 
chromatin immunoprecipitated with either non-specific IgG or SRF antibody at 
NHS, 12’HS, and 60’HS.  
(B) Screenshot of Vcl gene shows the SRF ChIP-seq density (top panel) and 
the PRO-seq density (bottom panel) during HS. SRF binding is significantly 
enriched on the promoter of the gene at 12’HS and returns to the basal level 
by 60’HS. 
(C) Composite profile of SRF ChIP-seq density around the TSS of transiently 
induced genes upon HS that contain SRF binding element on their promoters. 
(D) Experimental set-up, PRO-seq libraries were made in duplicates at NHS 
and 12’HS using WT MEFs treated with either DMSO (control) or SRF inhibitor 
(CCG-203971). 
(E) Screenshot of PRO-seq density in Myl9 gene shows attenuation of 
transcription induction at 12’HS by SRF inhibitor in WT MEFs. 
(F) Metagene profile of PRO-seq density at NHS and 12’HS in the scaled 
gene-body and a kb upstream and downstream of TSS and poly(A) site (PAS) 
respectively in WT MEFs treated with DMSO (top panel) and SRF inhibitor 
(bottom panel). 
 
 
 
 
 
		
	
	
101	
 
 
 
		
	
	
102	
Table 2.5. Sequencing depth and alignment statistics of SRF ChIP-seq 
libraries. ChIP-seq reads that pass the Illumina quality filter were retained, 
adapters were clipped and the reads longer than 15 bp were mapped to the 
mouse genome. 
 
Library Sequenced Adaptor dimers Unaligned 
Uniquely 
aligned 
WT_NHS_IgG 31,175,847 3,395 611,608 30,560,844 
WT_12'HS_IgG 20,594,110 4,019 445,030 20,145,061 
WT_60'HS_IgG 42,710,902 2,851 1,164,766 41,543,285 
     
WT_NHS_SRF 30,745,291 3,479 5,337,140 25,404,672 
WT_12'HS_SRF 48,588,256 17,937 12,867,045 35,703,274 
WT_60'HS_SRF 24,566,920 3,312 7,766,984 16,796,624 
 
 
 
 
 
Table 2.6. Sequencing depth and alignment statistics of PRO-seq 
libraries in DMSO or SRF-inhibitor treated WT MEFs. Multiple aligned 
reads are not shown. Libraries were sequenced in Illumina HiSeq-2000. 
 
Library Sequenced Adaptor dimers Unaligned 
Uniquely 
aligned 
WT_NHS_DMSO_BR1 39,729,711 6,119,806 5,444,773 15,181,544 
WT_NHS_DMSO_BR2 42,029,198 6,900,242 5,475,811 16,074,055 
WT_12’HS_DMSO_BR1 2,252,435 283,488 249,187 968,610 
WT_12’HS_DMSO_BR2 46,179,281 6,616,866 6,181,491 18,557,328 
     
WT_NHS_SRFin_BR1 40,662,367 6,558,681 4,734,773 17,152,039 
WT_NHS_SRFin_BR2 43,718,316 8,110,595 5,600,733 16,660,386 
WT_12’HS_SRFin_BR1 43,864,184 6,146,750 5,930,696 18,637,707 
WT_12’HS_SRFin_BR2 43,207,291 7,129,489 5,842,233 17,229,355 
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Figure 2.11. Cytoskeletal genes are induced as early as Hsps in HSF1-
independent manner 
(A) Screenshots of Tle4 and Lmod1 genes with distinctive PRO-seq waves. 
Green bars represent the distance traversed by new waves of Pol II calculated 
by three-state HMM.  
(B) Difference in PRO-seq density calculated by the three state HMM in Tead1 
gene in WT MEFs at 2.5’HS (left panel) and Tle4 gene in Hsf1-/- MEFs at 
12’HS (right panel). X-axis shows the distance from TSS, y-axis shows the 
difference in PRO-seq density in 50bp bins, and the orange bar represents 
estimated Pol II wave called by HMM. 
(C) Density plot of distance traversed by PRO-seq waves in HSF1-dependent 
(green) and HSF1-independent (olive) genes induced at 2.5’HS. 
(D) Distribution of length of PRO-seq waves at 2.5’HS and 12’HS in EI genes 
that are significantly upregulated at 12’HS as well. 
(E) Cumulative fraction of cytoskeleton genes and Hsps and their length of 
PRO-seq waves at 2.5’HS. 
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Here we used a three-state Hidden Markov Model (HMM) (Danko et al., 2013) 
to calculate the distance traveled by waves of newly released Pol II in EI 
genes. Our approach calculates the difference in PRO-seq density between 
time points in 50-bp windows throughout the gene and identifies the region 
(wave) with a difference in transcription (Figure 2.11B). PRO-seq wave 
measurement using this approach indicates that Pol II release from the pause 
region of EI genes occurs on average within the first minute and a half! - the 
median distance travelled by PRO-seq wave at 2.5’HS is 2.7 kb (Figure 
2.11C), and the average elongation rate of Pol II in EI genes is 2.6 kb/min, 
calculated using the length of PRO-seq wave at 2.5’HS and 12’HS in genes 
induced at both time points (Figure 2.11D). Moreover, the length of PRO-seq 
waves at 2.5’HS in cytoskeleton genes and classical Hsps are very similar 
(Figure 2.11E), and the induction kinetics of HSF1-dependent and HSF1-
independent genes is also highly analogous (Figure 2.11C). Together, these 
findings demonstrate that transcription is induced very early during HSR and 
the kinetics of induction is similar between HSF1-dependent (Hsps) and HSF1-
independent (cytoskeleton) genes. 
 
Inhibition of pause release causes massive downregulation of 
transcription  
 Historically, transcriptionally induced genes have been the focus of HS 
studies. However, we find that many genes are transcriptionally repressed 
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than induced upon HS and this global repression is independent of HSF1 
(Figure 2.12A). Genes undergoing repression display two distinct kinetics: 
some genes are gradually and consistently repressed over the course of HS 
(Pcdh18) and others are repressed only after 12’HS (Cdkal1) (Figure 2.12B). 
The majority of the repressed genes fall into the late repressed class (Figure 
2.12C).  
 It is unlikely that a repressor directly binds to promoters of such a large 
number of downregulated genes. Instead, inhibition of regulatory steps in 
transcription such as recruitment of Pol II or release from promoter-proximal 
pause seems more plausible mechanism for global repression. Consistent with 
this hypothesis, we see an increase in PRO-seq density in the first 100bp 
downstream of TSS (Figure 2.12D). This accumulation of Pol II in the 5’ end of 
repressed genes upon HS in WT (Figure 2.13A) and Hsf1-/- MEFs (Figure 
2.13B) demonstrates that the transcriptional repression in the majority of the 
downregulated genes is mediated by inhibition of paused Pol II release into 
productive elongation in an HSF1-independent manner.  
 To examine if the apparent extensive downregulation observed here is 
simply a result of thermal-induced increase in transcription rate of elongating 
Pol II that would decrease Pol II density over the gene-body, we calculated the 
elongation rate by comparing clearing wave of Pol II in downregulated genes 
at 12’HS and 60’HS. The average elongation rate of Pol II during HS is 2.1 
kb/min (Figure 2.13C), which is highly comparable to the elongation rate of Pol  
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Figure 2.12. Transcription is repressed upon HS in majority of the active 
genes 
(A) Center-of-mass plot shows the status of PRO-seq density change in all 
active genes (n = 15893). 
(B) Screenshots of two downregulated genes with different kinetics of 
transcription repression upon HS: early- downregulated (top panel) late- 
downregulated (bottom panel).  
(C) Breakdown of significantly downregulated genes at 60’HS into two classes 
- early and late. 
(E) Histogram of average PRO-seq density in 10 bp bins from TSS to 1 kb into 
the gene-body for significantly downregulated genes at 60’HS (n= 7923). 
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II under normal temperature in mouse embryonic stem cells (1.8 – 2.4 
kb/min)(Jonkers et al., 2014). Furthermore, the downregulation of transcription 
observed by PRO-seq is nicely reflected at the mRNA level measured by 
RNA-seq (Figure 2.4B, right panel). Thus, the decrease in gene-body PRO-
seq reads is not the result of an increase in elongation rate, but rather results 
from a genuine downregulation in the frequency with which Pol II transitions 
from the pause to productive elongation. 
 We performed GO analyses to examine the enriched functional classes 
in downregulated genes. Genes involved in metabolism, cell cycle, and mitosis 
are represented in the early-repressed class, while genes in the late-repressed 
class are enriched for mRNA splicing, mRNA processing and nuclear transport 
functions (Figure 2.13D). Conceivably, cells may enter into a low metabolic 
profile upon HS by immediately shutting down genes involved in cell cycle and 
metabolism. However, mRNA processing and efficient splicing could be critical 
in the early phase of HSR when Hsps and IE genes are robustly induced. 
These two kinetic classes of genes that have distinct functions imply that 
repression of transcription is a highly-regulated process, rather than a 
previously suggested non-discriminatory HS-induced global repression of 
transcription (Teves and Henikoff, 2011). 
 
HS-regulated Hsps are dependent on HSF1 
 Expression of Hsps has served as an indicator of HSR. There are ~75  
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Figure 2.13. Global downregulation during HS is mediated by lack of 
paused Pol II release 
(A) Heatmap of PRO-seq density before HS (left), after 60’HS (mid), and fold 
change from 60’HS to NHS (right) for significantly downregulated genes (early 
– top panels and late – bottom panels) at 60’HS in WT MEFs. Each row 
represents a gene, scaled to same length and divided into 100 bins, from TSS 
up to polyA site for genes shorter than 24 kb and up to 24 kb for genes longer 
than 24kb. 
(B) Heatmap of PRO-seq density before HS (left), after 60’HS (mid), and fold 
change from 60’HS to NHS (right) for significantly downregulated genes (early 
– top panels and late – bottom panels) at 60’HS in Hsf1-/- MEFs. Each row 
represents a gene, scaled to same length and divided into 100 bins, from TSS 
up to polyA site for genes shorter than 24 kb and up to 24 kb for genes longer 
than 24kb. 
(C) Density of elongation rates of Pol II during HS in downregulated genes. 
Elongation rates were calculated by first measuring the distance travelled by 
Pol II between 12’HS and 60’HS in significantly downregulated genes at both 
12’HS and 60’HS and then dividing the distance by the time (60 - 12 = 48 
minutes). 
(D) GO analysis of the significantly downregulated genes using DAVID. GO 
terms enriched in early and late downregulated classes are represented by 
color scheme in Figure 2.12C. The heatmap denotes the number of genes in 
each GO class.  
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genes in HSP family (Kampinga et al., 2009), some of which are highly related 
paralogs and likely serve in different cellular compartments, cell types, or 
developmental stages. It is unclear whether transcription of all Hsps increases 
upon HS. Here, we examined transcriptional change in genes in the HSP 
family. While classical Hsps show HSF1-dependent induction upon HS, more 
than half of Hsps are transcriptionally repressed (Figures 2.14A and 2.15A). 
For example, Hsp90b1, an endoplasmic reticulum associated chaperone 
involved in unfolded protein response, is repressed upon HS in both cell types, 
while other Hsp90s are robustly induced in an HSF1-dependent manner 
(Figure 2.14D). Strikingly, almost all transcriptionally induced Hsps have 
prominent HSF1 peaks in their promoters (Figures 2.14B and 2.15B), 
accompanied by the presence of HSEs underneath the peaks (Figures 2.14C 
and 2.15C). Overall, our results show that some Hsps are rapidly and robustly 
induced upon HS; however, many genes in the HSP family are not bound by 
HSF1 and are not transcriptionally induced in response to HS, suggesting the 
role of post-transcriptional (Theodorakis and Morimoto, 1987; Yost et al., 
1990) and translational regulation (Lindquist, 1987; Storti et al., 1980; Zhou et 
al., 2015) in increase in gene expression of some Hsps upon HS or the likely 
specialization of different HSPs in different tissues or stress responses.  
 
HSF1 induces transcription by increasing promoter-proximal pause 
release 
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Figure 2.14. HSF1 is required for induction of classical Hsps upon HS  
(A) PRO-seq density change upon HS in 30 Hsp genes in WT MEFs (top 
panel) and Hsf1-/- MEFs (bottom panel) ordered by increasing fold change at 
WT 60’HS. 
(B) HSF1 fold enrichment in the promoter of the corresponding 30 Hsp genes 
in WT MEFs before and after HS. 
(C) Motif match score p-value of HSE in the promoter of the corresponding 30 
Hsp genes. 
 (D) Screenshots of three Hsp90 genes. HSP90b1 is downregulated upon HS 
in HSF1-independent manner and Hsp90aa1 and Hsp90ab1 are robustly 
upregulated in HSF1-dependent manner.  
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Figure 2.15. Most Hsp40s are not induced by HS 
(A) PRO-seq density change upon HS in 45 Hsp40 genes in WT MEFs (top 
panel) and Hsf1-/- MEFs (bottom panel) ordered by increasing fold change at 
WT 60’HS. 
(B) HSF1 fold enrichment in the promoter of the corresponding 45 Hsp40 
genes in WT MEFs before and after HS. 
(C) Motif match score p-value of HSE in the promoter of the corresponding 45 
Hsp40 genes. 
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 The PRO-seq profiles across the promoter proximal and gene-body 
regions provide insight to Pol II’s progress through the distinct steps in the 
transcription cycle and the changes occurring in response to HS.  Moreover, 
contrasting these profiles in both WT and Hsf1-/- MEFs reveals the role of 
HSF1 in the changes observed. We first examined the genes that exhibit a 
significant increase in PRO-seq density in their gene-body by 60’HS in WT but 
not in Hsf1-/- MEFs (n=102) (Figure 2.16A, middle panel) and also have HSF1 
bound in their promoter region (Figure 2.16A, left panel). A simple 
interpretation of these profiles is that HSF1 acts to increase the rate of Pol II 
release from the pause, a step that is accelerated by P-TEFb kinase, which is 
known to be recruited to HS loci in an HSF1-dependent manner (Lis et al., 
2000). P-TEFb phosphorylates components of the paused Pol II complex and 
enables Pol II to embark into productive elongation (Renner et al., 2001). An 
alternative mechanism to explain these profiles is that HS-induces an HSF1-
dependent decrease in early termination that leads to higher gene-body Pol II 
density. However, this anti-termination model was ruled out, at least for 
Hsp70, by our previous study showing the termination rate of promoter-
proximal paused Pol II is similar in HS and NHS cells and could not account 
for the HS-induced increase in gene-body Pol II density (Buckley et al., 2014). 
A second alternative explanation for these profiles is that elongation rates are 
slowed during HS in an HSF1-dependent manner leading to increases in 
gene-body Pol II density. However, such a decrease in elongation rate is 
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Figure 2.16. HSF1 induces transcription by increasing paused Pol II 
release 
(A) Heatmap of HSF1 binding (left), change in PRO-seq density in gene-body 
(center) and pause region (right) of the 102 genes that are bound by HSF1 in 
the promoter and show HSF1-dependent transcription induction at 60’HS.  
(B) Change in PRO-seq density in gene-body (left) and pause region (right) of 
the 150 genes that are not bound by HSF1 in the promoter but show HSF1-
dependent transcription induction at 60’HS.  
(C) PRO-seq density (with 95% confidence interval in light shades) before and 
at time points after HS in WT MEFs around the center of HSF1-intergenic-
bound sites at NHS (left), common only in 12’HS & 60’HS (center), and only in 
60’HS (right). The color of text in the titles refers to the three classes 
represented by the same colors in Figure 2.7A. 
(D) PRO-seq density (with 95% confidence interval in light shades) before and 
at time points after HS in WT MEFs around the center of HSF1-intragenic-
bound sites at NHS (left), common only in 12’HS & 60’HS (center), and only in 
60’HS (right). The color of text in the titles refers to the three classes 
represented by the same colors in Figure 2.7A. 
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neither consistent with the increases in the mRNA levels of these genes 
(Figures 2.4B and 2.4C), nor supported by the direct measurement of 
elongation rates (Figures 2.11C-E and 2.13C) (Ardehali and Lis, 2009). Thus, 
these 102 HSF1-promoter-bound and transcriptionally induced genes appear 
to be regulated by HSF1 upon HS in an HSF1-dependent manner at the step 
of pause Pol II release into productive elongation.  
 Interestingly, this class of 102 genes also shows an increase in PRO-
seq density in their pause region upon HS. In contrast to the gene-body, this 
increase is independent of HSF1 (Figure 2.16A, right panel). We hypothesize 
that this increase is simply a consequence of the massive HSF1-independent 
downregulation of genes (Figures 2.4A & 2.4D) upon HS, which increases the 
cellular pool of Pol II and thereby drives Pol II loading on promoters by mass 
action in the presence and absence of HSF1. Furthermore, this model is 
consistent with the fact that the broad downregulation of thousands of genes is 
also HSF1 independent (Figure 2.4D). This hypothesis can be tested by 
quantifying chromatin-bound and chromatin-unbound Pol II during HS. 
 HSF1 is also capable of acting from a distal enhancer, at least when 
bound to sites composed of an array of HSEs (Bienz and Pelham, 1986). We 
identified many genes that show HSF1-dependent induction upon HS but don’t 
have HSF1 bound in their promoters (n=150) (Figure 2.8B) suggesting that 
these genes could be regulated by HSF1 acting from distal enhancers. Indeed, 
these genes show the same changes in PRO-seq profile in both gene bodies 
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and pause regions as the class of 102 HSF1-promoter-bound, HSF1-
dependent induced genes (Figure 2.16B). Therefore, HSF1 bound at distal 
enhancers likely regulates genes by increasing the release of paused Pol II, 
indicating that the promoter-proximal pause release is the primary step 
regulated in all HSF1-mediated transcription induction during HSR. 
 HSF1 enhancers would be expected to have the divergent transcription 
profile characteristic of active enhancers (Core et al., 2014; Hah et al., 2011; 
Kim et al., 2010). PRO-seq profiles around the intergenic and intragenic HSF1-
bound regions show that the divergent transcription appears upon HS (Figures 
2.16C and 2.16D), suggesting that these distal HSF1 bound regions become 
active enhancers during the HSR. This increase in divergent transcription 
around the distal HSF1-bound sites is unlikely to be an effect of HSF1 directly 
stimulating the recruitment of Pol II, because the initiation of divergent 
transcription is detectable only at 60’HS even though the sites are occupied by 
HSF1 prior to 60’HS (Figures 2.16C and 2.16D - left and mid panels). The 
delayed recruitment of Pol II is more consistent with an indirect role of HSF1 
on Pol II recruitment to enhancers, perhaps a consequence of opening of 
promoter regions that allows the binding of other TFs and Pol II, and of the 
increased pool of Pol II made available during the massive downregulation of 
thousands of genes.  
 
HS-regulated genes have concomitant change in P-TEFb level 
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 Our findings implicate the step of Pol II release from the promoter-
proximal pause as the major regulatory knob in transcription cycle during HS. 
HSF1 induces transcription by promoting the release of paused Pol II and the 
massive repression is caused by the lack of efficient release of paused Pol II. 
These observations encouraged us to probe the change in global occupancy 
of the pause release factor P-TEFb during HS. P-TEFb has two subunits – 
cyclin T and cyclin-dependent kinase 9 (Cdk9) (Zhou et al., 2012). Because 
the Pol II pause release is dependent on the kinase subunit (Peterlin and 
Price, 2006), we performed ChIP-seq before and after 60 min of HS in WT 
MEFs using Cdk9 antibody (Figure 2.17A and Table 2.7).  
The occupancy of Cdk9 significantly increases upon HS in the 
representative Hsph1 gene (Figure 2.17B) and all HS-inducible Hsps (Figure 
2.17C), whereas the Cdk9 level in HS-uninducible Hsps remain unchanged 
(Figure 2.17D). Cdk9 occupancy also increases in all HSF1-dependent 
upregulated genes that include a much larger pool of genes beyond HS-
inducible Hsps (Figure 2.17E), suggesting interplay between HSF1 and P-
TEFb in transcription induction by increasing Pol II pause release. Although 
the pause region has more prominent increase in P-TEFb level, this increase 
occurs throughout the gene body indicating that P-TEFb tracks with Pol II into 
gene body (Jonkers and Lis, 2015; Ni et al., 2008). Similarly, the decrease in 
Pol II release from promoter-proximal pause of transcriptionally repressed 
genes during HS suggests a decrease in P-TEFb activity. Therefore, we 
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Figure 2.17. P-TEFb is enriched in induced and depleted in repressed 
genes 
(A) Experimental set-up, ChIP-seq libraries in WT MEFs were made with 
chromatin immunoprecipitated with either non-specific IgG or Cdk9 antibody at 
NHS and 60’HS. 
(B) Screenshot of Hsph1 gene shows the ChIP-seq density in WT MEFs with 
IgG or Cdk9 antibody during HS. Cdk9 occupancy is significantly enriched on 
the promoter gene-body at 60’HS. 
(C) Metagene profile of normalized Cdk9 density in HS-inducible Hsps at NHS 
and 60’HS in WT MEFs. The x-axis represents the scaled gene-body and a kb 
upstream and downstream of TSS and PAS respectively. 
(D) Metagene profile of normalized Cdk9 density in HS-uninducible Hsps at 
NHS and 60’HS in WT MEFs. The x-axis represents the scaled gene-body and 
a kb upstream and downstream of TSS and PAS respectively. 
(E) Metagene profile of normalized Cdk9 density in all HSF1 bound and HS-
inducible genes at NHS and 60’HS in WT MEFs. The x-axis represents the 
scaled gene-body and a kb upstream and downstream of TSS and PAS 
respectively. 
(F) Metagene profile of normalized Cdk9 density around the TSS of HS-
repressed genes at NHS and 60’HS in WT MEFs.  
(G) Screenshots of Cdk9 (top panel) and Ccnt1 (bottom panel) genes, two 
subunits of P-TEFb complex, showing a lack of transcriptional regulation 
during HS.  
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Table 2.7. Sequencing depth and alignment statistics of Cdk9 ChIP-seq 
libraries. ChIP-seq reads that pass the Illumina quality filter were retained, 
adapters were clipped and the reads longer than 15 bp were mapped to the 
mouse genome. 
 
Library Sequenced Adaptor dimers Unaligned 
Uniquely 
aligned 
WT_NHS_IgG 31,175,847 3,395 611,608 30,560,844 
WT_12'HS_IgG 20,594,110 4,019 445,030 20,145,061 
WT_60'HS_IgG 42,710,902 2,851 1,164,766 41,543,285 
     
WT_NHS_Cdk9 7,876,051 1,525 1,010,967 6,863,559 
WT_12'HS_Cdk9 21,852,365 1,929 2,145,718 19,704,718 
WT_60'HS_Cdk9 24,589,485 6,106 3,055,814 21,527,565 
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quantified Cdk9 level around the TSS of HS-repressed genes and as expected 
found a reduction in Cdk9 occupancy (Figure 2.17F).  
Together, these observations suggest that the increase and decrease in 
transcription level in different sets of genes is tightly coordinated - an increase 
in free pool of nuclear P-TEFb level due to global downregulation of genes 
during HS paves the groundwork for HSF1-dependent increase in P-TEFb 
level at the HS-induced genes, likely through the known HSF1-dependent 
recruitment of P-TEFb kinase (Lis et al., 2000). The availability of free pool of 
P-TEF-b level is critical for transcription induction of survival genes because 
the transcription of either subunits of P-TEFb is uninduced during HS (Figure 
2.17G) and the nuclear P-TEFb level decreases during HS (Raychaudhuri et 
al., 2014). Thus, the measurement of global Cdk9 occupancy change 
implicates a critical role for P-TEFb in both upregulation and downregulation of 
transcription during HS. 
 
HS-regulated genes have different kinetics, dynamics, chromatin marks, 
and functions 
 Our results demonstrate an elaborate network of transcriptional 
regulation in response to heat stress; hundreds of genes are induced and 
thousands of others are repressed. This coordinated regulation exhibits 
temporal precision and selectivity for functional gene groups. We broadly 
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divided the kinetics and dynamics of transcription regulation during HS in five 
unique classes (Figure 2.18).  
 Class I represents the HS-inducible genes including Hsps that are 
induced throughout the duration of HS in this study. Upon HS, many of these 
genes are bound by HSF1 to the promoter. The binding motif of AP-1 is 
enriched within the HSF1 peaks in the promoter of these genes (Figure 2.19A) 
suggesting a likely co-operation between HSF1 and AP-1. We show that the 
HSF1 induces transcription in HSF1-dependent genes of this class by 
increasing the release of paused Pol II into productive elongation. In addition 
to HSF1, the binding motif of SIX4 is also enriched in the promoters of some 
genes in this class (Figure 2.19B).  
 Class II comprises EI genes described in Figure 3. HS rapidly and 
transiently induces transcription of these genes. Many genes in this class 
belong to cytoskeleton family and are characterized by a strong enrichment of 
SRF binding motif in their promoters. Metagene profile of PRO-seq density in 
the pause region of these genes also shows a comparable net increase of 
paused Pol II at 2.5’HS and 12’HS that decrease at 60’HS (Figure 2.19C). 
Thus, both Pol II pause release and recruitment appear rapidly and transiently 
regulated during HSR, and SRF and its coregulators are strong candidates for 
mediating this response. 
 Class III represents genes that are induced during the late phase of the 
HSR. Most of these genes are regulated independently of HSF1 and are likely  
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Figure 2.18. Kinetics and dynamics of transcription induction and 
repression during HSR 
Kinetics, dynamics, and the proposed mechanism of the five major classes of 
HS-regulated genes in WT MEFs. Heatmap on the left panel shows the gene-
body PRO-seq density change upon HS for all genes in each class. The mid 
panels show the average change in gene-body PRO-seq density - the red 
points represent the average log2 fold change for all genes and the green error 
bars represent 95% confidence interval. The right panels show the step(s) in 
transcription being regulated. Green arrow indicates positive regulation, the 
orange arrow represents likely but uncertain regulation, red cross indicates 
negative regulation, and thickness of the arrows indicates the extent of 
regulation. The most highly enriched TF motifs in different classes are shown 
at the bottom. 
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Figure 2.19. Kinetic classes have different TF motifs enriched in their 
promoters 
(A) AP-1 TF motif is highly enriched within the HSF1 peaks. 
(B) Significantly represented TF motifs out of 1200 different TF motifs scanned 
in the promoter region of the three kinetic classes of upregulated genes in WT 
MEFs. P-value of motif enrichment over 3rd order Markov model is shown in 
heatmap in negative Log10 scale (left) with sequence logo of most enriched 
motif (mid), and the TFs that bind to sequences similar to the motifs. 
(C) PRO-seq density (with 95% confidence interval in light shades) around the 
TSS of transiently induced genes (class II) upon HS. 
(D) PRO-seq density (with 95% confidence interval in light shades) around the 
TSS of late induced genes (class III) upon HS. 
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targets of TFs that are induced in the earlier phase of HSR. Promoters of 
genes in this class are enriched in antioxidant binding elements where Nuclear 
Factor, Erythroid 2-Like 2 (NFE2L2) is known to bind and induce oxidative 
stress response genes (Li and Kong, 2009). Unlike class II genes, PRO-seq 
density in the pause regions of these genes increases over the course of HS 
(Figure 2.19D), while increase in the gene-body only occurs at the 60’HS. 
 Class IV comprises genes that are downregulated immediately upon 
HS. These genes are characterized by progressive reduction in PRO-seq 
density over the course of HS due to the inhibition of Pol II release into 
productive elongation from the promoter-proximal paused state. This class is 
enriched for genes related to metabolism, cell cycle, and protein synthesis.  
 Class V consists genes that are unaffected during the early phase of 
the HSR but are downregulated in the late phase. Similar to the class IV, these 
genes are also regulated at the level of pause release. Interestingly, genes in 
this class are highly enriched for processes like splicing, mRNA processing, 
and nuclear transport.  
 To distinguish the characteristic features of five kinetic classes, we 
probed for all published and ENCODE-deposited genome-wide data in MEFs. 
We found that the kinetic classes are differentially enriched for several histone 
marks and Pol II prior to HS (Figures 2.20A and 2.20B). The class II genes are 
primed with higher levels of paused Pol II and higher permissive histone 
modifications compared to both class I and class III. In contrast, we did not 
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Figure 2.20. Kinetic classes have different chromatin modification 
enriched in their promoters 
(A) Level of different histone marks and Ser5 Pol II (with 95% confidence 
interval in light shades) prior to HS around the TSS of three kinetic classes of 
transcriptionally-induced genes upon HS. PRO-seq density around the TSS for 
those genes is also shown. 
(B) Level of different histone marks and Ser5 Pol II (with 95% confidence 
interval in light shades) prior to HS around the TSS of two kinetic classes of 
transcriptionally-repressed and unregulated genes upon HS. PRO-seq density 
around the TSS for those genes is also shown. 
 
 
		
	
	
131	
 
 
 
 
		
	
	
132	
find significant differences in histone modifications between the downregulated 
classes (class IV and class V). Overall, the differences in the kinetics and 
dynamics of regulation, in the associated TFs, Pol II, and histone marks, and 
in the specific biological processes targeted by each gene class indicate a 
highly regulated and carefully calibrated response mechanism that cells have 
evolved to cope with heat stress. 
 
Discussion 
 Transcriptional regulation provides a major and primary level of defense 
from various proteotoxic stresses in cells from yeast to humans, yet the 
precise mechanism of global changes in gene expression during the HSR has 
remained unknown. Characterizing the complete network of regulated genes 
and understanding the molecular mechanisms involved in HSR are also critical 
for discovering novel therapeutic tools for cancer and neurodegenerative 
disorders as many players in the HSR are involved in these diseases. Here, 
we show that the HSR modulates an extensive fraction of the transcriptome, 
significantly upregulating 10% and downregulating 55% of the active genes at 
the level of transcription. HSR is extremely rapid, inducing changes in 
transcriptional patterns in as little as a minute and half, and different classes of 
genes exhibit diverse kinetics and dynamics of regulation. Mechanistically, we 
show that Pol II release from the promoter-proximal pause is a major 
regulatory step in both induction and repression of genes upon HS, and our 
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comprehensive analyses show that HSR is rapid, robust, and much more 
extensive than generally appreciated.  
 HSF1 is generally considered to be the master regulator of the HSR. In 
this study, while we demonstrate that HSF1 is critical for induction of over 250 
genes, including the classical Hsps, we also show that HSF1 accounts for only 
a fraction of the transcriptionally-induced genes upon HS. Moreover, HSF1 
has no detectable role in genome-wide repression. We demonstrate this by 
quantifying HS-induced changes in the density of transcribing Pol II complexes 
across the genome at high temporal and spatial (base pair) resolution using 
the extremely sensitive PRO-seq assay. We assessed the role of HSF1 both 
by performing a kinetic analysis of genome-wide changes in HSF1 binding 
upon HS using highly-specific antibodies in ChIP-seq, and by repeating the 
PRO-seq kinetic measurements in MEFs that have knock out of HSF1.  
HSF1 is critically required during HS for induction of Hsps and over 200 
other HSF1-dependent genes. HSF1 induces transcription in these genes by 
increasing the release of paused Pol II into productive elongation. These 
HSF1-dependent, upregulated genes also show concomitant increase in the 
level of paused Pol II; however this occurs in both WT and Hsf1-/- MEFs 
indicating the recruitment of Pol II to these genes during HS is mostly HSF1-
independent. While this increased recruitment could be regulated by other HS-
sensing TFs, we prefer the simple explanation that the increased availability of 
Pol II, which is caused by the global downregulation of transcription, drives this 
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Pol II loading onto the genes. Because global downregulation of transcription 
is also HSF1-independent, this increase availability of Pol II occurs in both WT 
and Hsf1-/- MEFs. 
Interestingly, some genes bound by HSF1 in their promoters are not 
transcriptionally induced. This indicates that HSF1 that is bound near 
promoters requires a compatibility with other features of the promoter and its 
regulatory regions. This compatibility may require a promoter have both 
paused Pol II and features that recruit P-TEFb kinase, which is required 
generally for pause release in mammals (Jonkers et al., 2014; Price, 2000; 
Takahashi et al., 2011). In Drosophila polytene chromosomes, recruitment of 
the pause release factor P-TEFb to the heat shock loci was found to be 
dependent on HSF1 but this recruitment appeared not to be through a direct 
interaction with P-TEFb (Lis et al., 2000).). In this study, we observed an 
increase in P-TEFb level at the promoters of HS-induced genes and decrease 
in its level at the promoters of HS-repressed genes. We hypothesize that the 
nuclear P-TEFb level is redirected in HSF1-dependent manner to genes that 
are induced during HS. This active delivery of P-TEFb drains its free pool and 
results in reduced P-TEFb level at the promoters of non-critical genes resulting 
in their repression due to lack of pause release. This hypothesis can be tested 
by overexpression of P-TEFb. If the global redistribution of P-TEFb is driving 
the genome-wide transcription repression, we would expect rescue of 
transcription repression during HS due to higher availability of P-TEFb for non-
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critical genes. This would be a critical step in understanding the precise 
interplay of HSF1 and other promoter elements and TFs in recruitment of P-
TEFb. 
In addition to promoters, HSF1 binds to many intragenic and intergenic 
sites. Intragenic HSF1 bound sites were previously proposed to repress 
transcription by creating a barrier in the gene-body to transcription. This 
particular hypothesis does not explain the bulk of downregulation observed in 
our study, as we find the intragenic HSF1 has very little influence on 
transcriptional downregulation on the bound gene. The intragenic-bound HSF1 
bound genes that show transcriptional repression in WT, are also repressed in 
Hsf1-/- MEFs with comparable magnitude and kinetics. We further show that 
the density of Pol II upstream of the intragenic-bound HSF1 does not increase, 
indicating gene-bound HSF1 does not create appreciable impediment to 
elongating Pol II.  
Intergenic-bound HSF1 is difficult to assign to a target gene without a 
high-resolution chromatin interaction map. Nevertheless, the divergent PRO-
seq profile around the intergenic-bound HSF1 and the presence of HSF1-
dependent genes without promoter bound HSF1 indicates that at least some of 
the intergenic-bound HSF1 functions as enhancer. The 150 HSF1-dependent 
genes that are not bound in their promoter region by HSF1 are potential 
targets of enhancer-bound HSF1. The transcription induction of these genes 
also occurs by an HSF1-dependent increase in pause release. This further 
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strengthens the role of HSF1 in HSR as a factor that increases the release of 
paused Pol II into productive elongation.  
 Theoretically, enhancer-bound HSF1 could not only induce but also 
repress transcription. We identify 232 genes in this study that have no 
detectable HSF1 binding but are induced at 60’HS in Hsf1-/- MEFs only. These 
genes could either be directly repressed by enhancer-bound HSF1, which is 
very unlikely given the absence of a documented role of HSF1 in repression, 
or indirectly repressed by HSF1 through HSF1-dependent TFs. While many of 
the genes induced in Hsf1-/- MEFs encode subunits of ATPase machinery, 
understanding the role of HSF1 in induction of these genes upon HS and the 
precise mechanism of their induction require study beyond the scope of this 
thesis. Nevertheless, our work redefines the role of HSF1 as the master 
regulator of HSR and demonstrates that the function of HSF1 is specialized in 
the robust activation of Hsps and over 200 other genes during HSR. This study 
also identifies over 900 genes that are induced upon HS in HSF1-independent 
manner and identifies additional TFs as potential activators of HSR.  
 One such TF that appears to play a large role in mediating the HSR is 
SRF. Arsenite-mediated stress is known to activate SRF via MAPK pathway, 
(Heidenreich et al., 1999); however, SRF’s role in HSR was completely 
uncharacterized until now. The DNA-binding element of SRF is exceptionally 
enriched in promoters of transiently-induced genes during HSR, majority of 
which are cytoskeleton proteins. We hypothesize that the dramatic 
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cytoskeletal changes at the onset of HSR is the trigger that selectively induce 
genes in cytoskeleton family via the action of SRF.  SRF activity depends on 
the MAL cofactor, which also binds to monomeric actin, and this actin binding 
sequesters MAL to the cytoplasm (Miralles et al., 2003; Vartiainen et al., 
2007).  In this model, the cytoskeletal polymerization caused by HS reduces 
the level of monomeric actin allowing MAL to form a complex with SRF and 
activate SRF-responsive genes.  The transient induction of these genes could 
be mediated by the known feed-back loop where monomeric actin expression 
driven by SRF inhibits MAL association and activation of SRF (Sotiropoulos et 
al., 1999). 
 Transcriptional downregulation in response to HSR is one of the major 
regulatory adaptations proposed to reduce protein synthesis and misfolded 
protein aggregates (Jamrich et al., 1977; Lindquist, 1986). Our results indicate 
that the global downregulation is mediated by inhibition of promoter-proximal 
paused Pol II release into productive elongation and is independent of HSF1. 
However, the recruitment of Pol II to the downregulated genes is generally 
unaffected during HS causing an increase in paused Pol II, in contrast to a 
previous study in Drosophila cells that reported a reduction in paused Pol II 
levels upon HS, perhaps reflecting an evolutionary plasticity in the 
transcription steps that can be targeted (Teves and Henikoff, 2011). 
Identification of pause escape as a targeted regulatory step in transcription, 
provides a set of candidate factors associated with Pol II release from the 
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pause for future explorations of the mechanisms of repression during HS. By 
examining the mechanism of induction and repression, we demonstrate that 
the rapid HS-induced changes in PRO-seq density for both induced and 
repressed genes emanate from the promoter-associated pause region as a 
wave. Therefore, the increase and decrease in transcriptionally-engaged Pol II 
densities are not a consequence of thermally induced effects on Pol II 
elongation rates or processivity, but rather to changes on the rates of Pol II 
release from the pause. 
 Previous studies probing the genome-wide transcriptome regulated 
during HSR were unable to observe the primary transcriptional kinetics due to 
the requirement of longer HS treatment duration to accumulate or deplete 
polyadenylated mRNAs. Our approach of sequencing nascent RNAs before 
and after HS at multiple time points revealed that the transcription regulation is 
not a monolithic response. It comprises several classes of regulated genes 
with characteristic kinetics and dynamics. For instance, some genes are 
transcriptionally induced very early during HSR and they continue to be 
induced. Some are transiently induced and others are induced after a certain 
delay. Many in the latter class are likely the target of TFs induced in the early 
phase of HSR or late-binding HSF1. Identification of the precise step in 
transcription regulated in transient and late induction of genes requires further 
exploration. Similarly, downregulation also occurs in two distinct phases: early 
repressed genes encode proteins involved in cell cycle and metabolism and 
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late repressed genes encode proteins involved in mRNA processing. Post-
transcriptional mRNA splicing is compromised after two hours of HS in MEFs 
(Shalgi et al., 2014), and our results indicate that a downregulation of splicing 
factors within the first hour of HS could be a contributing mechanism.  
In summary, this study demonstrates the extensive nature of 
transcriptional regulation during HSR, where many hundreds of genes are 
activated and thousands repressed and with different classes of genes 
showing remarkably rapid and distinct kinetic profiles of regulation. This study 
also redefines the prevailing opinion that HSF1 is the master regulator of HSR: 
it demonstrates HSF1 as one major regulator specializing in robust induction 
of only a subset of genes regulated during HSR, and it identifies additional TFs 
as candidate regulators of HSR. The profiles of Pol II in wild type and Hsf1-/- 
MEFs also establishes that the release from promoter-proximal pause is the 
mechanistic step in transcription induction targeted by HSF1, and in global 
HSF1-independent repression of genes. Finally, the insights into the 
mechanism of HSF1 action and its primary gene targets will hopefully prove 
useful in the development of HSF1-based therapeutics for cancer and 
neurodegenerative disorders. 
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CHAPTER 3b 
 
ROLE OF HSF2 IN MAMMALIAN HEAT SHOCK RESPONSE 
 
Summary 
 Transcription is one of the major nodes of regulation of the heat shock 
response orchestrated by the heat shock factor (HSF). Mammals have 
multiple HSFs: HSF1-4, and HSF1 is the primary inducer of heat shock protein 
genes (Hsps) that are responsible for restoration of proteostasis during stress. 
However, stress specific function of HSF2, which shares sequence homology 
to HSF1 and binds to the same DNA sequence, is poorly understood. Here, 
we show that HSF2 has a role in transcription repression but does not regulate 
transcription induction during HSR. Although HSF2 binds to the promoters of 
some heat-inducible Hsps, the binding is dependent on HSF1, and the 
induction of these Hsps is not dependent on HSF2. Strikingly, the vast majority 
of HSF2-dependent down-regulated genes lack HSF2 binding, suggesting an 
indirect role of HSF2 in repression. Together, this study decouples HSF2 from 
rapid and robust induction of Hsps during mammalian HSR, and elucidates its 
broader repressive role, which is likely mediated through other factors. 
																																																						
b Partially adapted from Mahat, D. B., Salamanca, H. H., Duarte, F. M., Danko, 
C. G., & Lis, J. T. (2016). Mammalian Heat Shock Response and Mechanisms 
Underlying Its Genome-wide Transcriptional Regulation. Molecular Cell, 62(1), 
63–78. Reprinted with permission from Elsevier. 
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Introduction 
 One major environmental change that organisms have to endure during 
their lifespan is temperature fluctuation. Exposure to elevated temperature 
could alter protein homeostasis and eventually disrupt optimal cellular 
environment. In order to cope with heat and other proteotoxic agents, species 
of all complexity from bacteria to humans have evolved with a highly 
conserved defense mechanism known as the heat shock response (HSR). 
This protective response is orchestrated at transcriptional level by heat shock 
factor (HSF).  
 Model organisms such as bacteria, yeast, worms, and fruit flies have a 
single HSF and are capable of mounting a robust HSR. However, mammalian 
model species such as mouse, rats, and humans have multiple HSFs: HSF1, 
HSF2, HSF3, and HSF4 (Akerfelt et al., 2010).  HSF1 and HSF2 are 
ubiquitously expressed and share sequence homology (Ahn et al., 2001) and 
structural similarity (Jaeger et al., 2016; Neudegger et al., 2016). They bind to 
identical DNA sequence known as heat shock element (HSE) as homo- or 
hetero-trimer (Manuel et al., 2002; Sandqvist et al., 2009). Moreover, Hsf2 
gene is not essential for survival as Hsf2-/- mouse exhibit normal growth and 
viability (McMillan et al., 2002).  
 Despite HSF2’s striking similarity with HSF1 and its apparent 
dispensability in organism’s growth and survival, HSF2 has overcome 
evolutionary scrutiny of this apparent redundancy, indicating its importance in 
		
	
	
153	
non-critical cellular functions. Indeed, HSF2 is required for optimal brain 
development and differentiation of reproductive organs (Kallio et al., 2002). 
HSF2 occupies hundreds of loci in mitotic cells (Vihervaara et al., 2013), binds 
in a cluster and regulates genes in male-specific region of the Y chromosome 
(Akerfelt et al., 2008). It also binds to the promoters of selected Hsps under 
normal temperature and modulates their expression (Wilkerson et al., 2007) 
indicating its specialization in non-stress-related functions. However, HSF2 
has a limited role in stress response. HSF2 heterotrimerizes with HSF1 upon 
HS and binds to the Hsp70 promoter (Ostling et al., 2007). It preferentially 
binds to satellite III repeats in nuclear stress granules (Alastalo et al., 2003). 
Nevertheless, the genome-wide role of HSF2 in transcription regulation during 
HSR remains to be fully elucidated. 
 Understanding the contribution of HSF2, either by coordinating with 
HSF1 or as a compensatory factor of HSF1, in regulation of HSF1-dependnet 
genes during HS would underscore the evolutionary relevance of multiple 
HSFs in vertebrates. Similarly, if HSF2 has evolved to regulate a different set 
of genes than HSF1, identifying those genes and understanding the 
mechanism of their regulation would reveal the evolutionary rationale in 
diversification of heat shock transcription factor. More importantly, as 
modulation of HSF1’s level and activity are being considered in treatment of 
neurological disorders and cancers (Neef et al., 2011; Whitesell and Lindquist, 
2009), knowing HSF2-regulated genes, its mode of action, and its interaction 
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with HSF1 is critical in making informed decision on HSF1 inhibition or 
activation. 
 In this study, we examined the transcriptional roles of HSF2 in stress 
response with and without HSF1. We used precision nuclear run-on 
sequencing assay (PRO-seq) (Kwak et al., 2013) to measure nascent 
transcription prior to and at various time points during heat shock (HS) in Hsf2-
/- and Hsf1&2-/- mouse embryonic fibroblasts (MEFs). To identified the HSF2-
regulated genes and to decipher HSF2’s role in global transcriptional changes 
during HS, we assessed the genome-wide transcriptional changes upon HS in 
these cell types and compared to our previously published study in WT and 
Hsf1-/- MEFs (Mahat et al., 2016). We carried out a time course of HSF2 
chromatin immunoprecipitation and sequencing (ChIP-seq) in WT and  Hsf1-/- 
MEFs to distinguish the primary targets of HSF2. We also dissected the role of 
HSF1 and HSF2 in regulation of Hsps and elucidated HSF2’s dependence on 
HSF1 for DNA binding during stress. Although the precise mechanism of 
HSF2-mediated global repression remains to be resolved, the findings 
presented here reveal features of the mechanism and functions of HSF2 in 
regulation of transcription during HSR. 
 
Materials and methods 
Hsf2-/- cell line 
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 Mouse embryonic fibroblasts were generated from Hsf2-/- mouse 
(McMillan et al., 2002) and were kindly gifted to us by Yves Le Dréan, 
Universite de Rennes 1, Rennes, France. 
 
Data on wild type, Hsf1-/-, and Hsf1&2-/- MEFs 
 PRO-seq and ChIP-seq data on wild type, Hsf1-/-, and Hsf1&2-/- MEFs 
are taken from our previously published study (Mahat et al., 2016). 
 
Cell culture, heat shock, and nuclei isolation 
 Cell culture, heat shock, and nuclei isolation were performed as 
described previously (Mahat et al., 2016). In short, MEFs were grown in 
Dulbecco's Modified Eagle Medium supplemented with 10% heat inactivated 
fetal bovine serum (v/v) and 1% Penicillin Streptomycin (v/v) at 370C with 5% 
CO2 and 90% humidity.  
 Instantaneous HS was performed using ~80% confluent cells by adding 
pre-heated (420C) conditioned media collected from identically growing cells 
and by incubating the cell plates at 420C for the desired time. After the desired 
duration of HS, NHS cells grown at 370C and the heat shocked cells were 
harvested identically.  
 Nuclei isolation was done by douncing cells 25 times in cell membrane 
lysis buffer. The isolated nuclei were washed twice in lysis buffer and 
resuspended in storage buffer. 
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Nuclear run-on and PRO-seq library preparation 
 Nuclear run-on experiments were carried out by mixing 10 × 106 nuclei 
in 100µl of storage buffer with 100µl of 2x nuclear run-on buffer. The mix was 
incubated at 370C for three minutes. RNAs were isolated and base-hydrolyzed 
with 200 nM final concentration of NaOH to an average size between 100-150 
nucleotides. Biotinylated nascent RNAs were isolated with magnetic beads 
coated with streptavidin followed by 3’ adapter ligation. After another round of 
biotin-streptavidin affinity purification, the mRNA cap was removed and the 5’ 
adapter was ligated. After the third biotin-streptavidin affinity purification, cDNA 
was generated by reverse transcription and PRO-seq libraries were prepared 
for sequencing using Illumina TruSeq small-RNA adaptors. 
 
Mapping, normalization, and differential expression of PRO-seq libraries 
 PRO-seq reads were mapped against mm10 genome. Libraries were 
normalized using PRO-seq reads in 3’ end of long genes. Differential 
expression of PRO-seq libraries were performed using DESeq2. These 
methods are described in detail previously (Mahat et al., 2016). 
 
HSF2 ChIP-seq library preparation and peak calling 
 ChIP was performed as described previously with some modifications 
(Mahat et al., 2016). The HSF2 antibody was a generous gift of Lea Sistonen 
at University of Turku, Finland. HSF2 peaks were called against library 
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prepared with non-specific IgG using MACS2 (Zhang et al., 2008). In order to 
minimize the false positive peaks, we only considered HSF1 peaks that were 
identified with both antibodies at a threshold of 1e-05.  
 
Results 
Lack of HSF2 mitigates global downregulation during HSR 
 To decipher the role of HSF2 in HSR and to test whether HSF2 is 
compensating for the lack of HSF1 in Hsf1-/- MEFs, we performed PRO-seq in 
nuclei isolated from Hsf2-/- and Hsf1&2-/- MEFs at 0’, 2.5’, 12’, and 60’ after HS 
(Figure 3.1A and Table 3.1). Hsf2-/- MEFs were isolated from Hsf2-/- mouse that 
was generated by deletion of a 3 kb region in the 5’ end of the gene including 
exon 1 (McMillan et al., 2002), and Hsf1&2-/- MEFs were isolated from mouse 
generated by crossing Hsf1-/- and Hsf2-/- mouse (Lecomte et al., 2010; 2013). 
PRO-seq profiles confirm targeted genomic deletion in Hsf2 and Hsf1 & Hsf2 
genes to make Hsf2-/- and Hsf1&2-/- mice respectively (Figure 3.1B). Two 
PRO-seq libraries were made for each cell type and condition, and the 
biological replicates correlated well (Figure 3.1C and Table 3.2).  
 We then quantified PRO-seq density in all genes and measured 
genome-wide change in transcription during HS. Similar to WT and Hsf1-/- 
MEFs, few genes are regulated as early as 2.5 min of HS in both Hsf2-/- and 
Hsf1&2-/- MEFs and the number of transcriptionally changed genes increases 
with HS time (Figure 3.2A). Although the overall profile of transcriptional  
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Figure 3.1. PRO-seq in Hsf2-/- and Hsf1&2-/- MEFs 
(A) Experimental set-up, PRO-seq assay was performed in nuclei isolated 
from Hsf2-/- and Hsf1&2-/- MEFs at NHS, 2.5’HS, 12’HS, and 60’HS. 
(B) Genome browser screenshot of Hsf1 and Hsf2 gene. The 2 kb region 
devoid of PRO-seq reads (green box) in Hsf1 gene represents half of the DNA 
binding domain and trimerization domain excised to create Hsf1-/- MEFs. 
Similarly, the 3 kb region including the 1st exon of Hsf2 gene devoid of PRO-
seq reads (green box), was excised to create Hsf2-/- MEFs. 
(C) A representative correlation plot between the biological replicates of PRO-
seq libraries in the pause region (left) and the gene-body region. Complete 
table of Pearson and Spearman correlation values are listed in Table 3.2. 
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Table 3.1. Sequencing depth & alignment statistics of PRO-seq libraries. 
 
Library Sequenced Unaligned (%) 
Non-
unique (%) 
Aligned to 
mm10 
Hsf2-/-_NHS_BR1 32,689,692 16.81 29.97 13,572,909 
Hsf2-/-_NHS_BR2 34,713,509 20.27 26.50 15,449,435 
Hsf2-/-_2.5’HS_BR1 34,068,909 18.58 30.08 13,279,281 
Hsf2-/-_2.5’HS_BR2 34,866,606 17.73 32.03 12,460,068 
Hsf2-/-_12’HS_BR1 36,229,989 16.97 30.67 14,824,815 
Hsf2-/-_12’HS_BR2 35,287,736 17.82 30.41 14,322,306 
Hsf2-/-_60’HS_BR1 35,282,523 12.95 30.79 15,522,593 
Hsf2-/-_60’HS_BR2 36,252,164 13.17 30.41 16,167,571 
Hsf1&2-/-_NHS_BR1 51,583,525 11.06 16.46 20,802,253 
Hsf1&2-/-_NHS_BR2 49,804,354 11.67 12.17 26,097,930 
Hsf1&2-/-_2.5’HS_BR1 93,139,446 3.57 23.88 14,574,252 
Hsf1&2-/-_2.5’HS_BR2 76,230,283 3.49 30.35 15,304,152 
Hsf1&2-/-_12’HS_BR1 61,272,461 9.43 15.40 24,686,166 
Hsf1&2-/-_12’HS_BR2 89,042,556 9.71 14.22 36,080,133 
Hsf1&2-/-_60’HS_BR1 91,113,987 9.18 17.64 39,617,211 
Hsf1&2-/-_60’HS_BR2 57,704,222 7.51 20.76 22,096,193 
 
 
 
Table 3.2. Correlation between biological replicates of PRO-seq libraries. 
 
Library Pearson correlation Spearman correlation 
 Promoter Gene body Promoter Gene body 
Hsf2-/-_NHS 0.99 0.99 0.98 0.97 
Hsf2-/-_2.5’HS 0.99 0.99 0.98 0.98 
Hsf2-/-_12’HS 0.98 0.99 0.98 0.97 
Hsf2-/-_60’HS 0.99 0.99 0.98 0.98 
Hsf1&2-/-_NHS 0.99 0.99 0.98 0.97 
Hsf1&2-/-_2.5’HS 0.99 0.99 0.98 0.98 
Hsf1&2-/-_12’HS 0.98 0.99 0.98 0.97 
Hsf1&2-/-_60’HS 0.99 0.99 0.98 0.98 
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Figure 3.2. More upregulated and less downregulated genes during HSR 
in absence of HSF2 
(A) 'Minus-average' (MA) plots represent PRO-seq density change in the 
gene-body of all genes (n=23460) between NHS and 2.5’HS (left panels), 
12’HS (mid panels), and 60’HS (right panels) in Hsf2-/- MEFs (top panels) and 
Hsf1&2-/- MEFs (bottom panels). Significantly upregulated genes (p-value < 
0.001 in DESeq2) are shown in gold and significantly downregulated genes 
are shown in blue. 
(B) Number of significantly changed genes upon HS in Hsf2-/- and Hsf1&2-/- 
MEFs at NHS, 2.5’HS, 12’HS, and 60’HS. Number of significantly changed 
genes upon HS in WT and Hsf1-/- MEFs are shown as well. Upregulated genes 
are shown in gold and downregulated genes are shown in blue. 
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change in Hsf2-/- and Hsf1&2-/- MEFs resemble the WT and Hsf1-/- MEFs, a 
closer inspection of actual number of changed genes at 60 min of HS, a 
duration for full-fledged HSR, and comparison with WT and Hsf1-/- MEFs 
reveal a higher number of genes were upregulated and fewer genes were 
downregulated in absence of HSF2 (Figure 3.2B). Similarly, comparison of 
Hsf1&2-/- with WT and Hsf1-/- MEFs also indicate that the decrease in number 
of upregulated genes in Hsf1-/- is compensated by further loss of HSF2 in 
Hsf1&2-/- MEFs, whereas HSF2’s absence results in fewer downregulated 
genes (Figure 3.2B). The number of upregulated genes in Hsf2-/- is also higher 
than in Hsf1&2-/- MEFs; however, the pool of downeregulated genes is 
relatively unchanged (Figure 3.2B). Together, these observations suggest that 
the HSF1 is a transcription inducer, whereas lack of HSF2 mitigates global 
downregulation during HSR. 
 
HSF2 plays a role in transcription repression during HS 
 To further investigate the opposing regulation of HSF1 and HSF2 during 
HSR, we correlated the HS-regulated genes, upregulated and downregulated 
separately, between all cell types. The upregulated genes have higher 
correlation between WT and Hsf2-/- and between Hsf1-/- and Hsf1&2-/- 
compared to other pairwise correlation, indicating HSF1’s presence or 
absence respectively as a major determinant in the number and the extent of 
upregulated genes (Figure 3.3A). Hsph1 gene is an example of HSF1- 
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Figure 3.3. Divergent roles of HSF1 and HSF2 during HSR 
(A) Correlation matrix showing the pairwise correlation between significantly 
upregulated genes in four cell types: WT, Hsf1-/-, Hsf2-/-, and Hsf1&2-/- MEFs. 
Correlation values are represented as heatmap and are also numerically 
stated. 
(B) Screenshots of Hsph1 gene representing HSF1-dependent induction (left 
panel) and Arfgef2 gene representing HSF2-dependent repression (right 
panel). PRO-seq density in sense and antisense direction is shown in red and 
blue respectively. Small vertical black bars at the bottom of PRO-seq tracks 
represent the genomic regions that do not map uniquely at 36bp resolution. 
(C) Correlation matrix showing the pairwise correlation between significantly 
downregulated genes in four cell types: WT, Hsf1-/-, Hsf2-/-, and Hsf1&2-/- 
MEFs. Correlation values are represented as heatmap and are also 
numerically stated. 
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dependent induction, which is induced in WT and Hsf2-/- but not in Hsf1-/- and 
Hsf1&2-/- MEFs (Figure 3.3B, left panel). In contrast, the downregulated genes 
have higher correlation between WT and Hsf1-/- and between Hsf2-/- and 
Hsf1&2-/-, compared to other pairwise correlation, indicating HSF2’s presence 
or absence respectively in this case as a key element in downregulation 
(Figure 3.3C). Arfgef2 gene is an example of HSF2-mediated repression, 
which is downregulated in WT and Hsf1-/- but not in Hsf2-/- and Hsf1&2-/- MEFs 
(Figure 3.3B, right panel). These analyses indicate that HSF1 induces 
transcription during HSR but has no role in repression, which is also 
demonstrated by our earlier study of HSR in WT and Hsf1-/- MEFs (Mahat et 
al., 2016), whereas HSF2 plays a role in transcription repression and has little 
to no effect in induction.  
 Because HSF2 is present in both WT and Hsf1-/- MEFs, we examined 
whether similarly regulated genes in WT and Hsf1-/- MEFs (494 significantly 
upregulated and 7257 significantly downregulated genes) were in fact 
regulated by HSF2. We measured transcriptional changes on those genes in 
Hsf2-/- and Hsf1&2-/- and compared alongside WT and Hsf1-/- MEFs. Many 
genes similarly regulated in WT and Hsf1-/- show comparable regulation in 
Hsf2-/- and Hsf1&2-/- MEFs as shown by the two examples (Figure 3.4A). All 
upregulated genes in WT and Hsf1-/- are upregulated to the same extent in 
Hsf2-/- and Hsf1&2-/- (Figure 3.4B, left panel) indicating that they were not a 
result of HSF2-mediated compensation. However, the number of significantly  
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Figure 3.4. HSF2 likely plays a role in transcription repression during HS 
(A) Screenshots of Atf3 gene representing similarly induced genes in all cell 
types (left panel) and Iggap3 gene representing similarly repressed genes in 
all cell types (right panel). PRO-seq density in sense and antisense direction is 
shown in red and blue respectively. Small vertical black bars at the bottom of 
PRO-seq tracks represent the genomic regions that do not map uniquely at 
36bp resolution. 
(B) Heatmap showing the transcriptional status in Hsf2-/- and Hsf1&2-/- MEFs 
upon HS for significantly upregulated genes (left) and significantly 
downregulated genes (right) in WT and Hsf1-/- MEFs.  
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downregulated genes is lower in Hsf2-/- and Hsf1&2-/- compared to the WT and 
Hsf1-/- MEFs and the extent of downregulation is also relatively low (Figure 
3.4B, right panel). This observation that some genes dowregulated in WT and 
Hsf1-/- are not downregulated in Hsf2-/- and Hsf1&2-/- strengthens our 
hypothesis that HSF2 mediates repression of at least some genes in WT and 
Hsf1-/- cells. 
 
HSF2-dependent HS-regulated genes are not bound by HSF2 
 The HSF2-dependent regulation could either be a result of direct HSF2 
binding to the promoters of regulated genes or a secondary effect mediated 
through other factors. To discern these possibilities, we probed genome-wide 
HSF2 binding during HS in WT and Hsf1-/- MEFs using ChIP-seq (Figure 3.5A 
and Table 3.3). The HSF2 antibody used in this ChIP-seq study is specific to 
mammalian HSF2 (Vihervaara et al., 2013), and as a control, we used non-
specific IgG. We found that HSF2 binds to the promoters of heat-inducible 
Hsps such as Hsph1 gene (Figure 3.5B), similar to HSF1 (Figure 3.5C) (Mahat 
et al., 2016). Interestingly, HSF2 binding at the promoter of Hsph1 gene is 
severely limited in Hsf1-/- cells (Figure 3.5B) indicating HSF2’s dependence on 
HSF1 for binding. We tested whether the reliance of HSF2 on HSF1 for DNA 
binding upon HS is a general feature or limited to Hsps. We took the union of 
all HSF2 peaks in WT cells and then quantified HSF2 ChIP-seq signal around 
those peaks in WT and Hsf1-/- cells. In WT cells, HSF2 binding gradually  
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Figure 3.5. HSF2 ChIP-seq in WT and Hsf1-/- MEFs 
(A) Experimental set-up, ChIP-seq libraries in WT MEFs were made in 
duplicates with chromatin immunoprecipitated with non-specific IgG and a 
HSF2 specific antibody at NHS, 12’HS, and 60’HS. Additionally, ChIP-seq 
libraries were also made with the HF2 antibody in Hsf1-/- MEFs. 
(B) Screenshot of Hsph1 gene shows HSF2 ChIP-seq read density in WT and 
Hsf1-/- MEFs. The scale on the y-axis represents the relative number of ChIP-
seq tags under the peaks. 
(C) Screenshot of Hsph1 gene shows HSF1 ChIP-seq (previously published) 
read density in WT and Hsf1-/- MEFs. The scale on the y-axis represents the 
relative number of ChIP-seq tags under the peaks. 
(D) Composite profile of HSF2 ChIP-seq signal in WT MEFs (left panel) and 
Hsf1-/- MEFs (right panel) around all HSF2 peaks in WT MEFs. 
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Table 3.3. Sequencing depth & alignment statistics of ChIP-seq libraries 
made with HSF2 antibody or IgG. 
 
Library Sequenced reads 
Adapter 
dimers  Unaligned 
Uniquely 
aligned (mm10) 
WT_NHS_IgG 31,175,847 3,395 611,608 30,560,844 
WT_12'HS_IgG 20,594,110 4,019 445,030 20,145,061 
WT_60'HS_IgG 42,710,902 2,851 1,164,766 41,543,285 
     
WT_NHS_HSF2 45,864,673 3,588 888,834 44,972,251 
WT_12'HS_HSF2 19,904,271 2,683 1,051,611 18,849,977 
WT_60'HS_HSF2 16,100,424 2,975 1,081,322 15,016,127 
     
Hsf1KO_NHS_IgG 13,825,759 4,717 1,154,664 12,666,378 
     
Hsf1KO_NHS_HSF2 22,189,379 2,735 999,132 21,187,512 
Hsf1KO_12'HS_HSF2 39,710,601 16,583 1,296,544 38,397,474 
Hsf1KO_60'HS_HSF2 16,754,781 2,241 986,932 15,765,608 
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increases upon HS and exhibit prominent binding by 60 min of HS (Figure 
3.5D, left panel). However, HSF2 binding is severely impaired in Hsf1-/- cells 
(Figure 3.5D, right panel). Together, these observations indicate that the 
dependence of HSF2 on HSF1 for DNA binding during HS is a general feature. 
At certain genes, HSF2 is known to heterotrimerize with HSF1 for binding 
(Sandqvist et al., 2009), and the requirement of HSF1 for HSF2 binding to the 
Hsp70 promoter was previously reported (Ostling et al., 2007), however, 
HSF1’s role in guiding HSF2 to the HS-specific genomic loci was not 
appreciated as a general rule.  
 Because HSF2 binding is virtually absent in Hsf1-/- cells, we focused 
HSF2 binding analysis on WT cells. We examined HSF2 binding on two class 
of genes: HSF2-dependent upregulated genes, an example of which is shown 
in Figure 3.6A, left panel, and HSF2-dependent downregulated genes, 
example shown in Figure 3.6A, right panel. HSF2 binding was absent from all 
HSF2-dependent upregulated genes and HSF2 binds to only 4% of the HSF2-
dependent downregulated genes (Figure 3.6B). These results indicate that 
both HSF2-dependent transcription upregulation and downregulation during 
HS is a secondary effect of HSF2 likely mediated through other factors.   
 
Transcription repression is mediated by inhibition of promoter-proximal 
pause release 
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Figure 3.6. HSF2-dependent HS-regulated genes are not bound by HSF2 
(A) Screenshots of II13ra1 gene representing HSF2-dependent induction 
during HS (left panel) and Trim33 gene representing HSF2-dependent 
repression (right panel). PRO-seq density in sense and antisense direction is 
shown in red and blue respectively. Small vertical black bars at the bottom of 
PRO-seq tracks represent the genomic regions that do not map uniquely at 
36bp resolution. 
(B) Total numbers of genes regulated in HSF2-dependent manner are shown 
in darker shades (induced in orange and repressed in green) and the numbers 
of genes bound by HSF2 within those catagories are shown in lighter shades. 
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The lack of HSF2 severely reduces the pool of downregulated genes during 
HS, from ~8000 in WT and Hsf1-/- to ~5000 in Hsf2-/- and Hsf1&2-/- cells. 
Nevertheless, 5000 genes still account for a third of actively transcribing 
genes. We previously showed that the global downregulation of transcription in 
WT and Hsf1-/- cells is caused by inhibition of Pol II release from promoter- 
proximal pause (Mahat et al., 2016). We found the same regulatory 
mechanism being responsible for global downregulation of genes in Hsf2-/- and 
Hsf1&2-/- (Figure 3.7A). The increase in paused Pol II is confined to the first 
few hundred bps from the TSS (Figure 3.7B). This finding further establishes 
the promoter-proximal pause release as the key regulatory step in 
transcription regulation during HS. 
 
HSF2 does not compensate for the loss of HSF1 during HSR 
 Our recent work established the dependence of transcription induction 
of heat-inducible Hsps on HSF1. However, the interplay of HSF1 and HSF2 in 
induction of Hsps is unclear. HSF1 and HSF2 can form heterotrimer and we 
showed earlier that HSF2 binds to the promoter of heat-inducible Hsps in WT 
MEFs (Figure 3.5B). To dissect the contribution of HSF2 in induction of Hsps, 
we compared the transcriptional change in major Hsps in Hsf2-/- and Hsf1&2-/- 
with WT and Hsf1-/- cells. The profile of transcriptional change in Hsf2-/- looks 
very similar to WT – heat-inducible Hsps are robustly induced in both cell 
types (Figure 3.8). Similarly, the heat-inducible Hsps are not induced in Hsf1-/-  
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Figure 3.7. Transcription repression is mediated by inhibition of 
promoter-proximal pause release 
(A) Heatmap of PRO-seq density fold change from 60’HS to NHS for 
significantly downregulated genes at 60’HS in Hsf2-/- (top) and Hsf1&2-/- MEFs 
(bottom). Each row represents a gene, scaled to same length and divided into 
100 bins, from TSS up to polyA site for genes shorter than 24 kb and up to 24 
kb for genes longer than 24kb. 
(B) Histogram of average PRO-seq density in 10 bp bins from TSS to 1 kb into 
the gene-body for significantly downregulated genes at 60’HS in Hsf2-/- (top) 
and Hsf1&2-/- MEFs (bottom).  
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Figure 3.8. HSF2 does not compensate for the loss of HSF1 during HSR 
PRO-seq density change upon HS in 30 Hsps in WT, Hsf1-/-, Hsf2-/-, and 
Hsf1&2-/- MEFs (top to bottom) at 2.5, 12, and 60 min of HS. The genes are 
ordered from left to right by increasing fold change at WT 60’HS. 
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and Hsf1&2-/-, emphasizing their dependence on HSF1 (Figure 3.8). The 
similarity in the regulation of Hsps in Hsf1-/- and Hsf1&2-/- further indicates that 
HSF2 does not compensate for the lack of HSF1.  
 Although the regulation of Hsps look very similar between WT and Hsf2-
/- cells, the extent of upregulation is higher and downregulation is lower in  
Hsf2-/- compared to WT cells. This suggests that the binding of HSF2 to the 
Hsps promoters, possibly as a heterotrimer with HSF1 in HSF1-dependent 
manner, likely compromises the induction potential of HSF1. Again, this role of 
HSF2 in attenuating the upregulation of Hsps further bolsters our hypothesis of 
HSF2 being more of a repressor than inducer of transcription during HS. 
 
Discussion 
  The discovery of HSF2 (Sarge et al., 1991; Schuetz et al., 1991) – a 
paralog of HSF1 that shares similarity to HSF1 in sequence composition, 
protein structure, and DNA substrate for binding – has incited long-standing 
questions on its functional relevance and evolutionary discretion for its 
selection. It is exclusively present in vertebrates but whether it complements 
HSF1 or compromises it remained poorly understood. Past studies on a few 
Hsp genes using biochemical, optical, and genetic tools have provided 
valuable information on HSF2’s role. However, the generality of such 
anecdotal evidence required comprehensive studies. In this study, we used 
genome-wide approaches to explore some unresolved aspects of HSF2 
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biology. We quantified global nascent transcription at multiple time-points 
during HSR in Hsf2-/- and Hsf1&2-/- cells using PRO-seq – a genomic assay 
with high sensitivity and base pair resolution. Comparing the transcriptional 
profile change in these two cell types and with our previously reported study 
on WT and Hsf1-/- cells, we found 45 genes induced in HSF2-dependent 
manner during HSR, but no Hsps. On the contrary, HSF2 was responsible for 
more than a third of repressed genes in WT and Hsf1-/- cells. To distinguish 
the primary from secondary role of HSF2 on transcription regulation, we 
generated HSF2 ChIP-seq data. Binding landscape of HSF2 revealed that the 
HSF2-dependent repressed genes were likely mediated through a secondary 
factor, as they lacked direct HSF2 binding. Furthermore, we showed that the 
inducible binding of HSF2 at some Hsp promoters during HS is dependent on 
HSF1, likely as a heterotrimer, and the hitchhiked HSF2 marginally attenuates 
the activating potential of HSF1.  
 Our previous study of HSR in WT and Hsf1-/- MEFs identified many 
genes that were similarly induced in these cell types. HSF2 is a conceivable 
candidate that could compensate for the lack of HSF1 in controlling the 
commonly regulated genes in WT and Hsf1-/-. Despite the identical DNA 
binding sites and similar DNA binding domain, we learned from this study that 
HSF2 does not compensate for the absence of HSF1 for induction of 
commonly regulated genes in WT and Hsf1-/- MEFs, nor does it for Hsps, 
indicating non-redundant roles of this ubiquitously-expressed HSF1 paralog. 
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This observation warrants an explanation for evolutionary favorability of 
multiple HSFs in vertebrates. One likely explanation may reside beyond the 
sphere of HSR. Perhaps the HSF2 that resulted from duplication of HSF1 prior 
to the vertebrate radiation structurally evolved and specialized on non-critical 
constitutive cellular functions. DNA-proximal domains of HSF1 and HSF2 
share similar features, however, DNA-distal parts such as trimerization and 
activation domains exhibit different characteristics thereby driving diverse 
post-translational modifications and interacting partners (Jaeger et al., 2016). 
Constitutive HSF2 function is implicated in brain development (Kallio et al., 
2002) and fetal alcohol syndrome (Fatimy et al., 2014). HSF2 is known to 
suppress prostate cancer invasion (Björk et al., 2016) and mutations in HF2 is 
associated with idiopathic azoospermia (Mou et al., 2013; Wilkerson et al., 
2008). Therefore, the limited role of HSF2 in transcription induction during 
HSR should not be confused for its lack of significance as it may have 
specialized in non-stress-related cellular functions, many of which remain to 
be shown. 
 HSF2 clearly played a major role in transcription repression during 
HSR. Anecdotal evidence of HSF2’s role in repression has been previously 
documented – it is known to repress HSR in mitotic cells, (Elsing et al., 2014), 
but the dominant repression of 1411 genes during HS has not been reported 
before in interphase cells. Lack of HSF2 binding at these promoters supports a 
model where either inducer of these genes during HS is constitutively 
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repressed by HSF2 or their repressor is induced by HSF2 upon stress. 
Alternatively, HSF2 could bind to distal regulatory elements and control 
transcription through long-range mediated interaction, although this scenario is 
rather unlikely due to lack of HSF2-bound intergenic and intragenic genomic 
sites (data not shown). The use of knock-out cells in this study, where the cells 
have likely compensated for the constitutive lack of HSF1 or HSF2, 
complicates our attempt to identify underlying mechanism of their function. In 
future, novel tools and approaches that can rapidly and robustly impair the 
function of specific domains or the entire protein can be used to directly probe 
the primary role of HSF2 during HSR. 
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CHAPTER 4 
 
TRANSCRIPTIONAL RECOVERY AFTER HEAT SHOCK RESPONSE 
 
Summary 
 Heat shock response is a cellular defense mechanism against heat 
stress and its activation can protect cells from stress-induced apoptosis. Cells 
that have recovered from heat stress perform better against subsequent 
exposure to such stress. This acquired thermotolerance is prevalent across 
wide spectrum of life. However, the molecular mechanism for this evolutionary 
beneficial response is poorly understood. Heat shock proteins (HSPs), which 
are molecular chaperones, are known to be critical for thermotolerance, 
however, the significance of heat shock transcription factor that drive the 
expression of HSPs remains disputed. Here we probed the transcriptional 
control of thermotolerance at genome-wide scale. We found a surprising lack 
of transcriptional changes at genes and enhancers after recovery from HS. 
Nevertheless, a subset of anti-apoptotic genes that respond slowly to heat 
stress shows an increase in RNA polymerase II level at promoter-proximal 
sites upon recovery. This increase pausing may serve to prime the rapid 
induction of anti-apoptotic genes during re-exposure to heat stress and could 
explain the survival benefits of acquired thermotolerance by providing time-
advantage for rapid deployment of anti-apoptotic factors. 
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Introduction 
 Heat shock response (HSR) is widely studied for its role in maintaining 
protein homeostasis under proteotoxic conditions. Although some aspects of 
this protective mechanism remain to be understood, the field of stress biology 
has made significant progress in elucidating the stress-responsive genes, 
mechanisms involved in their regulation, and the regulatory factors driving the 
response. The primary hallmark of HSR is the fast and furious induction of 
heat shock protein genes (Hsps) by the heat shock transcription factor-1 
(HSF1). While severe or sustained subjection to elevated temperature is 
detrimental to cells, successful HSR restores proteostasis and prevents cells 
from stress-induced apoptosis. Once cells overcome the first exposure to heat 
stress, they tend to perform significantly better when they re-encounter 
exposure to heat stress again. This acquired ability to withstand heat stress 
due to mild conditioning pretreatments is known as thermotolerance.  
 Although thermotolerance is a widely-shared acquired phenotype from 
archaea to fungi to plants to animals (Kregel, 2002; Queitsch et al., 2000; 
Singer and Lindquist, 1998; Trent, 1996), the precise mechanisms of its 
establishment and employment are not fully understood. Previous works on 
thermotolerance in various species also have provided support for 
contradictory mechanisms. HSP101 is critical for theromotolerance in 
Arabidopsis, while HSP104 is critical in yeast (Lindquist and Kim, 1996; 
Queitsch et al., 2000). In yeast, neither expression of HSP104 nor 
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thermotolerance is dependent on HSF (Lindquist and Kim, 1996), while in 
mammals, thermotolerance is dependent on HSF1 (Baird et al., 2014; 
McMillan et al., 1998; Zhang et al., 2002). These observations collectively 
suggest a likely role of HSPs in a cell’s ability to tolerate heat stress despite 
HSF-independent and HSF1-dependent induction of chaperone proteins in 
yeast and mammals respectively. Most of the past studies on thermotolerance 
were done shortly after the conditioning treatment, which raises the possibility 
that their ability to tolerate heat stess is due to higher levels of HSPs 
generated during the conditioning treatment and thus conferring 
thermotolerance. However, proteomic analysis of yeasts under prolonged 
thermal stress, presumably thermotolerant, found significant difference in 
protein composition from that of yeast undergoing heat shock response (HSR) 
(Shui et al., 2015) suggesting a major departure from HS in regulatory 
programs during thermotolerance. If altered expression of certain genes is the 
source of thermotolerance, whether it is higher expression of HSPs or change 
in expression of a different set of genes, we would expect either transcription, 
steady-state mRNA level, translation, or a combination of these should deviate 
from the basal level.  
 In this study, we tested whether earlier exposure to heat stress modifies 
transcription regulatory switches and if those modifications contribute to 
thermotolerance. We used a highly sensitive genome-wide PRO-seq assay to 
measure transcriptionally-engaged RNA Polymerase II (Pol II) in mouse 
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embryonic fibroblasts before and after recovery from HS. We found a complete 
recovery of transcriptional changes at HS-regulated genes and enhancers. 
However, we observed a higher level of promoter-proximal paused Pol II at 
many genes upon recovery form HS. When we probed genes with increased 
pausing after recovery form HS that were also induced during HS, we found 
that those genes encode anti-apoptotic factors and were late responders 
during the first HS. It is possibility that the higher pause in late-responding 
anti-apoptotic genes can shorten the non-responsive period by accelerating 
the induction kinetics of these genes when they re-encounter HS again. 
Perhaps this enhanced responsiveness of anti-apoptotic genes is one of many 
paths to thermotolerance. 
 
Materials and methods: 
Cell culture 
 Mouse embryonic fibroblasts were grown in 150mm TC-treated and 
gamma irradiated cell culture dish in Dulbecco's Modified Eagle Medium 
supplemented with 10% heat inactivated fetal bovine serum (v/v) and 1% 
Penicillin Streptomycin (v/v) at 370C with 5% CO2 and 90% humidity.  
 
HS and recovery from HS 
 HS was performed at 420C incubator with 5% CO2 and 95% humidity. 
Tissue culture plates at ~80% confluency were moved from 370C incubator 
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directly to 420C incubator. Unlike our previous work, these cells were not 
instantaneously heat shocked. We allowed 15 minutes for temperature in 
tissue culture plates to equilibrate to 420C and then continued for full 60 
minutes of HS after equilibration.  
 For short recovery from HS, cells were placed back into 370C for 4 hrs. 
For long recovery from HS, cells were place back into 370C for 4 hours and 
were split 1:8 to let it recover for another 44 hours (total 48 hours). Based on 
the doubling time, we estimated the long recovery from HS allowed ~2 cell 
divisions.  
 
PRO-seq library preparation and data analysis 
 PRO-seq library preparation and data analysis were performed as 
described previously (Mahat et al., 2016). 
 
Results 
HS-induced transcriptional changes in genes recover completely upon 
reverting to normal temperature 
 To test the transcriptional status of HS-regulated genes after recovery 
from HS, we used PRO-seq to measure genome-wide change in transcription. 
The information on transcriptionally engaged Pol II density obtained from 
PRO-seq provides direct and quantitative measure of transcription level. We 
made PRO-seq libraries in mouse embryonic fibroblasts at four different  
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Figure 4.1. Transcriptional status of HS-regulated genes after recovery 
from HS 
(A) Experimental set-up, PRO-seq assay was performed in nuclei isolated 
from WT MEFs at prior to HS (370C - NHS), during HS (1 hour at 420C – 1hr-
HS), short recovery after HS (1 hr at 420C followed by 4 hrs at 370C - 1hr-
HS_4hr-Recovery), and long recovery after HS (1 hr at 420C followed by 48 
hrs at 370C - 1hr-HS_48hr-Recovery). 
(B) Screenshots of upregulated genes during HS (left panels) and 
downregulated genes during HS (right panels) showing PRO-seq density 
before, during, and after recovery from HS. PRO-seq density in sense and 
antisense direction is shown in orange and green respectively. Small vertical 
black bars at the bottom of PRO-seq tracks represent the genomic regions 
that do not map uniquely at 36bp resolution. 
(C) 'Minus-average' (MA) plots show change in PRO-seq density in all genes 
between NHS and 1hr-HS (left panel), 1hr-HS_4hr-Recovery (mid panel), and 
1hr-HS_48hr-Recovery (right panel) in WT MEFs. Significantly upregulated 
genes are shown in green, significantly downregulated ones are shown in 
orange, and the rest are shown in grey. 
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Table 4.1. Sequencing depth and alignment statistics of PRO-seq 
libraries before, during, and after recovery from HS.  
 
Library Sequenced Un-
aligned 
Multi-
aligned 
Uniquely 
aligned 
(mm10) 
NHS_BR1 99,557,605 46.57% 35.67% 14,665,417 
NHS_BR2 51,324,882 40.13% 34.88% 10,019,742 
1hr-HS _BR1 39,204,942 26.09% 38.94% 12,351,604 
1hr-HS _BR2 37,285,781 39.12% 31.68% 8,045,648 
1hr-HS_4hr-Recovery _BR1 42,695,172 37.46% 39.24% 8,880,102 
1hr-HS_4hr-Recovery _BR2 57,075,503 52.53% 30.13% 5,870,107 
1hr-HS_48hr-Recovery _BR1 39,152,023 43.65% 37.22% 6,521,228 
1hr-HS_48hr-Recovery _BR2 27,108,022 46.64% 32.52% 4,064,154 
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conditions: prior to HS (370C - NHS), during HS (60 min at 420C – 1hr-HS), 
short recovery after HS (1 hr at 420C followed by 4 hrs at 370C - 1hr-HS_4hr-
Recovery), and long recovery after HS (1 hr at 420C followed by 48 hrs at 370C 
- 1hr-HS_48hr-Recovery) (Figure 4.1A and Table 4.1). The choice of 4 and 48 
hours of recovery after HS allows observation of transcription recovery kinetics 
at short- and long-term respectively. Comparison of PRO-seq profiles show 
that the genes induced by HS, both HSPs and non-HSPs, transcriptionally 
recover to basal level by 4 hours at normal temperature (Figure 4.1B, left 
panels). Similarly, transcription of genes repressed by HS also recovers to 
basal level within 4 hours in recovery temperature (Figure 4.1B, right panels). 
At genome-wide level, transcription of most genes restores by 4 hours in 
recovery temperature, and by 48 hours, virtually all genes recover 
transcriptionally (Figure 4.1C). Genes that are significantly upregulated or 
downregulated even after 4 hours of recovery are the genes that were most 
robustly upregulated and downregualted respectively at 60 min of HS. These 
and other genes that are still called significantly changed after 48 hours of 
recovery lie at the border of unchanged and changed and are likely result of 
higher statistical significance due to high read density. Overall, our analyses of 
PRO-seq profiles indicate that transcriptional changes in genes during HS 
completely restore to basal level upon recovery from HS. 
 
Transcriptional changes at enhancers also recover from HS 
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 Transcription is not limited to the stable-RNA-encoding genes. It is well 
established that many regions of the genome are transcribed (Djebali et al., 
2012), including enhancers. Enhancers can act from a distance to regulate 
transcription of genes (Plank and Dean, 2014).  Our previous study identified 
many genes that are regulated in HSF1-dependent manner but without 
detectable HSF1 binding at their promoters (Mahat et al., 2016) suggesting a 
possibility of distant-acting HSF1-bound enhancers regulating those genes. 
Thus, we hypothesized that the thermotolerance could partially be mediated 
by HS-induced enhancers that remain activate after HS recovery. The 
heightened activity of these enhancers prior to HS in recovered cells could 
provide time-advantage for rapid and robust activation of target genes when 
exposed to HS again. To test this hypothesis, we examined PRO-seq 
densities around the known HS-activated enhancers (Mahat et al., 2016). 
Active enhancers are characterized by divergent transcription that produce 
short unstable RNAs (Core et al., 2014; 2008; Seila et al., 2008), represented 
by divergent peaks in PRO-seq metagene profile. We looked at intergenic and 
intragenic HS-activated enhancers and found a complete recovery of 
transcription at both sets of enhancers (Figure 4.2). This observation 
disproves our hypothesis of constitutive activation of HS-activated enhancers 
upon recovery from stress and suggests a lack of enhancer role in 
thermotolerance of stress-recovered cells.  
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Figure 4.2. Transcriptional status at HS-activated enhancers after 
recovery from HS 
PRO-seq density before, during, and at time points after recovery from HS in 
WT MEFs around the center of HS-activated enhancers at intergenic sites 
(left) and intragenic sites (right). 
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Increased pausing after recovery in late-induced genes during HS  
The lack of transcriptional change at annotated genes and HS-activated 
enhancers after recovery from HS was at the very least surprising. Our 
imagination of transcriptional preparedness bestowing thermotolerance in  
stress-recovered cells, analogous to a city’s preparedness in fire protection 
that was once engulfed in flames, lacked evidence. After ruling out two major 
candidates in our quest for identifying the genomic features responsible for 
thermotolerance, we focused on other areas of transcription that has potential 
to increase the reaction time of transcription induction. One genomic feature 
with such potential is promoter-proximal paused Pol II (Adelman and Lis, 
2012). Segmentation genes and HS-inducible genes in Drosophila have high 
pausing (Duarte et al., 2016; Levine, 2011; Wang et al., 2007), and one major 
difference between early induced and late induced genes during mammalian 
HSR is also the level of Pol II pausing (Mahat et al., 2016). Therefore, we 
hypothesized that some genes may have increased Pol II pausing after 
recovery from HS priming those genes for faster than intrinsic induction 
kinetics during re-exposure to HS. To test this hypothesis, we measured the 
genome-wide Pol II pausing and found an increase in global pausing after HS 
recovery even though the gene-body transcription returns to basal level 
(Figure 4.3A). As promising as this observation was, there is a possibility that 
it could be a result of slow recovery of transcription at pause regions of HS-
activated genes. To rule out this suspicion, we juxtaposed PRO-seq density  
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Figure 4.3. Increased promoter-proximal Pol II pausing after recovery 
from HS in a selected class of genes  
(A) A meta-gene profile showing PRO-seq density around the TSS of all genes 
before, during, and at time points after recovery from HS. Positive value on y-
axis represents transcription in sense strand and negative value represents 
transcription in anti-sense strand. 
(B) Heatmap of PRO-seq density fold change during HS in the gene body 
region and after complete recovery from HS in pause region shown side-by-
side. The orange bars at the bottom of heatmap indicate a special class of 
genes that have increased transcription during HS and also have higher 
pausing after recovery from HS. 
(C) Barplot showing the percentage of genes that have increased transcription 
during HS and also have higher pausing after recovery from HS (shown as 
orange bars in Figure 4.3B) in three different classes based on kinetics of 
induction (2.5 min of HS, 12 min of HS, and 60 min of HS from our previously 
published work) during HS. The green arrows indicate increase in transcription 
at that time point and the blue bars represent no change in transcription. 
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fold-change in gene body at 60 min of HS with change in pause region after 
complete (48 hours) recovery from HS (Figure 4.3B). Interestingly, genes with 
an increase in reads in the pause region after HS recovery did not overlap well 
with genes with an increase in gene body reads during HS (Figure 4.3C); 
many genes with increased pausing after recovery were downregulated during 
HS. We speculated the genes that are upregulated during HS (and thus have 
pro-survival functions) and have higher pausing after HS recovery might have 
a role in thermotolerance (orange bars in Figure 4.3B). We examined the 
induction kinetics of these genes using data from our previous study (Mahat et 
al., 2016) and found most of these genes are induced late during HS (Figure 
4.3C). These genes are enriched for anti-apoptotic functions according to gene 
ontology analysis (Mahat et al., 2016).  Therefore, it is tempting to assume that 
the higher pausing in anti-apoptotic genes allows faster-than-intrinsic 
transcription induction of these genes when cells re-encounter HS.  Such 
‘readiness’ can enable early deployment of anti-apoptotic factors and likely 
boost cell’s survival chances. 
 
Discussion 
 Our preliminary study of transcriptional recovery kinetics after HS 
provides key insights into the field of stress response biology. Organisms 
naturally encounter various sources of stresses including HS, which they deal 
by activating a cellular defense mechanism known as HSR. Successful 
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recovery form HS develops an acquired tolerance to thermal stress, enabling 
cells to perform better when they re-encounter HS again. However, the precise 
mechanism and the factors involved in thermotolerance are unclear.  
 In this study, we provide one possible mechanism that could at least 
partially contribute if not fully explain the acquired thermotolerance. Although 
transcription of genes and enhancers returns to basal level, a class of genes is 
characterized by increased level of paused Pol II after recovery from HS. 
Interestingly, these genes exhibit slowest induction kinetics during HS. Pol II 
pausing at promoter-proximal region potentiates genes for rapid and 
synchronous induction upon various stimuli. Accordingly, it is plausible that 
these genes with increased pausing will rapidly and synchronously induce 
when they re-encounter HS.  As many of these genes encode anti-apoptotic 
factors, the faster-than-intrinsic induction kinetics due to increased pausing 
may allow enough time for cells to make anti-apoptotic factors and overcome 
apoptosis. This ability of cells to combat apoptosis may have been a 
contributing factor in acquired thermotolerance.  
 To conclusively prove our hypothesis, a PRO-seq time course during 
second round of HS in stress-recovered cells showing faster induction kinetics 
of the anti-apoptotic genes is necessary. This observation would be critical in 
attributing thermotoleranceto increased Pol II pausing. It is important to 
emphasize the limitation of our study as we only probed transcriptional 
changes in our attempt to understand thermotolerance. We are aware that 
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post-transcriptional and translational control, and protein stability can modulate 
thermotolerance. Further studies are required to examine these possibilities.  
 In this study, we primarily used immortalized mouse embryonic 
fibroblasts that have been cultured in non-native environment. This perhaps is 
not the ideal system for studying thermotolerance. More importantly, the 
fluctuation in glucose and growth factors can trigger mild stress response. 
Addition of fresh tissue-culture media is known to induce HSPs in HSF1-
independent manner (Mahat and Lis, 2016). This raises the possibility that 
cells in tissue-culture to already gain thermotolerance due to repeated 
activation of mild HSR. This could also explain the lack of transcriptional 
changes in annotated genes and enhancers after recovery from HS. A well-
controlled experiment using an animal model that has not been stressed 
before could provide a more definitive answer to whether or not there is a 
transcriptional change at genes and enhancers. 
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CHAPTER 5c 
 
USE OF CONDITIONED MEDIA IS CRITICAL FOR STUDIES OF 
REGULATION IN RESPONSE TO RAPID HEAT SHOCK 
 
Summary 
 Heat shock response (HSR) maintains and restores protein 
homeostasis when cells are exposed to proteotoxic heat stress. Heat shock 
(HS) triggers a rapid and robust change in genome-wide transcription, protein 
synthesis, and chaperone activity; and therefore, the HSR has been widely 
used as a model system in these studies. The conventional method of 
performing instantaneous HS in the laboratory uses heated fresh media to 
induce HSR when added to cells. However, addition of fresh media to cells 
may evoke additional cellular responses and signaling pathways. Here, we 
compared the change in global transcription profile when HS is performed with 
either heated fresh media or heated conditioned media. We found that the use 
of heated fresh media induces transcription of hundreds of genes that HS 
alone does not induce, and masks or partially masks HS-mediated 
downregulation of thousands of genes. The fresh-media-dependent 
upregulated genes encode ribosomal subunit proteins involved in translation 
																																																						
c Adapted from Mahat, D. B., & Lis, J. T. (2016). Use of conditioned media is 
critical for studies of regulation in response to rapid heat shock. Cell Stress & 
Chaperones, 1–8. Reprinted with permission from Springer. 
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and RNA processing factors. More importantly, fresh media also induces 
transcription of several heat shock protein genes (Hsps) in a heat shock factor 
1 (HSF1) independent manner. Thus, we conclude that a conventional method 
of HS with heated fresh media causes changes in transcription regulation that 
confound the actual change caused solely by elevated temperature of cells.  
 
Introduction 
Exposure of organisms to various kinds of cellular stresses is an 
inevitable consequence of living in a dynamic environment. Stresses disrupt 
protein homeostasis and give rise to a proteotoxic cellular environment, which 
is detrimental to the proper cellular functions (Morimoto, 1998). To cope with 
stresses such as elevated temperature, heavy metals, toxins, oxidants, and 
bacterial and viral infections, organisms mount a rapid and robust response, 
known as the heat shock response (HSR). This cellular defense mechanism 
against stresses is evolutionarily conserved in organisms of all complexities 
(Lindquist, 1986). The characteristic feature of the HSR is the dramatic 
induction of heat shock protein (HSP) genes (Hsps), which are molecular 
chaperones specialized in proper folding of de novo synthesized peptides and 
refolding of misfolded proteins (Morimoto, 1993). Successful rescue by Hsps 
to regain protein homeostasis returns cells to their native state; however, cells 
subjected to a prolonged proteotoxic environment can lead to a failure of 
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molecular chaperones to maintain proteostasis and eventually trigger cellular 
apoptosis pathways (Jolly and Morimoto, 2000).  
In mammals, the rapid and robust induction of Hsps upon stress is 
regulated by heat shock transcription factor 1 (HSF1) (Wu, 1995) at the 
transcriptional level, which is a primary and major point of regulation (Lis and 
Wu, 1993). Upon stress, HSF1 trimerizes and binds to the promoter of Hsps at 
three or more inverted repeats of nGAAn pentamers (Perisic et al., 1989), 
known as the heat shock element (HSE). HSF1 recruits co-factors that 
promote release of paused Pol II into productive elongation (Lis et al., 2000). 
Increasing evidence suggests that the number of HSF1 regulated genes 
exceed the repertoire of genes referred to as Hsps (Trinklein et al., 2004; 
Vihervaara and Sistonen, 2014). HSF1 and its target genes are implicated in 
obesity (Ma et al., 2015), longevity (Morley and Morimoto, 2004), and 
cardiovascular diseases (Yan et al., 2002). More importantly, HSF1 plays 
opposing roles in cancer and neurological disorder (Ciocca and Calderwood, 
2005; Dai et al., 2007). These findings support a broad role of HSF1 and HSR 
in homeostasis and disease. Nonetheless, much work remains in elucidating 
the totality of the stress response and its interplay with disease states. 
 The field of stress biology has greatly benefited from using the HSR as 
a model to study stress response. Presence and importance of the HSR from 
lower eukaryotes to mammals, similarity in factors involved, and the ease of 
use in laboratory settings makes it highly desirable system. HSR is robust, 
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extensive, and rapid: previous studies have documented recruitment of 
transcription factors and major transcriptional changes occurring within a few 
minutes of HS (O'Brien and Lis, 1993; Zobeck et al., 2010). Therefore, a 
precise method to instantly trigger HS in laboratory settings is important to 
further investigate the first-order kinetic changes in HS induced transcription 
regulation. To perform instantaneous HS, many labs substitute the existing 
cell-culture media (hereafter called conditioned media) with heated fresh 
media for adherent cells or add heated fresh media to cells in suspension. 
Although this strategy achieves instantaneous HS, it also possesses a risk, as 
addition of heated fresh media could evoke other cellular responses beyond 
the HSR. Transcriptional changes induced by treating serum-starved cells with 
fresh media are well documented (Pirkmajer and Chibalin, 2011), and 
substituting conditioned media with heated fresh media could induce a similar 
response. The potential unsolicited transcriptional changes caused by heated 
fresh media have not been explored.  
We recently reported a robust and simple method of performing 
instantaneous HS using heated conditioned media from same cells growing for 
same period in same conditions (Mahat et al., 2016a), and we documented the 
changes in global distribution of transcriptionally engaged RNA polymerase at 
a base-pair resolution by our Precision Run-on and sequencing (PRO-seq) 
method (Kwak et al., 2013), In the present manuscript, we compare the use of 
conditioned media and fresh media in transcription profile changes during HS. 
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We performed PRO-seq in WT and Hsf1-/- mouse embryonic fibroblasts 
(MEFs) before and 12 minutes and 60 minutes after HS with either fresh 
media or conditioned media, both heated to 420C. We found that the 
transcription induction of some genes is entirely dependent on fresh media but 
not HS when fresh media is used for HS. We also discovered that the global 
change in transcription profile upon HS is severely confounded by the use of 
fresh media. More importantly, fresh media induces transcription of heat-
inducible Hsps in both WT and Hsf1-/- MEFs indicating the activation of an 
HSF1-independent pathway for Hsps expression by some component of fresh 
media. Our work reveals potential pitfalls in experimental design of stress 
response studies in laboratory settings and strongly supports the use of 
heated conditioned media for instantaneous HS experiments. 
 
Materials and methods 
Cell culture  
 WT and Hsf1-/- MEFs generated from wild type mice and Hsf1-/- 
littermate were provided by Ivor Benjamin lab (McMillan et al., 1998). MEFs 
were grown in Dulbecco's Modified Eagle Medium supplemented with 10% 
heat inactivated fetal bovine serum (v/v) and 1% Penicillin Streptomycin (v/v) 
at 370C with 5% CO2 and 90% humidity. Cells were grown to ~80% confluence 
for HS treatment in 150mm TC-treated and gamma irradiated cell culture dish. 
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Heat shock with fresh media 
 To harvest non-heat shocked cells, conditioned media from the cell 
plates were discarded and cells were rinsed with ice-cold PBS. To perform 
qPCR, cells were harvested by elution in 1 ml of Trizol. To prepare samples for 
PRO-seq, nuclei were isolated from the cells as described in the nuclei 
isolation section. 
 To perform instantaneous heat shock using fresh media, conditioned 
media from cells were discarded. 20 ml of fresh media heated to 420C was 
gently added to the cell culture plate and immediately placed in 420C incubator 
with 5% CO2 and 90% humidity. The cells were heat shocked for desired time 
and harvested as described in the nuclei isolation section. 
 
Heat shock with conditioned media 
 Non-heat shocked cells were harvested as described above. 
Conditioned media from the cell plates were discarded and cells were rinsed 
with ice-cold PBS. To perform qPCR, cells were harvested in 1 ml of Trizol. To 
prepare samples for PRO-seq, nuclei were isolated from the cells as described 
in the nuclei isolation section. 
 Heat shock with conditioned media was performed as described 
previously (Mahat et al., 2016a). It requires two sets of identical cell plates for 
a HS experiment. Conditioned media from the first cell plate was collected and 
heated to 420C in water bath. The cells on this cell plate are discarded. Once 
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the conditioned media was heated to 420C, conditioned media from the 
second cell plate was discarded and 20 ml of heated conditioned media 
collected from the first cell plate was gently added, and immediately placed in 
420C incubator with 5% CO2 and 90% humidity. The cells were heat shocked 
for desired time and harvested as described in the nuclei isolation section. 
 
Nuclei isolation, nuclear run-on, and PRO-seq library preparation 
 Isolation of nuclei from WT and Hsf1-/- MEFs, nuclear run-on reactions, 
and PRO-seq library preparation were performed as described previously 
(Mahat et al., 2016b).  
 
Differential expression analysis 
 DESeq2 was used to identify differentially expressed genes (Love et al., 
2014). PRO-seq reads were calculated from the body of genes (+500 from 
Transcription start sites to -100 from polyA site) in both biological replicates 
and the differential expression was calculated between NHS and HS 
conditions. Genes with p-value less than 0.001 were considered to be 
significantly changed. 
 
Gene ontology analysis 
 Differentially regulated genes in fresh media versus conditioned media 
were analyzed for enriched classes of molecular functions and biological 
		
	
	
211	
processes using the database for annotation, visualization and integrated 
discovery (DAVID) (Huang et al., 2009). Highly enriched and non-redundant 
GO terms from the PANTHER database were selected using the option 
provided in DAVID. 
 
Results 
Heated fresh media induces immediate early genes 
Instantaneous heat shock is typically performed using heated fresh 
media (Figure 5.1A). When working with adherent cells (such as mammalian 
fibroblasts and Hela cells), conditioned media from the cells is discarded and 
fresh media heated to a desired temperature is added. Then the cells are 
placed in the heated incubator for a desired period of time (however, this 
practice is not always explicitly stated). When working with cells in suspension 
(such as Drosophila S2 cells and human K562 cells), adequate volume of 
heated fresh media is added to the existing media in order to attain the desired 
temperature (Kim and Gross, 2013; O'Brien and Lis, 1993; Zhang et al., 2014). 
These approaches of using heated fresh media for HS ensures the cells are 
instantaneously heat shocked; however, additional cellular responses and 
signaling pathways could be triggered by fresh serum or glucose present in 
fresh media and eventually confound the HSR. Therefore, to avoid the 
unwanted effects of fresh media for instantaneous HS, we used conditioned 
media for HS (Figure 5.1B). For each experiment, two sets of cells are plated.  
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Figure 5.1. Fresh media transcriptionally induces IE genes 
(A) Schematics of the conventional method of instantaneous HS. Conditioned 
media is discarded from cells and fresh media heated to the desired 
temperature is added to instantaneously HS the cells. 
(B) Schematic of HS method using heated conditioned media. Conditioned 
media from one of a pair of identically growing cell cultures is collected and 
heated to the desired temperature. Conditioned media from the second set of 
cells is discarded and heated conditioned media is added to instantaneously 
HS the cells. 
(C) Relative change in transcription of eight IE genes as measured by RT-
qPCR in three conditions: i) fresh media for 12 min at 370C, ii) fresh media for 
12 min at 420C and, iii) conditioned media for 12 min at 420C. Error bars 
represent standard deviation from three qPCR replicates. 
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Conditioned media from the first set of identically growing cells is collected and 
heated to a desired temperature. Once the media reaches the desired 
temperature, conditioned media from the second set of cells is discarded and 
heated conditioned media from the first set of cells is added to it, followed by 
incubation in a cell-culture incubator set to the desired temperature for the 
desired time. This approach ensures instantaneous HS and eliminates the 
possibility of unwanted transcriptional changes that could be caused by the 
use of fresh media. 
To examine the effect of fresh media, we measured transcription 
change on a set of immediate early (IE) genes (Esnault et al., 2014). Addition 
of fresh media after serum-starvation immediately and transiently induces 
transcription of these genes (Schratt et al., 2001). To distinguish the 
contribution of fresh media from HS, we treated MEFs in three different ways: 
i) adding fresh media without HS, ii) adding fresh media and HS, and iii) 
adding conditioned media and HS, and then examined the changes in 
transcription level of eight IE genes compared to NHS cells (Figure 5.1C). We 
found that the transcription induction of these genes is dependent on fresh 
media, and HS has little to no effect on their transcription induction. This 
observation highlights the confounding effects caused by the use of fresh 
media for instantaneous HS in transcriptional induction of at least a few genes.  
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Fresh media causes significant change in genome-wide transcription 
profile  
To examine the genome-wide transcriptional changes caused by the 
use of heated fresh media for HS, we performed PRO-seq using heated fresh 
media and compared with PRO-seq that was performed using heated 
conditioned media (Mahat et al., 2016a). We found that the fresh media used 
in HS strongly induces transcription of some IE genes, confirming the qPCR 
results. For example, transcription induction of Nr4a1 gene is entirely 
dependent on fresh media, whereas transcription of Vcl gene is slightly 
induced by HS alone, which is further increased by fresh media (Figure 5.2A).   
We measured the PRO-seq density change in all genes prior and after 
HS using DESeq2 (Love et al., 2014). An additional number of genes are 
upregulated at both 12 min and 60 min of HS when heated fresh media is used 
instead of heated conditioned media (Figure 5.2B). Moreover, ~25% of actively 
transcribing genes are downregulataed after 12 min of HS using fresh media; 
however, many of these genes are no longer downregulated at 60 min of HS 
indicating the transient nature of downregulation caused by the fresh media. In 
contrast, transcription downregulation during HS using conditioned media is 
gradual, and by 60 min of HS, ~55% of the actively transcribing genes are 
repressed.  
To identify genes that are dramatically affected by the condition of 
media used for HS, we analyzed significantly upregulated genes at 12 min of  
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Figure 5.2. Genome-wide transcription profile change caused by fresh 
media is different than caused by HS 
(A) Genome-browser screenshots of PRO-seq density in three conditions with 
two biological replicates each. PRO-seq density in sense and antisense 
direction is shown in blue and red respectively. Small vertical black bars at the 
bottom represent the genomic regions that do not map uniquely at 36 bp 
resolution. 
(B) Number of significantly changed genes using heated fresh media or 
heated conditioned media for HS. Upregulated genes are shown in green and 
downregulated genes are shown in red.  
(C) Heatmap showing the status of PRO-seq density change in all genes that 
show significant upregulation at 12 min of HS with either fresh or conditioned 
media (left) and all genes that show significant downregulation at 60 min of HS 
with either fresh or conditioned media (right). The color bars represent genes 
that were examined in gene ontology analysis in (d).  
(D) Gene ontology analysis of enriched molecular functions and biological 
processes in significantly upregulated genes at 12 min of HS with fresh media 
but significantly downregulated in conditioned media is indicated by the blue 
bar, while significantly downregulated genes at 12 min of HS with fresh media 
but significantly upregulated in conditioned media are indicated by the 
magenta bar. 
(E) Gene ontology analysis of enriched molecular functions and biological 
processes in significantly upregulated genes at 60 min of HS with fresh media 
but significantly downregulated in conditioned media (purple bar). 
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HS and significantly downregulated genes at 60 min of HS in either fresh or 
conditioned media (Figure 5.2C). This side-by-side visualization of regulated 
genes in two different media conditions allows characterization of genes that 
undergo complete reversal in regulation. While some genes upregulated at 12 
min of HS in conditioned media are also upregulated in fresh media, many 
genes downregulated in conditioned media are upregulated in fresh media 
(Figure 5.2C, left panel - blue bar), and a few genes upregulated in 
conditioned media are downregulated in fresh media (Figure 5.2C, left panel - 
magenta bar). Similarly, some genes that are significantly downregulated at 60 
min of HS in conditioned media are upregulated in fresh media (Figure 5.2C, 
right panel - purple bar). These three classes, marked by magenta, blue, and 
purple bar, represent genes whose activities are either induced or repressed 
depending on the external cues.  
Intrigued by this dramatic change in transcriptional regulation that is 
dependent on the media used for HS, we examined the above three classes of 
differentially regulated genes for their cellular functions using gene ontology 
(GO) analysis. The upregulated genes only in fresh media at 12 min of HS 
(blue bar in Figure 5.2C) are enriched for ribosomal subunits, its structural 
components, and translation (Figure 5.2D). In contrast, upregulated genes 
only in conditioned media at 12 min of HS (magenta bar in Figure 5.2C) are 
enriched for zinc ion binding proteins, negative regulators of transcription, and 
focal adhesion genes. Similarly, downregulated genes in conditioned media at 
		
	
	
218	
60 min of HS but induced in fresh media (purple bars in Figure 5.2C) are 
enriched for RNA binding, RNA processing, and ribosomal structures involved 
in translation machinery (Figure 5.2E). While these findings conform the 
general consensus in the field of stress biology that global transcription and 
translation are repressed during HS (Anckar and Sistonen, 2011), it also 
indicates that the fresh media overrides the HS-mediated repression and in 
turn activates these genes involved in increase mRNA and protein production. 
Overall, this observation further supports our hypothesis that heated 
conditioned media should be used for instantaneous HS to avoid the 
confounding regulation caused by fresh media.  
 
Fresh media induces Hsps in an HSF1-independent manner 
The broad class of Hsps includes 75 genes that play a role in protein 
homeostasis (Kampinga et al., 2009). To dissect the role of fresh media in 
transcription regulation of Hsps, we examined the PRO-seq density change in 
all 75 genes upon HS with heated fresh media or heated conditioned media. In 
order to access the role of HSF1 in transcription regulation of Hsps, we also 
performed PRO-seq in Hsf1 knockout (Hsf1-/-) MEFs. We focused our analysis 
on 48 genes that are induced in at least one time-point or cell type during HS. 
~33% of these genes, including major Hsps, are robustly induced in WT MEFs 
while almost all of the 48 genes are either downregulated or unchanged in 
Hsf1-/- MEFs in conditioned media (Figure 5.3A). In contrast, most of these 48  
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Figure 5.3. Fresh media induces many Hsps in HSF1-independent 
manner 
(A) PRO-seq density change during HS with conditioned media in 48 genes 
within the broad HSP family in WT and Hsf1-/- MEFs. 
(B) PRO-seq density change during HS with fresh media in the corresponding 
48 genes in WT and Hsf1-/- MEFs. 
(C) HSF1 fold enrichment, as measured by HSF1 ChIP-seq, in the promoter of 
the corresponding 48 genes in WT MEFs. 
(D) HSE motif match score in the promoters of the corresponding 48 genes. 
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genes are transcriptionally induced during HS with heated fresh media (Figure 
5.3B). More importantly, transcription of these genes is also induced in Hsf1-/- 
MEFs. The profile of HSF1 binding to the promoter of the genes (Figure 5.3C) 
and the presence of HSE in the corresponding promoters (Figure 5.3D) 
resembled the induced Hsps with conditioned media, which further indicates 
that the induction of Hsps with fresh media is mediated by factors other than 
HSF1. Together, these findings reveal the potential of some component of 
fresh media to transcriptionally induce Hsps in HSF1-independent manner that 
are either repressed or unchanged during a proper, conditioned-media HS. 
 
Discussion 
HS is widely used as the model system to study stress response. It 
triggers a rapid and robust transcriptional response, and it is convenient to use 
in a laboratory settings. However, the widespread approach of using heated 
fresh media for instantaneous HS carries a risk of undesired transcriptional 
changes. Recently, we demonstrated a simple but effective method of 
performing instantaneous heat shock using conditioned media from same cells 
growing in identical conditions (Mahat et al., 2016a) . Here, we now report the 
changes in transcription profile during HS when heated fresh media or heated 
conditioned media is used for instantaneous HS. In genome-wide 
transcriptional analysis using PRO-seq, we found that fresh media causes HS-
independent transcription induction of additional genes and also mediates HS-
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independent transient repression of several genes. These fresh media 
dependent genes are enriched in ribosomal machinery components and 
mRNA translation. More importantly, we found that fresh media induces many 
Hsps that are either repressed or unchanged transcriptionally during HS and 
this induction potential of fresh media is independent of HSF1. We also 
discovered that the heated fresh media used for instantaneous HS strongly 
induces some IE genes in addition to Hsps. 
One defining feature of IE genes is the presence of serum response 
element (SRE) in their promoters, and all eight IE genes examined in this 
study contains strong SRE. In serum-stimulation studies, serum response 
factor (SRF) binds to SRE and transiently induces expression of IE genes. 
Therefore, it is possible that either fresh serum or fresh glucose in fresh media 
activates SRF, which is responsible for the dramatic induction of IE genes in 
this study. Nevertheless, some of the eight IE genes also showed small but 
detectable induction by HS alone. Because the common feature of these 
genes is the presence of SRE in their promoters, the HS dependent mild 
induction of these genes is also likely mediated by SRF. In fact, we recently 
identified SRF as a novel transcription factor activated by HS, which transiently 
binds to the promoters of transiently induced genes during HS (Mahat et al., 
2016a). Based on these findings, we believe that HS itself is also capable of 
activating SRF. However, the mechanism of SRF activation by fresh media 
and HS could be different. Addition of fresh media after serum-starvation 
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activates mitogen-activated protein kinase (MAPK) pathway and SRF is a 
known target of MAPK pathway (Heidenreich et al., 1999). Whereas, the 
interaction of SRF with the nuclear imported MAL, which is released from 
monomeric actin (Miralles et al., 2003), possibly due to actin polymerization 
during HS, is the proposed mechanism of SRF activation during HS (Mahat et 
al., 2016a).  
Fresh media transcriptionally induces another class of genes, which 
encode components of ribosomal machinery involved in mRNA translation. 
This could be an indication of likely increased demand in translation caused by 
the activation of cell proliferation signaling pathways by fresh media. Fresh 
media also induces some Hsps in an HSF1-independent manner, whereas HS 
only induces the major Hsps. One likely candidate for the broad induction of 
Hsps by fresh media is the activator protein 1 (AP-1) transcription factors 
(TFs). AP-1 TFs are activated by serum stimulation (Poimenidi et al., 2009), 
and AP-1 binding element is highly enriched in the proximity of HSEs present 
in the promoters of Hsps (Mahat et al., 2016a). The highly significant 
enrichment of AP-1 motifs around HSEs suggests either collaboration or 
redundancy between AP-1 and HSF1 in induction of Hsps. When fresh media 
is added, perhaps cells trigger HSF1-independent induction of Hsps through 
AP-1 in order to chaperone the influx of newly synthesized proteins to support 
cell proliferation. 
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The unwanted transcriptional changes caused by fresh media after 
instantaneous HS has eluded detection until now for several reasons. First, the 
major HSF1-dependent Hsps, which are the primary focus of HS studies, are 
induced to similar level when either fresh media or conditioned media is used 
for HS. Second, genome-wide assays such as RNA-seq and mass-
spectrometry have contributions from post-transcriptional regulatory steps of 
mRNA stability and translation efficiency respectively and may not reflect the 
precise change in transcription level. Third, genomic tools with sensitivity 
required to detect small changes in nascent transcription were unavailable 
until now. In the last few years, highly sensitive genomic methods to quantify 
nascent transcription have been developed. These methods, such as GRO-
seq (Core et al., 2008), PRO-seq (Kwak et al., 2013), and NET-seq 
(Churchman and Weissman, 2011), will help to investigate the outstanding 
questions in the field of stress response. Because of the sensitivity of these 
assays, careful consideration should be taken in experimental setups, and at 
the very least, use of heated fresh media for instantaneous HS should be 
avoided. 
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CHAPTER 6 
 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Old questions, new tools, and novel insights 
An organism’s primal purpose, from evolutionary perspective, is to 
reproduce and survive. The primary factors that dictate survival are food 
availability, predator-prey relationship, and environmental changes. Long-term 
environmental variation provides an anatomical and physiological canvas for 
evolutionary forces to fiddle with broad strokes, whereas temporary fluctuation 
in ambient condition stimulates evolution of adaptive mechanisms. One such 
adaptive mechanism for protection against elevated temperature, known as 
heat shock response (HSR), is highly conserved across domains of life. 
Despite significant variation in optimal growth temperature among organisms, 
increase of few degree Celsius triggers HSR. Such precise calibration of ideal 
temperature for growth and survival underscores the delicate balance in 
protein structure and homeostasis. No wonder cells under stress engage 
entire suite of gene regulatory switches from transcription to translation to 
orchestrate a finely tuned gene expression program that boosts survival and 
unplugs non-critical activity.  
Among the major regulatory switches administered during HSR, 
transcription is the earliest and the primary mode of regulation. Cells sense 
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heat stress through multiple non-overlapping mechanisms and ultimately 
activate heat shock transcription factor (HSF1 in vertebrates). Activated HSF1 
trimerizes via a coiled-coiled central domain, gains competency to bind heat 
shock element (HSE – an inverted repeat of three nGAAn pentamers) in the 
promoters of heat shock protein genes (Hsps), and dramatically induces their 
expression. These molecular events in a nutshell represent transcriptional 
control of HSR, which were discovered over the span of four decades, largely 
through focused gene studies in lower eukaryotes.  
The dawn of affordable sequencing spurred genome-wide analyses of 
gene expression changes during HSR. mRNA sequencing in cells undergoing 
heat shock (HS) revealed changes in steady-state mRNA pool, which 
represent cumulative effect of transcriptional and post-transcriptional 
regulation. It was only after the development of highly sensitive genomic 
assays, which measured transcription by directly quantifying actively 
transcribing RNA polymerases (Core et al., 2008; Kwak et al., 2013), that 
precise and comprehensive assessment of transcriptional changes during HS 
was made possible.  
In work presented in this dissertation, we used precision nuclear run-on 
sequencing (PRO-seq) to measure transcriptional changes immediately and 
after full-blown HS in mouse embryonic fibroblasts that lacked either HSF1, 
HSF2, both, or none. Genome-wide data on transcriptional changes from 
PRO-seq was complemented with transcription factor binding information from 
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ChIP-seq. The major findings tabulated below are reported in detail in this 
dissertation (Chapters 2 & 3).  
• HSR triggers rapid, large-scale, and diverse changes in transcription.  
• Majority of the genes regulated upon HSR are independent of HSF1.  
• Heat-inducible HSP genes are entirely dependent on HSF1 for transcription 
induction. 
• HSF1 regulates transcriptional induction by facilitating the release of 
promoter-proximal paused Pol II. 
• HSF1 does not contribute to the genome-wide repression of transcription. 
• Genome-wide transcriptional repression during HSR is caused by the 
inhibition of paused Pol II release into productive elongation. 
• Pause release factor P-TEFb occupancy increases at the promoters of 
HSF1-induced genes and decreases at the promoters of repressed genes. 
• A class of anti-apoptotic genes is induced late during HSR. 
• Cytoskeleton genes are activated as early as classical HSP genes. 
• Serum response factor (SRF) transiently binds to the promoters of 
cytoskeletal gens and transiently induces their transcription. 
• HSF2 does not compensate the loss of HSF1. 
• ~20% of the actively transcribed genes are repressed in HSF2-dependent 
manner during HSR. 
• HSF2 requires HSF1 for DNA binding. 
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The evaluation of HSF1’s contribution during HSR indicated that HSF1 is 
more like a ‘specialized paramedic’ rather than the all-powerful ‘fire chief’. 
While these new insights may have deflated HSF1’s perceived global 
contribution in stress repsonse, they have undoubtedly unveiled the enormity 
and complexity of the HSR. Yet, many questions remain unanswered. What 
stimulates and what impairs promoter-bound HSF1’s ability to induce 
transcription? Is the correlation between P-TEFb occupancy and 
transcriptional changes during HSR a causative relationship? Can P-TEFb 
explain both induction and repression of transcription? Are the genes without 
promoter-bound HSF1 but induced in HSF1-dependent manner regulated by 
enhancer bound HSF1? What other transcription factors besides HSF1 and 
SRF regulate transcription during HSR? Is the enrichment of Nuclear Factor 
Erythroid 2 Like 2 (NFE2L2) in the promoters of late-induce anti-apoptotic 
genes functional? These are some of the few unanswered questions for future 
pursuit that arose directly from the work presented on this dissertation, one of 
which is elaborated below. 
Understanding P-TEFb’s role in HSR 
One particular preliminary finding that has a broad implication in 
regulation of the HSR is the role of P-TEFb. P-TEFb occupancy increases in 
HSF1-induced genes and decreases in repressed genes, while transcription of 
the P-TEFb subunit genes remain unchanged during HSR (unpublished data). 
This apparent redistribution of the limited amount of cellular P-TEFb prompts 
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us to speculate that the concerted recruitment of P-TEFb to the HS-induced 
genes by HSF1 and other transcription factors from the genes that will 
eventually end up being repressed due to P-TEFb’s unavailability is the 
primary mechanism of transcription regulation during HSR. The two key 
experiments to test this hypothesis are listed below. 
P-TEFb overexpression 
 If lack of P-TEFb availability is the underlying mechanism of global 
downregulation during HSR, overexpression of P-TEFb should rescue or 
mitigate the global repression. Overexpression of kinase-mutant P-TEFb 
would decipher whether P-TEFb’s role in HSR is dependent on its kinase 
activity or mediated through kinase-independent domain-specific interactions. 
Inhibition of HSF1’s ability to recruit P-TEFb 
  P-TEFb is recruited to heat shock loci in HSF1-dependent manner (Lis 
et al., 2000). Inhibiting HSF1’s ability to recruit P-TEFb by a synthetic 
compound KRIBB11 (Yoon et al., 2011) should attenuate transcription 
induction of HSF1-bound and dependent genes upon HS. Concurrently, 
because the HSF1 cannot recruit P-TEFb, the P-TEFb level should remain 
unaffected at other genes and the global repression should be mitigated 
simultaneously. 
 If this ‘redistribution of limited P-TEFb’ hypothesis can’t be proved, 
other hypotheses of P-TEFb-mediated global regulation in HSR should be 
tested. The ‘reset’ model (Chapter 1), which argues an instantaneous 
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genome-wide dislodgement of engaged P-TEFb and the subsequent 
requirement of assisted delivery to selected genes for transcription induction 
by factors such as HSF1, can be tested by quantifying chromatin bound vs 
unbound P-TEFb levels immediately upon HS. P-TEFb could also be limiting 
either by reduction in its kinase activity, which is required for Pol II pause 
release, or due to its depletion from nucleus and sequestration in cytoplasmic 
stress granules. 
 
A peek into human health through the window of HSR 
The mechanisms and machinery of stress response, primarily evolved 
to protect against proteotoxic stress, have major implications in health and 
diseases. Research recommendations in three areas that deeply interest me 
and with direct relevance to human health are briefly explained below. 
Thermotolerance 
 On Chapter 4 of this dissertation, I presented preliminary work on 
exploration of the underlying mechanism of thermotolerance. Do cells retain 
transcriptional memory upon recovery from stress? In addressing this 
physiologically relevant question, I discovered that the promoter-proximal Pol 
II pausing in anti-apoptotic genes increases upon recovery from stress, 
despite lack of change in gene-body and enhancer transcription globally. 
Interestingly, these anti-apoptotic genes are induced late during heat shock. 
These two observations put together suggest a possible mechanism of 
		
	
	
235	
thermotolerance in stress-recovered cells. Perhaps thermotolerance is 
manifested through rapid induction of anti-apoptotic genes that confer survival 
advantages. This hypothesis can be tested by the experiment below. 
Using HS-recovered cells, examine the induction kinetics of anti-apoptotic 
genes during subsequent HS 
 Cells that have recovered from 1 hour of HS for at least 48 hours are re-
exposed again to 1 hour of HS (Figure 6.1A). Cells are harvested at various 
time points during both rounds of HS (Figures 6.1B & 6.1C) to measure the 
kinetics of transcription induction. Induction kinetics of the anti-apoptotic genes 
are monitored by measuring PRO-seq wave using a three-state hidden Markov 
model (HMM) (Danko et al., 2013).  
 If the anti-apoptotic genes in HS-recovered cells indeed exhibit faster 
than their normal induction kinetics in a subsequent HS, the finding would be a 
first step in establishing the functional consequence of transcriptional memory 
in the form of paused Pol II in thermotolerance. The second step would be to 
test whether the rapid induction of the anti-apoptotic genes confers survival 
advantage in HS-recovered cells undergoing subsequent HS. 
 In case of the disproval of this hypothesis, other likely explanations 
such as change in chromatin marks should be examined. Because pausing is 
a manifestation of promoter architecture, increased pausing in selected genes 
upon recovery from stress could be a result of change in chromatin structure 
and histone marks. 
		
	
	
236	
 
 
 
 
 
Figure 6.1. Design of thermotolerance experiment 
(A) Schematics of re-exposing HS-recovered cells to new HS. 
(B) HS time course performed on first HS. PRO-seq data needs to be collected 
for the time points shown in green. PRO-seq data exists for time points shown 
in grey. 
(C) HS time course for new HS of HS-recovered cells. 
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Cancer  
 Cancer cells are characterized by higher level of HSF1 in tumor 
samples (Santagata et al., 2011). However, little is known about the molecular 
switches that drive increased expression of HSF1 in cancer. Conversely, the 
effects of over-expression or constitutive-activation of HSF1 in promoting 
cellular transformation remain to be explored. Whether high level of HSF1 in 
highly malignant cells is the cause or the consequence of transformation has a 
profound significance in design of HSF1-based cancer therapeutics. 
Role of increased HSF1 level or activity in transformation 
 HSF1 is over-expressed by introducing ectopic copy or constitutively-
activated through substitution of hydrophobic residues in heptad repeats 
(Rabindran et al., 1993; Zuo et al., 1994). Transformation cues below the 
transformation threshold are provided and transformation efficiency in 
presence and absence of HSF1 over-expression or constitutive-activation is 
compared. Increased transformation efficiency in cells with HSF1 over-
expression or constitutive-activation would support our hypothesis. 
This study would provide insights on whether some cellular 
environment can be more conducive for transformation due to activating 
mutations on HSF1 or copy number amplification of HSF1.  
Transcription read-through 
 Inability of RNA polymerase to initiate or to terminate transcription at 
predefined sites results in generation of non-canonical transcripts. The 
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transcription read-through beyond the termination site generates fusion 
transcripts in breast, prostate, gastric, and kidney cancers (Choi et al., 2016; 
Grosso et al., 2015; Kim et al., 2015; Nacu et al., 2011). The RNA chimeras 
formed by transcription invasion of neighboring genes can encode novel 
oncogenic proteins (Valentijn et al., 2006), and the higher degree of 
transcription read-through correlates with poorer prognosis in renal carcinoma 
patients (Grosso et al., 2015).  
 Transcription read-through is also prominent in HSR. Transcription of a 
specific group of genes extends beyond the canonical termination site 
resulting in extended 3’ UTR (Ubr4) or a possible fusion transcript by the 
transcription encroachment of a downstream gene (Abca5) (Figure 6.2) 
(Mahat et al., 2016). Because cancer cells are under proteotoxic stress (Dai et 
al., 2012), transcription read-through in stressed cells and cancers likely arises 
from a common mechanism that goes awry in both conditions. Examining the 
mechanism and machinery involved in transcription read-through during the 
stress response offers critical insights on the aberrant molecular mechanism 
and provides new set of targets for cancer therapeutics.  
Characterize the RNA species generated by transcription read-through 
 RNAs with extended 3’-region and fusion transcripts generated by 
transcription read-through are characterized by assessing nascent 
transcription in untransformed human cell lines prior to stress, during stress, 
and after recovery from stress using enhanced PRO-seq (ePRO-seq,  
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Figure 6.2. Transcription read-through in heat stress  
Precision nuclear run-on sequencing (PRO-seq) in MEFs showing 
transcription read-through beyond transcription termination site. The arrows 
indicate direction of genes and PRO-seq density in plus and minus strands are 
shown in red and blue respectively. Green boxes highlight transcription read-
through. 
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manuscript in prep). The translational output of these RNAs are evaluated 
using ribosome profiling (Ingolia et al., 2009), and the temporal control and 
efficiency of translation of transcription read-through products are elucidated.  
High-throughput CRISPR/Cas9 & plasmid cDNA library screens to identify 
factors regulating transcription read-through 
 To identify factors responsible for transcription read-through, a reporter 
gene for qualitative evaluation of transcription read-through is created by 
inserting a GFP cDNA in-frame in the intergenic region downstream of a gene 
that undergoes transcription read-through upon stress (identified in Aim 1). 
After stably expressing the reporter gene and Cas9 in a cell line, cells are 
transfected with genome-scale lentiviral single-guide RNA (sgRNA) library 
(Wang et al., 2014). Lack of GFP expression after heat stress (FACS-sorted 
non-fluorescent cells) indicates the suppression of transcription read-through. 
Targeted sgRNA sequencing in the non-fluorescent cells identifies factors 
essential for transcription read-through. Conversely, transfecting plasmid 
cDNA library (Wan et al., 2006) and targeted sequencing of transfected cDNA 
in non-fluorescent cells identifies factors whose limitation induce transcription 
read-through. 
  
HSR in everyday life 
Beyond the sphere of the molecular mechanism of HSR presented in 
this dissertation and the three aforementioned areas of stress response with 
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direct relevance to human health, other relatively unexplored sides of stress 
response are equally intriguing. Acute and chronic exercise increases the 
expression of HSP72 (Leon, 2016; Yamada et al., 2008) and exercise-induced 
transient increase in HSP levels restricts vascular inflammation (Noble and 
Shen, 2012). Nutrients and growth hormone mediated activation of stress 
response, which we inadvertently discovered (Chapter 5), provide novel 
insights on HSF1-independent induction of HSPs. Exposure of worms and flies 
to mild stress confers health benefits and increases their lifespan (Le Bourg et 
al., 2001; Rattan, 2005). These aspects of HSR are primed for in-depth 
exploration. 
   
Perspective 
 HSR is an old play, running on broadway for decades. Everyone who 
visited the theater was enamored by the lead actor. She was fast, she was 
furious, and she had a dramatic way of bringing changes that mattered to the 
life of the play. There was no debate that she was the heart and soul of the 
show. But for the longest time, everyone believed that this was one-man show. 
Then times changed. Slowly and steadily, people got closer and closer to the 
stage. Rumors started that the play was more complex than the role of the 
lead actor. Finally, one day, someone who had the front-row seat climbed to 
the stage and lifted the curtain. And all of sudden, right then and there, the 
cast and the crew behind the lead actor came to light. The show was definitely 
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complex, a lot more complex than anyone had imagined. People soon found 
out that the lead actor was not as powerful as she was portrayed to be.  
 Since then, a lot of new information has come out about the show. It 
apparently is a very intriguing show. Many folks walk out of the theater 
believing that they now know everything about the show. They seem content. 
They are happy. But the one with a smile is the old lady by the door of the 
theater, fixing her worn-out mat to sleep under the sky. She knows that there is 
still a lot more in the show that the folks don’t know. She knows the play has 
more players and multiple layers. She also knows that someday someone will 
get even closer than anyone ever has been and reveal more secrets. But for 
today, she quietly slips under her blanket and whispers – “the show goes on!” 
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APPENDIX Ad 
 
BASE-PAIR RESOLUTION GENOME-WIDE MAPPING OF ACTIVE RNA 
POLYMERASES USING PRECISION NUCLEAR RUN-ON (PRO-seq) 
 
Summary 
 We provide a protocol for precision nuclear run-on sequencing (PRO-
seq) and its variant, PRO-cap, which map the location of active RNA 
polymerases (PRO-seq) or transcription start sites (TSSs) (PRO-cap) genome-
wide at high resolution. The density of RNA polymerases at a particular 
genomic locus directly reflects the level of nascent transcription at that region. 
Nuclei are isolated from cells and, under nuclear run-on conditions, 
transcriptionally engaged RNA polymerases incorporate one or, at most, a few 
biotin-labeled nucleotide triphosphates (biotin-NTPs) into the 3’ end of nascent 
RNA. The biotin-labeled nascent RNA is used to prepare sequencing libraries, 
which are sequenced from the 3’ end to provide high-resolution positional 
information for the RNA polymerases. PRO-seq provides much higher 
sensitivity than ChIP-seq, and it generates a much larger fraction of usable 
																																																						
d Adapted from Mahat, D. B.*, Kwak, H.*, Booth, G. T., Jonkers, I. H., Danko, 
C. G., Patel, R. K., Waters, C.T., Munson, K., Core, L.J., & Lis, J.T. (2016). 
Base-pair-resolution genome-wide mapping of active RNA polymerases using 
precision nuclear run-on (PRO-seq). Nature Protocols, 11(8), 1455–1476. 
*denotes equal contribution. Contribution is shown in each figure. Reprinted 
with permission from Nature Publishing. 
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sequence reads than ChIP-seq or NET-seq (native elongating transcript 
sequencing). Similarly to NET-seq, PRO-seq maps the RNA polymerase at up 
to base-pair resolution with strand specificity, but unlike NET-seq it does not 
require immunoprecipitation. With the protocol provided here, PRO-seq (or 
PRO-cap) libraries for high-throughput sequencing can be generated in 4–5 
working days. The method has been applied to human, mouse, Drosophila 
melanogaster and Caenorhabditis elegans cells and, with slight modifications, 
to yeast. 
 
Introduction  
 The ability to measure the density of RNA polymerase across the 
genome provides a comprehensive and quantitative snapshot of 
transcription(Fuda et al., 2009). Collecting a series of these snapshots in 
response to regulatory switches reveals the identity of genes that respond 
immediately or secondarily to specific signals, and provides critical insights to 
the mechanisms of their regulation(Adelman and Lis, 2012). Quantifying RNA 
polymerase density along the genes is also critical for deciphering the 
regulatory steps involved in transcription.  
  In addition to protein coding genes, many other regions in the genome 
(such as upstream divergent regions, regions downstream of mRNA poly A 
sites, and enhancers) are transcribed to various extents. Enhancers produce 
short unstable RNAs (eRNAs) that do not encode proteins(Core et al., 2014) 
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but delineate major hubs of transcription regulation(Heinz et al., 2015). 
Differential regulation of enhancer mediated transcription is implicated in 
various diseases(Vahedi et al., 2015), and understanding this regulation is 
important for deciphering the transcriptional changes in response to 
developmental, nutritional, and environmental cues. However, sequencing of 
total RNA by RNA-seq is inefficient in detecting these unstable RNAs.   
A number of methods have been described that enrich and sequence 
nascent RNAs associated with RNA polymerase. These methods are either 
based on immunoprecipitation of RNA polymerase(Churchman and 
Weissman, 2011; Larson et al., 2014; Nojima et al., 2015) or are dependent on 
purification of insoluble chromatin(Weber et al., 2014). Therefore, these 
methods are highly dependent on antibody specificity or the purity of the 
chromatin fraction respectively. We have developed nuclear run-on based 
methods to map active RNA polymerases and their start sites genome-wide at 
up to base pair resolution(Core et al., 2008; Kwak et al., 2013). In these 
methods, the endogenous activity of RNA polymerase is used to selectively 
label nascent RNAs. The ability to affinity-purify nuclear run-on RNA multiple 
times during the course of library preparation provides an approximate million-
fold enrichment of the nascent RNA over other forms of RNA and thereby 
effectively eliminates background(Core et al., 2008). Furthermore, because the 
RNA is sequenced, the direction of transcription can be unambiguously 
identified. 
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Development of PRO-seq 
 PRO-seq is based on Global Run-On sequencing (GRO-seq), a 
genome-wide adaptation of nuclear run-on assays that have been used 
classically to measure transcription of target genes. In GRO-seq, 
bromouridine-labeled nascent RNAs are affinity-purified and analyzed by high-
throughput sequencing to map RNA polymerase positions. Extremely high 
sensitivity and specificity is achieved through multiple distinct affinity-
purification steps(Core et al., 2008; Jonkers et al., 2014). GRO-seq uses 
bromouridine as the substrate for the nuclear run-on reaction, enabling RNA 
polymerase to add multiple nucleotides to the nascent RNA. Therefore, the 
resolution of GRO-seq is tens of bases.  
 However, to understand the molecular mechanisms of transcriptional 
elongation and promoter-proximal pausing, RNA polymerase mapping at 
base-pair resolution is required. Such resolution enables mechanistic modeling 
of how DNA sequences, nucleosomes, or other DNA-binding factors affect 
RNA polymerase elongation and gene expression(Adelman and Lis, 2012; 
Kwak and Lis, 2013). To achieve base-pair resolution, we used a modified 
nuclear run-on that limits the number of labeled nucleotides added to the 
nascent RNA(Core et al., 2008; Hah et al., 2011; Kwak et al., 2013; Larschan 
et al., 2011; Min et al., 2011). In PRO-seq, biotin-labeled nucleotide 
triphosphates are provided as the substrates for the nuclear run-on reaction. 
The incorporation of a biotin-NTP by an RNA polymerase inhibits further 
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incorporation of biotin-NTPs into the nascent RNA. Sequencing from the 3’ 
end of the nascent transcript therefore identifies the last incorporated NTP and 
reveals the precise location of the active site of the RNA polymerase engaged 
with its nascent RNA. 
 Identification of the precise position of transcription start sites (TSSs) is 
also important to understand how DNA elements, general transcription factors 
and transcription activators recruit RNA polymerase to genes and enhancers. 
RNA polymerase initiates transcription at TSS and quickly transcribes a short 
region before pausing at a promoter-proximal site. However, because the 
nascent transcripts are sequenced from the 3’ end in PRO-seq, the positional 
information of where RNA polymerase began transcription is mostly lost. We 
therefore developed PRO-cap by modifying the sequencing strategy of PRO-
seq to sequence the capped nascent RNA from 5’ end, enabling transcription 
start sites to be identified at the RNA synthesis level(Kwak et al., 2013). 
 
Overview of the procedure 
 A general overview of the PRO-seq and PRO-cap experimental 
procedures is shown in Figure A.1. Nuclei from cells are rapidly isolated and 
native nucleotides are washed away to halt transcription. However, RNA 
polymerases remain engaged on the DNA and retain their enzymatic activity. 
Incubation of isolated nuclei with biotin-labeled nucleotide triphosphates allows 
the RNA polymerases to actively elongate and label the nascent RNA. For 
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Figure A.1. Flowchart of the PRO-seq and PRO-cap protocol 
PRO-seq and PRO-cap share common steps, but are different at the adaptor 
ligation, reverse transcription, and 5’ modification stages. In PRO-seq, the 3’ 
RNA adaptor is modified to have the reverse complement sequence of a 
standard 5’ RNA adaptor. Similarly, the 5’ RNA adaptor and the reverse 
transcription primer are modified for PRO-seq. This allows 3’ sequencing of 
the RNA on a standard Illumina platform. For PRO-cap, standard small RNA 
adaptors are used, and result in a 5’ sequencing as usual. In the 5’ 
modification step, PRO-seq RNAs are de-capped and re-phosphorylated to 
ensure all RNA is accessible for 5’ RNA adaptor ligation. PRO-cap RNAs are 
de-phosphorylated first to convert all forms of 5’ end except for the 5’ capped 
ends to a 5’ hydroxyl end, in order to restrict the ligation of 5’ adaptor only to 
the cap containing nascent RNAs after cap removal. Then the 5’ caps are 
converted to 5’ monophosphates using the tobacco acid pyrophosphatase, 
and can be ligated to a 5’ RNA adaptor. 
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PRO-seq only, the labeled nascent RNA is hydrolyzed with NaOH to generate 
RNA fragments suitable for sequencing (~100 bp in length). The RNA 
containing a biotin nucleotide is then enriched by affinity purification using 
streptavidin-coated magnetic beads. The biotin-streptavidin interaction is very 
stable (Kd ~ 10-14 mol/L), which allows stringent washing of the magnetic 
beads to minimize contamination with unlabeled RNA. A 3’ sequencing 
adapter is then ligated to the hydroxyl (OH) group at the 3’end of nascent RNA 
followed by another affinity purification to further enrich nascent RNA and 
remove unligated adapter sequences. Preparation for 5’ sequencing adaptor 
ligation differs for PRO-Seq and PRO-cap. For PRO-seq, the 5’ cap is 
removed from unhydrolyzed short nascent RNA using either Tobacco acid 
pyrophosphatase (TAP) or RNA 5' Pyrophosphohydrolase (RppH). The 5’ OH 
generated by base hydrolysis is then converted to 5’ phosphate by treatment 
with T4 polynucleotide kinase (PNK) For PRO-cap, uncapped RNA with a 5’-
monophosphate is degraded using 5´-Phosphate-dependent exonuclease. 5’ 
triphosphates and monophosphates are removed from any remaining 
contaminating uncapped RNA with Alkaline phosphatase. Only then is the 5’ 
cap of nascent RNA removed with TAP or RppH treatment. After these 
chemical modifications, a 5’ sequencing adapter is ligated to the nascent RNA 
and a third round of affinity purification performed to enrich for nascent RNA 
with sequencing adapters on both ends. Nascent RNA is then reverse 
transcribed and test-PCR-amplified to determine an appropriate number of 
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PCR cycles for final amplification; this latter step is critical to avoid over 
amplification. During the final amplification, barcodes can be added so that 
multiple libraries can be pooled for sequencing. Finally, the PCR amplified 
libraries are size-selected for a range of 140-350 bp and sent for high-
throughput sequencing. Sequencing depth of 25-50 million for mammalian 
cells, 10-20 million for organisms with smaller genome size such as 
Drosophila, and 5-10 million for yeast cells provide useful information. 
Relatively short read length such as 40-50 bp is sufficient. The sequencing 
result is a text-based list of short nucleotide sequences and its sequencing 
quality parameters are provided in a ‘fastq’ format(Cock et al., 2010). The 
sequences may contain varying lengths of adapter sequences, which are 
removed, and the adaptor-removed sequences are then aligned to the 
appropriate genome. Finally, the aligned sequences are used to generate 
coverage files that can be used to visualize and analyze the data.   
 
Advantages and limitations of PRO-seq 
The key advantages of PRO-seq are: 
• It provides base-pair resolution and strand-specific information of global 
RNA polymerase occupancy. 
• Background RNA contamination is hugely reduced due to almost a million 
fold purification of biotinylated nascent RNAs. 
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• It is highly sensitive in detecting rare and common nascent RNAs with a 
large dynamic range (>105). 
• It can identify short unstable nascent RNAs transcribed from enhancer 
regions. 
PRO-seq also has a number of limitations that should be considered when 
deciding which genome-wide RNA polymerase mapping strategy to use. 
• In principle, PRO-seq results are ensemble profiles of potentially 
heterogeneous populations of cells - and this is generally true for all multi-
cell, high-throughput sequencing analyses. Unlike mature RNA molecules 
that are present in multiple copies per cell, RNA polymerase at a specific 
genomic position can only yield at most two copies of nascent RNA. So 
while it may be possible to adapt PRO-seq to measure nascent transcript 
levels for abundantly expressed genes in single cells, genome-wide 
mapping of RNA polymerase in single cells using PRO-seq would remain a 
challenge. 
• PRO-seq detects only the active RNA polymerase and so RNA 
polymerases in the pre-initiation complex will not be detected. There is also 
a possibility that other forms of stalled RNA polymerases, such as back-
tracked polymerases, may not be detected, although nuclear run-on 
conditions may allow some of these polymerases to realign the active site 
through thermal motion. Generally, the signals seen by ChIP-seq of RNA 
Polymerase II (Pol II) and our genome-wide run-on methods quantitatively 
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agree(Core et al., 2012), so the bulk of Pol II is detectable by GRO- and 
PRO-seq methods. 
• Compared to GRO-seq that adds a longer extension to the 3’ end of 
nascent RNA(Core et al., 2008), PRO-seq only adds one or a few 
nucleotides in order to provide higher resolution mapping. However, there 
is a possibility that RNA polymerases positioned very close to the TSS may 
not be detected because the nascent RNA may not be long enough to be 
uniquely mapped to the genome. In this case, GRO-seq may provide more 
accurate quantification of promoter proximal RNA polymerases. Likewise, 
RNA polymerases positioned in a repetitive sequence region of the 
genome is difficult to unambiguously map to a particular repeat. 
• PRO-seq does not distinguish nascent transcription derived from different 
RNA polymerases (Pol I vs Pol II vs Pol III) unless carried out in the 
presence of inhibitors of specific RNA polymerases. Also, unlike NET-Seq, 
nascent RNA associated with specific RNA polymerase modifications (e.g. 
phosphorylations of the C-terminal domain) cannot be selectively detected 
using PRO-seq(Nojima et al., 2015).  
 
Applications of PRO-seq and PRO-cap 
 The most common use of PRO-seq is for the analysis of genome-wide 
transcription levels with directional information and with higher resolution and 
sensitivity than an RNA polymerase ChIP-seq assay. PRO-seq provides an 
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independent layer of gene expression analysis distinct from mRNA-seq, 
revealing the transcriptional stages of regulation before the influence of mRNA 
processing or stability control. The increased resolution and the directional 
information become useful in distinguishing  upstream divergent (also called 
upstream antisense) transcription(Core et al., 2008; Seila et al., 2008).  
PRO-cap(Kwak et al., 2013) can capture TSS at the nascent RNA 
synthesis level in contrast to other TSS analyses that use mature 
RNA(Andersson et al., 2014; Carninci et al., 1996; Forrest et al., 2014). This 
becomes an advantage in detecting enhancer transcripts(Core et al., 2014; 
Hah et al., 2013; Wang et al., 2011), upstream antisense transcription(Core et 
al., 2008; 2014), or other types of unstable transcripts, and avoiding post-
transcriptional background capping events(Fejes-Toth et al., 2009). 
 
Alternatives to PRO-seq 
 RNA polymerase can be mapped genome-wide by a variety of different 
strategies. 
• ChIP-seq: In this approach, RNA polymerase proteins are cross-linked to 
the DNA and then RNA polymerase II (Pol II) is purified by immuno-
precipitation. Pol II associated DNA is identified and quantified by high-
throughput sequencing thereby providing an estimate of the amount of Pol 
II at different sites on the genome. The resolution of ChIP is usually limited 
by the size of the fragmented DNA in the chromatin at the 
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immunoprecipitation step. A variant of this method called ChIP-exo 
overcomes the resolution limitation by additionally treating the DNA 
fragments from the Pol II ChIP with a DNA exonuclease(Rhee and Pugh, 
2012). The exonuclease digests DNA from the 3’ end of both strands, 
stopping near the cross-linked polymerase complex. An additional 
limitation of ChIP-seq is that Pol II-unbound genomic regions that interact 
with a Pol II-bound region through three-dimensional looping can be falsely 
identified with this method due to the use of cross-linking. Finally, ChIP-seq 
will map all forms of Pol II, including transcriptionally inactive Pol IIs and 
Pol IIs in antisense orientation: therefore, the direction of the transcription 
is not directly disclosed.  
• Permanganate footprinting: this method can be used to identify the single 
stranded DNA created by the transcription bubble formed on DNA by the 
RNA polymerase. The non-template strand of the DNA is exposed to 
single-strand specific breakage at T residues through a series of chemical 
treatments. A method called Permanganate-ChIP-seq couples 
permanganate footprinting to Pol II ChIP and thereby maps the cleaved 
ends of the DNA from the single-stranded region of transcription bubbles(Li 
et al., 2013). This directly maps the transcription active site with high 
resolution. Permanganate mapping depends on the presence of thymine 
residues in the non-templated single-stranded DNA of the bubble that are 
not masked by protein binding. Although the protocol enriches for Pol II in a 
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single chromatin immunoprecipitation, other regions that expose single 
stranded thymine such as in other DNA-RNA hybrids or intra-strand DNA 
hairpins could contribute to background. 
• Native Elongating Transcript sequencing (NET-seq): a number of 
chromatin bound nascent RNA based methods, including NET-seq and its 
variants, have been developed for mapping RNA polymerase(Churchman 
and Weissman, 2011; Mayer et al., 2015; Nojima et al., 2015; Weber et al., 
2014). In the original NET-seq protocol(Churchman and Weissman, 2011), 
the RNA polymerase complex is immunoprecipitated and the co-purified 
native RNA is sequenced. The 3’ end of the nascent RNA provides base-
pair resolution mapping of RNA polymerase. This method is ideally suited 
to examine the occupancy of differently modified RNA polymerases. In 
practice, the efficiency of NET-seq relies on the degree of enrichment 
provided by the single immuno-precipitation step. Because the method 
detects the 3’ ends of all RNAs that are associated with Pol II, it also 
captures 3’ ends of intermediates of co-transcriptional splicing and micro-
RNA production that can complicate mapping of transcriptionally-engaged 
Pol II(Nojima et al., 2015). 
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Experimental design 
Cells. In our lab, we have successfully generated PRO-Seq libraries for cells 
from plant (unpublished, G.T.B.), yeast (unpublished, G.T.B.), 
Drosophila(Kwak et al., 2013), and mammals(Core et al., 2014; Mahat et al., 
2016). In general, the higher the number of cells the better the PRO-seq read 
coverage of the genome. However, a minimum of 5-10 million nuclei or 
permeabilized cells is required for a single PRO-seq library regardless of cell 
type. In principle, the application of PRO-seq in yeast, including S. pombe and 
S. cerevisiae, is very similar to that of other organisms; however, some 
alterations are required in yeast cell permeabilization(García-Martínez et al., 
2004), run-on reaction, and post run-on RNA extraction procedures(Collart and 
Oliviero, 2001); required modifications for yeast are indicated in the 
appropriate steps of the Procedure. 
Sample preparation. Isolation of nuclei for nuclear run-on is a critical step in 
the procedure not only to preserve the enzymatic activity of the RNA 
polymerase, but also to capture the precise position of the RNA polymerase on 
genes. Starting with 10-20 million cells per library is recommended considering 
the efficiency of nuclei isolation process (~50%). The whole process should 
take place in the cold room on ice as far as is possible. Isolated nuclei can be 
resuspended in the glycerol-containing storage buffer, and quickly frozen in 
liquid nitrogen for long term storage at -80°C. We have used permeabilized 
cells in PRO-seq as an alternative to isolating nuclei, making handling easier 
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and reducing loss of sample; cell permeabilization has a much higher 
efficiency (~90%) than nuclei isolation. Cell permeabilization conditions may 
differ between cell types and may need to be optimized; we provide a general 
method for permeabilization in the Procedure as well as a version optimized 
for yeast cells. 
Spike-in for library normalization. Disproportionate loss of RNA and/or 
cDNA can occur during multiple stages of the PRO-seq library preparation, 
which spans 4-5 days and involves several handling steps. Even with the use 
of identical starting material, uneven loss of libraries could affect the genome-
wide RNA polymerase density between libraries. To control for handling 
effects on library yield, a small fraction (1-5%) of cells with a distinct genome 
can be added during library preparation; adding an identical number of spike-
in cells to different libraries enables normalization between different 
conditions. We have used Schizosaccharomyces pombe to normalize 
Saccharomyces cerevisiae and vice versa, and Drosophila cells to normalize 
mammalian cells and vice versa. When using the cell-permeabilization 
approach, spike-in cells should be added and permeabilized together with the 
experimental cells. For the nuclei isolation approach, spike-in cells should be 
added to the experimental cells prior to nuclei isolation and dounced together. 
Nuclear run-on. In PRO-seq, biotin-NTPs are used as the nuclear run-on 
substrates. The Km of each of the NTPs as substrates for RNA polymerase lie 
in the range of 1–20 µM(Job et al., 1984). Therefore, final substrate 
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concentration greater than 1-20 µM range (~25 µM) is, in general, sufficient for 
each biotin-NTP substrate. Depending on the purpose of the experiment, 
biotin-NTP substrates can be supplied in different combinations: individual 
biotin run-on, 4 biotin run-on, 2 biotin run-on or 1 biotin run-on.  
• Individual-biotin run-on: To obtain the most precise mapping of the RNA 
polymerase, four separate PRO-seq libraries are made, each supplied with 
only one type of biotin-NTP in the run-on reaction. This ensures that the RNA 
polymerase adds only one, or at most a few (when the polymerase is 
positioned at multiple stretches of same nucleotide) biotin-NTPs to the 
nascent RNA. In this case, 4 times more sample is required. 
• 4-Biotin run-on: we found that all 4 biotin-NTPs can be supplied in a single 
reaction and the Pol II only incorporates one or at most a few bases, giving 
an equivalent resolution to single biotin run-on. The reason for this is 
unclear, but we speculate that steric hindrance in the active site of RNA 
polymerase prevents incorporation of multiple biotinylated nucleotides. 
• 2-Biotin run-on: When the amount of sample or the cost is limiting, unlabeled 
NTPs can be used in combination with biotin NTPs. Use of biotinylated 
purine nucleotides (biotin-ATP, biotin-GTP) is more costly than that of the 
pyrimidine nucleotides (biotin-CTP, biotin-UTP). A combination of biotin-
CTP, biotin-UTP, ATP, and GTP can be supplied to the nuclear run-on 
reaction, providing reasonable resolution and cost.  
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• 1-Biotin run-on: If a longer run-on RNA is preferred, combinations of biotin-
CTP with unlabeled CTP, UTP, ATP, and GTP can be used effectively in a 
biotin-NTP form of GRO-seq. This approach can be useful for increasing 
sequencing coverage of RNA polymerases that reside near the TSSs. While 
most transcriptionally-engaged RNA polymerases near the 5’ ends reside 
between 30-60 nucleotides from the TSS(Kwak et al., 2013), RNA 
polymerases closer to the TSS may fail to map uniquely. Additionally, the 
longer run-on extensions of nascent RNAs may be desired for distinguishing 
allele-specific nascent transcription. 
PCR amplification of PRO-seq library. When the number of cells and/or 
nuclei are limited for PRO-seq library preparation, a higher number of PCR 
amplification cycles will be required to generate sufficient library for reliable 
quantification and accurate loading into the sequencer. However, a higher 
number of PCR cycles can result in amplification bias of some sequences. To 
avoid PCR-induced biases, molecular barcodes(Fu et al., 2014) can be 
introduced as part of the 3’ RNA adapter, which is ligated to the nascent 
RNAs. Duplicate reads generated by PCR over-amplification can be identified 
by identical barcodes and computationally filtered at the stage of mapping the 
sequenced reads to the genome. 
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Materials 
Reagents 
CRITICAL: Extreme care should be taken to avoid nuclease contamination. 
Use nuclease-free reagents and change gloves routinely. 
• Appropriate cell line(s) e.g. K562, GM12878, MCF7, Hela, embryonic stem 
cells, MEFs, mouse 3T3 cells, Drosophila S2, yeast. 
CAUTION: Before use, cells should be checked for contamination. 
Chemical stocks 
• Diethyl pyrocarbonate (DEPC; Sigma-Aldrich, cat. no. D5758)  
CAUTION: DEPC is toxic and harmful. Proper eyeshield, faceshield, full-
face respirator, and gloves are required while handling DEPC. 
• Sodium chloride, NaCl (Sigma-Aldrich, cat. no. S9888)  
• Potassium chloride, KCl (Avantor, cat. no. 6858-04)  
• Magnesium chloride, MgCl2 (Avantor, cat. no. 5958-04)  
• Sucrose (Sigma-Aldrich, cat. no. S0389)  
• Calcium chloride, CaCl2 (Sigma-Aldrich, cat. no. C1016)  
• Magnesium acetate, MgAc2 (Sigma-Aldrich, cat. no. M5661)  
• Ammonium acetate, NH4Ac (Sigma-Aldrich, cat. no. A1542)  
• Sodium acetate NaOAc (Sigma-Aldrich, cat. no. S2889)  
• EDTA (Sigma-Aldrich, cat. no. E9884) 
• EGTA (Sigma-Aldrich, cat. no. E3889) 
• Protease inhibitor cocktail, EDTA-free (Roche, cat. no. 11873580001) 
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• Sodium hydroxide, NaOH (Avantor, cat. no. 7708-10) 
• Triton X-100, (Calbiochem, cat. no. 9410)  
• Nonidet P40 (NP40) Substitute, (Sigma-Adlrich, cat. no. 11332473001)  
• Sarkosyl (Sigma-Aldrich, cat. no. L5125)  
• Tween-20 (Sigma-Aldrich, cat. no. P9416) 
• Phosphate buffer saline, PBS pH 7.4 (Gibco, cat. no. 10010031). 
• TRIS (Avantor, cat. no. 4109-02)  
• Hydrochloric acid, HCl (Avantor, cat. no. 4613-05)  
• DTT (Sigma-Aldrich, cat. no. D0632) 
• Betaine (Sigma-Aldrich, cat. no. B0300) 
• Glycerol (Sigma-Aldrich, cat. no. G5516) 
Biotin Nuclear Run-On and enrichment 
• Biotin-11-ATP (PerkinElmer, cat. no. NEL544001EA) 
• Biotin-11-CTP (PerkinElmer, cat. no. NEL542001EA) 
• Biotin-11-GTP (PerkinElmer, cat. no. NEL545001EA) 
• Biotin-11-UTP (PerkinElmer, cat. no. NEL543001EA)  
• ATP, 10mM (Roche, cat. no. 11 277 057 001) 
• GTP, 10mM (Roche, cat. no. 11 277 057 001) 
• UTP, 10mM (Roche, cat. no. 11 277 057 001) 
• P-30 column, RNase free (BIORAD, cat. no. 732-6250) 
• Streptavidin M280 beads (Invitrogen, cat. no. 112.06D) 
Reagents for nucleic acid extraction 
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• Trizol (Ambion, cat. no. 115596018)  
CAUTION: Trizol is harmful and contact with skin, eye or inhalation should 
be avoided. Use it inside a fume hood. 
• Trizol LS (Ambion, cat. no. 10296028)  
CAUTION: Trizol is harmful and contact with skin, eye or inhalation should 
be avoided. Use it inside a fume hood. 
• Chloroform (Calbiochem, cat. no. 3150) 
• GlycoBlue (Ambion, cat. no. AM9515) 
• Ethanol, 100% (PHARMCO-AAPER, cat. no. 111000200) 
• Ethanol, 75%(vol/vol) 
• Phenol:Chloroform, Tris buffered (Thermo Scientific, cat. no. 17909) 
CAUTION: Phenol:Chloroform is harmful and contact with skin, eye or 
inhalation should be avoided. Use it inside a fume hood. 
• Phenol, (Ambion, cat. no. 9700).  
CAUTION: Phenol is harmful and contact with skin, eye or inhalation 
should be avoided. Use it inside a fume hood. 
Enzymes and recombinant protein reagents 
• RNase inhibitor, 40 units/µl (Ambion, cat. no. AM2696) 
• T4 RNA ligase I, 10 units/µl (NEB, cat. no. M0204). Supplied with 10× T4 
RNA ligase buffer, 10 mM ATP, and PEG, 50%(wt/vol). 
• 5´-phosphate-dependent exonuclease, 1 unit/μl (Epicenter, cat. no. 
TER51020) (required for PRO-cap only). Supplied with 10× rxn buffer A. 
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• Alkaline phosphatase, 10 units/µl (NEB, cat. no. M0290) (required for PRO-
cap only). Supplied with 10× Alkaline phosphatase buffer. Alternatively, 
Antarctic phosphatase, 5 units/µl (NEB, cat. no. M0289) can be used.  
• Tobacco acid pyrophosphatase, 10 units/µl (TAP) (Epicenter, cat. no. 
T19500). Supplied with 10× TAP buffer. Alternatively, RNA 5’ 
Pyrophosphohydrolase, 5 units/µl (RppH) (NEB, cat. no. M0356S) can be 
used with ThermoPol Reaction buffer (NEB, cat. no. B9004S). 
• T4 polynucleotide kinase, 10 units/µl (PNK) (NEB, cat. no. M0201) 
(required for PRO-seq only). Supplied with10× PNK buffer.  
• Superscript III reverse transcriptase (Invitrogen, cat. no. 56575). Supplied 
with 5× first strand buffer, and 0.1M DTT.  
• dNTP mix, 12.5 mM each (Roche, cat. no. 03 622 614 001) 
• Phusion polymerase, 2 units/µl (NEB, cat. no. M0530). Supplied with 5× 
High-Fidelity buffer. 
• RNA and DNA oligos. (Custom synthesis from IDT DNA, RNase-free HPLC 
purified) See Table 1 and Reagent Setup for details. Further information 
about barcoding and sequencing indexes can be found at 
http://support.illumina.com/content/dam/illumina-
support/documents/documentation/chemistry_documentation/samplepreps
_truseq/truseqsampleprep/truseq-library-prep-pooling-guide-15042173-
01.pdf  
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Electrophoresis 
• DNA grade agarose (BioRad, cat. no. 161-3102EDU) 
• Tris/Acetic acid/EDTA (TAE), 50× (BioRad, cat. no. 161-0773). 
Alternatively, a 50x TAE buffer can be made in house (see Reagent Setup 
section) 
• Glacial acetic acid (Sigma-Aldrich, cat. no. 537020) for in house 
preparation of 50x TAE.  
• Gel loading dye, Orange G 6× (NEB, cat. no. B7022S) 
• 100 bp DNA ladder (Life Technologies, cat. no. 15628-019) 
• 10 bp DNA ladder (Life Technologies, cat. no. 10821-015). Alternatively, 25 
bp DNA ladders (ThermoFisher, cat. no. 10597011) can be used. 
• SYBRGold nucleic acid gel stain, 6× (Life Technologies, cat. no. S-11494) 
• Acrylamide (Protogel), 30%(wt/vol) (National Diagnostics, cat. no. EC-980). 
30% acrylamide/methylene bisacrylamide solution from other sources is 
also compatible. 
• TEMED (BioRad, cat. no. 161-0800) 
• Ammonium Persulfate (APS), 10%(wt/vol) (BioRad, cat. no. 161-0700). 
Dissolve in H2O. 
• Tris/Boric acid/EDTA (TBE), 10× (BioRad, cat. no. 161-0770). Alternatively, 
a 10× TBE buffer can be made in house (see Reagent Setup section). 
• Boric acid (Sigma-Aldrich, cat. no. B6768) for in house preparation of 10x 
TBE. 
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Equipment 
• 2 heat blocks, one set at 37°C and the other at 65°C, each filled with water 
equilibrated at the appropriate temperature. 
• Dounce homogenizer (Wheaton scientific, cat. no. 357546) 
• Magnetic separator for Streptavidin magnetic beads (Invitrogen, cat. no. 
K1585-01) 
• Rotating stand (Thermo Barnstead Labquake rotator, cat. no. 415110) 
• Refrigerated centrifuge (Eppendorf, cat. no. 5417R) 
• Microcentrifuge (Eppendorf, cat. no. 5415D) 
• Speed vac dryer (Thermo Scientific, cat. no. 20-548-134) 
• Dark Reader transilluminator (Clare Chemical Research, cat. no. DR89X) 
 
Reagent setup  
CRITICAL: All reagents, solutions, and buffers should be made with DEPC-
treated water 
DEPC-H2O Add 0.1%(vol/vol) DEPC to H2O. Mix overnight then autoclave and 
filter-sterilize the solution with a 0.22 µm filter. DEPC-H2O can be prepared in 
advance and stored at room temperature (250C) for up to a year. 
CAUTION: DEPC is toxic and harmful. Proper eyeshield, faceshield, full-face 
respirator, and gloves are required while handling DEPC. 
5M NaCl Dissolve 14.61 g NaCl in 50 ml H2O with 0.1%(vol/vol) DEPC. Mix 
overnight and then autoclave and filter.  
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CRITICAL: 5M NaCl can be prepared in advance and stored at room 
temperature (250C) for up to a year. 
4M KCl Dissolve 3.73 g KCl in 50 ml H2O with 0.1%(vol/vol) DEPC, mix 
overnight then autoclave and filter-sterilize.  
CRITICAL: 4M KCl can be prepared in advance and stored at room 
temperature for up to a year. 
1M MgCl2 Dissolve 4.76 g MgCl2 in 50 ml H2O with 0.1%(vol/vol) DEPC, mix 
overnight then autoclave and filter-sterilize.  
CRITICAL: 1M MgCl2 can be prepared in advance and stored at room 
temperature for up to a year. 
1M Sucrose Dissolve 171.15 g Sucrose in 500 ml H2O with 0.1%(vol/vol) 
DEPC, mix overnight then autoclave and filter-sterilize.  
CRITICAL: 1M Sucrose can be prepared in advance and stored at room 
temperature for up to a year. 
1M CaCl2 Dissolve 5.55 g CaCl2 in 50 ml H2O with 0.1%(vol/vol) DEPC, mix 
overnight then autoclave and filter-sterilize.  
CRITICAL: 1M CaCl2 can be prepared in advance and stored at room 
temperature for up to a year. 
1M MgAc2 Dissolve 7.12 g MgAc2 in 50 ml H2O with 0.1%(vol/vol) DEPC, mix 
overnight then autoclave and filter-sterilize.  
CRITICAL: 1M MgAc2 can be prepared in advance and stored at room 
temperature for up to a year. 
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1M NH4Ac Dissolve 3.85 g NH4Ac in 50 ml H2O with 0.1%(vol/vol) DEPC, mix 
overnight then autoclave and filter-sterilize.  
CRITICAL: 1M NH4Ac can be prepared in advance and stored at room 
temperature for up to a year. 
1M NaOAc, pH 5.3 Dissolve 4.1 g NaOAc in 50 ml H2O and pH to 5.3, add 
0.1%(vol/vol) DEPC, mix overnight then autoclave and filter-sterilize.  
CRITICAL: 1M NaOAc can be prepared in advance and stored at room 
temperature for up to a year. 
0.5M EDTA Dissolve 29.22 g EDTA in 100 ml DEPC treated H2O, then 
autoclave and filter-sterilize.  
CRITICAL: 0.5M EDTA can be prepared in advance and stored at room 
temperature for up to a year. 
0.1M EGTA Dissolve 19.02 g EGTA in 50 ml DEPC treated H2O, then 
autoclave and filter-sterilize.  
CRITICAL: 0.1M EGTA can be prepared in advance and stored at room 
temperature for up to a year. 
1N NaOH Dissolve 2 g NaOH in 50 ml DEPC treated H2O, filter-sterilize.  
CRITICAL: 1N NaOH can be prepared in advance in 50 ul aliquots, stored at -
80°C for up to a year. Use freshly thawed aliquot each time.  
CAUTION: NaOH is corrosive and contact with skin, eye or inhalation should 
be avoided.  
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10% Triton X-100 Dissolve 5 ml of Triton X-100 in 45 ml DEPC H2O and filter-
sterilize.  
CRITICAL: 10% Triton X-100 can be prepared in advance and stored at room 
temperature for up to a year. 
10% NP40 Dissolve 5 ml of NP40 in 45 ml DEPC H2O and filter-sterilize.  
CRITICAL: 10% NP40 can be prepared in advance and stored at room 
temperature for up to a year. 
2% Sarkosyl Dissolve 1 g of Sarkosyl in 50 ml DEPC H2O and filter-sterilize.  
CRITICAL: 2% Sarkosyl can be prepared in advance and stored at room 
temperature for up to a year. CAUTION: Sarkosyl is an irritant and contact with 
skin, eye or inhalation should be avoided. 
1% Tween-20 Dissolve 1 ml of Tween-20 in 49 ml DEPC H2O and filter-
sterilize.  
CRITICAL: 1% Tween-20 can be prepared in advance and stored at room 
temperature for up to a year. 
1M Tris-HCl, pH 6.8 Dissolve 6.06 g TRIS base in 50 ml DEPC H2O, pH to 6.8 
with HCl then autoclave and filter-sterilize.  
CRITICAL: The buffer can be prepared in advance and stored at room 
temperature for up to a year. 
1M Tris-HCl, pH 7.4 Dissolve 6.06 g TRIS base in 50 ml DEPC H2O, pH to 7.4 
with HCl then autoclave and filter-sterilize.  
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CRITICAL: The buffer can be prepared in advance and stored at room 
temperature for up to a year. 
1M Tris-HCl, pH 8.0 Dissolve 6.06 g TRIS base in 50 ml DEPC H2O, pH to 8.0 
with HCl then autoclave and filter-sterilize.  
CRITICAL: The buffer can be prepared in advance and stored at room 
temperature for up to a year. 
1M DTT Dissolve 1.54 g DTT in 10 ml DEPC H2O and filter-sterilize.  
CRITICAL: 1M DTT can be prepared in advance and stored at -200C for up to 
a year. 
1mM Biotin-11-CTP Mix 10 µl of 10 mM stock in 90 µl DEPC H2O to get 1 mM 
dilution.  
CRITICAL: The buffer can be prepared in advance and stored at 40C for up to 
a year. 
1mM Biotin-11-UTP Mix 10 µl of 10 mM stock in 90 µl DEPC H2O to get 1 mM 
dilution.  
CRITICAL: The buffer can be prepared in advance and stored at 40C for up to 
a year. 
50x TAE Dissolve 121 g TRIS base, 28.55 g Glacial Acetic acid, and 50 ml 
0.5M EDTA in DEPC H2O to final volume of 500 ml then autoclave and filter-
sterilize.  
CRITICAL: The buffer can be prepared in advance and stored at 40C for up to 
a month. 
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10x TBE Dissolve 54 g TRIS base, 27.5 g Boric acid, and 20 ml 0.5M EDTA in 
DEPC H2O to final volume of 500 ml then autoclave and filter-sterilize.  
CRITICAL: The buffer can be prepared in advance and stored at 40C for up to 
a month. 
Douncing buffer (for nuclei isolation) 10 mM Tris-HCl pH 7.4, 300mM 
sucrose, 3 mM CaCl2, 2 mM MgCl2, 0.1% Triton X-100, 0.5 mM DTT, 1 tablet 
of protease inhibitors cocktail per 50ml, 4 u/ml RNase inhibitor.  
CRITICAL: The buffer without DTT, protease inhibitors, and RNase inhibitor 
can be prepared and stored at 40C for up to a month. Add fresh DTT, protease 
inhibitors, and RNase inhibitor immediately before use. 
Permeabilization buffer (for non-yeast cells) 10mM Tris-HCl pH 7.4, 
300mM sucrose, 10mM KCl, 5mM MgCl2, 1mM EGTA, 0.05% Tween-20, 
0.1% Nonidet P40 substitute, 0.5 mM DTT, 1 tablet of protease inhibitors 
cocktail per 50ml, 4 u/ml RNase inhibitor.  
CRITICAL: The buffer without DTT, protease inhibitors, and RNase inhibitor 
can be prepared and stored at 40C for up to a month. Add fresh DTT, protease 
inhibitors, and RNase inhibitor immediately before use. 
Permeabilization buffer (for yeast cells) 0.5% Sarkosyl, 0.5 mM DTT, 1 
tablet of protease inhibitors cocktail per 50ml, 4 u/ml RNase inhibitor.  
CRITICAL: The buffer without DTT, protease inhibitors, and RNase inhibitor 
can be prepared and stored at 40C for up to a month. Add fresh DTT, protease 
inhibitors, and RNase inhibitor immediately before use. 
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Storage buffer 10 mM Tris-HCl pH 8.0, 25%(vol/vol) glycerol, 5 mM MgCl2, 
0.1 mM EDTA, 5 mM DTT.  
CRITICAL: The buffer without DTT can be prepared and stored at 40C for up to 
a month. Add fresh DTT immediately before use. 
2x Nuclear run-on master mix (for non-yeast cells) 10 mM Tris-HCl pH 8.0, 
5 mM MgCl2, 300 mM KCl, and 1 mM DTT.  
CRITICAL: The buffer without DTT can be prepared and stored at 40C for up to 
a month. Add fresh DTT immediately before use. 
2x NRO master mix (for yeast cells) 40 mM Tris-HCl, pH 7.7, 400 mM KCl, 
64 mM MgCl2, 1 mM DTT.)  
CRITICAL: The buffer without DTT can be prepared and stored at 40C for up to 
a month. Add fresh DTT immediately before use. 
AES buffer (for yeast cells only) 50 mM NaOAc pH 5.3, 10 mM EDTA, 1% 
SDS. 
High-salt wash buffer 50 mM Tris-HCl pH 7.4, 2 M NaCl, 0.5%(vol/vol) Triton 
X-100 in DEPC H2O.  
CRITICAL: The buffer can be prepared in advance and stored at 40C for up to 
a month.  
Binding buffer 10 mM Tris-HCl pH 7.4, 300 mM NaCl, 0.1%(vol/vol) Triton X-
100 in DEPC H2O.  
CRITICAL: The buffer can be prepared in advance and stored at 40C for up to 
a month. 
		
	
	
275	
Low-salt wash buffer 5 mM Tris-HCl pH 7.4, 0.1%(vol/vol) Triton X-100 in 
DEPC H2O.  
CRITICAL: The buffer can be prepared and stored at 40C for up to a month. 
Pre-washed streptavidin-coated magnetic beads Take 90 μl of Streptavidin 
M280 beads per library. Place the beads on the magnetic separator for 1 min 
and discard the supernatant. Pre-wash by resuspending in 0.1 N NaOH + 50 
mM NaCl in DEPC H2O for 1 min, place on the magnetic separator for 1 min, 
remove supernatant. Wash beads twice with 100 mM NaCl in DEPC H2O. 
After removing the wash buffer, resuspend the beads in 150 μl of the Binding 
Buffer and make 3 aliquots of 50 μl each. Scale up accordingly when 
processing multiple samples.  
CRITICAL: The washed beads can be prepared in advance and stored at 40C 
for up to a week. 
2.2% Agarose gel 3.3 grams DNA grade agarose in 150 ml 1x TAE. Mix by 
swirling and heat using a microwave until the mix bubbles and clears. 
Gel elution buffer 10 mM Tris-HCl pH 8.0, 0.5 mM NH4Ac, 10 mM MgAc2, 1 
mM EDTA, 0.1% SDS.  
CRITICAL: The buffer can be prepared in advance and stored at room 
temperature for up to a month.  
Ammonium persulfate Dissolve 1 g of APS in 10 ml of DEPC-H2O and filter-
sterilize the solution with a 0.22-μm filter. 
CRITICAL: 10% (wt/vol) APS can be prepared in advance and stored at -20 °C 
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for up to a year. 
DNA and RNA oligos Oligos for PRO-seq and PRO-cap (Table A.1) should 
be dissolved in DEPC H2O at a concentration of 100 mM. PCR primers should 
be dissolved in DEPC H2O at a concentration of 25 mM.  
Software for data analysis 
• Adaptor removal software, such as ‘cutadapt’(Marcel, 2011) 
(http://code.google.com/p/cutadapt/) 
• Mapping or alignment software, such as ‘bwa’(Li and Durbin, 2009) 
(https://sourceforge.net/projects/bio-bwa/files/) or ‘bowtie’(Langmead et al., 
2009) (https://sourceforge.net/projects/bowtie-bio/files/)  
• Tools for generation of coverage information, such as SAMtools(Li et al., 
2009) (https://sourceforge.net/projects/samtools/files/) and 
BEDTools(Quinlan and Hall, 2010) 
(https://sourceforge.net/projects/bedtools/files/)  
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Table A.1. Oligonucleotides required for PRO-seq and PRO-cap 
CRITICAL: The DNA & RNA oligos can be stored at -800C for up to 10 years. 
 
 Oligo 
name 
Sequence (5’ to 3’) Purpose Comments 
Oligos 
for PRO-
seq 
VRA3 GAUCGUCGGACUG
UAGAACUCUGAAC-
/Inverted dT/ 
RNA adaptor for 
ligation to the 3’ 
end of nascent 
RNA at step 49 
The 5’ end is 
phosphorylated 
and the 3’ end is 
protected by an 
inverted dT 
VRA5 CCUUGGCACCCGA
GAAUUCCA 
RNA adaptor for 
ligation to the 5’ 
end of nascent 
RNA at step 75 
The 5’ end is not 
phosphorylated 
RP1 AATGATACGGCGA
CCACCGAGATCTA
CACGTTCAGAGTTC
TACAGTCCGA 
DNA oligo for 
reverse 
transcription of 
adaptor-ligated 
nascent RNA at 
step 84 
 
Oligos 
for PRO-
cap 
RA3 UGGAAUUCUCGGG
UGCCAAGG-
/Inverted dT/ 
RNA adaptor for 
ligation to the 3’ 
end of nascent 
RNA at step 49 
The 5’ end is 
phosphorylated 
and the 3’ end is 
protected by an 
inverted dT 
RA5 GUUCAGAGUUCUA
CAGUCCGACGAUC 
RNA adaptor for 
ligation to the 5’ 
end of nascent 
RNA at step 75 
The 5’ end is not 
phosphorylated 
RTP GCCTTGGCACCCG
AGAATTCCA 
DNA oligo for 
reverse 
transcription of 
adaptor-ligated 
nascent RNA at 
step 84 
 
PCR 
primers 
for 
library 
amplifica
tion 
RP1 AATGATACGGCGA
CCACCGAGATCTA
CACGTTCAGAGTTC
TACAGTCCGA 
DNA oligo for 
PCR amplification 
of cDNA in both 
PRO-seq and 
PRO-cap at steps 
94 & 102 
Same as the RT 
oligo for PRO-seq 
RPI-n CAAGCAGAAGACG
GCATACGAGAT 
NNNNNN 
GTGACTGGAGTT 
CCTTGGCACCCGA
GAATTCCA 
DNA oligo with 
barcodes for PCR 
amplification of 
cDNA in both 
PRO-seq and 
PRO-cap at steps 
94 & 104 
The six Ns 
represent the 
barcodes for 
Illumina TRU-seq 
multiplexing. For 
example, the 
barcode in RPI-1 
is CGTGAT  
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Procedure 
Cell culture | TIMING 24 h 
1. Seed cells at a concentration that will enable them to reach ~80% 
confluency in 24 hours. For a PRO-seq experiment using adherent 
fibroblasts, 4-6 150mm cell culture dishes yield sufficient cells (~107 
cells, see Experimental Design for further details). For yeast cells, plate 
them to ensure they are in the exponential phase of growth (OD600 = 0.5) 
at the time of harvest. 
CAUTION: Check cell lines for mycoplasma contamination before setting 
up the experiment. 
 
Sample preparation | TIMING: 1 h 
CRITICAL: Samples should be prepared in cold room (40C) to avoid 
unsolicited run-on. 
2. Prepare samples by isolating nuclei (Option A) or by cell permeabilization 
(use Option C for yeast cells and Option B for other cell types).  
All centrifugation steps for sample preparation are performed in a cold 
centrifuge (40C) at 1000 g (unless stated otherwise) for 5 min. 
A. Nuclei isolation  
i. Harvest adherent cells by scraping and centrifuging, and non-
adherent cells by centrifuging.  
ii. Resuspend the cell pellet in 10 ml ice-cold PBS and centrifuge. 
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iii. Resuspend the cell pellet in ice-cold douncing buffer (1x106 cells/ml).  
CRITICAL STEP: If using spike-in cells, add them at this point to the 
cells resuspended in douncing buffer.  
iv. Incubate for 5 min on ice and dounce 25 times using a dounce 
homogenizer.  
v. Transfer the dounced nuclei to either a 15 or 50 ml conical tube and 
centrifuge the nuclei. 
vi. Wash twice by resuspending the pellet in 5 ml douncing buffer and 
centrifuging. 
vii. Resuspend the pellet in storage buffer (5-10x106 nuclei per 100 µl of 
storage buffer), flash freeze in liquid nitrogen, and store at -800C. 
PAUSE POINT: The nuclei in storage buffer can be stored at -800C for 
up to 5 years. 
B. Cell permeabilization (non-yeast cells) 
i. Harvest adherent cells by scraping and centrifuging, and non-
adherent cells by centrifuging.   
ii. Resuspend the cell pellet in 10 ml ice-cold PBS and centrifuge. 
iii. Resuspend the cell pellet in ice-cold permeabilization buffer (1x106 
cells/ml).  
CRITICAL STEP: Spike-in cells, if used, should be added to the cells 
resuspended in permeabilization buffer.  
iv. Incubate for 5 min on ice and centrifuge the permeabilized cells.  
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v. Wash twice in 5 ml permeabilization buffer and centrifuging. 
vi. Resuspend the cell pellet in storage buffer (5-10x106 permeabilized 
cells per 100 µl of storage buffer), flash freeze in liquid nitrogen, and 
store in -800C.  
PAUSE POINT: The permeabilized cells in storage buffer can be 
stored at -800C for up to 5 years. 
C. Cell permeabilization (optimized for yeast) 
i. Harvest exponentially growing yeast cells by centrifuging at 400 g. 
ii. Resuspend the cell pellet in 10 ml ice-cold PBS and centrifuge. 
iii. Resuspend the cell pellet in ice-cold yeast permeabilization buffer 
(1x106 cells/ml). 
CRITICAL STEP: Spike-in cells, if used, should be added to the cells 
resuspended in yeast permeabilization buffer.  
iv. Incubate for 20 min on ice and centrifuge the cells at 400 g.  
v. Resuspend the cell pellet in storage buffer (25-50x106 permeabilized 
cells per 100 µl of storage buffer), flash freeze in liquid nitrogen, and 
store in -800C. 
PAUSE POINT: The permeabilized cells in storage buffer can be 
stored at -800C for up to 5 years. 
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Nuclear run-on | TIMING: 1.5 h 
3. Prepare a 2x nuclear run-on (NRO) master mix; for non-yeast cells, 
prepare the master mix according to the first table, for yeast cells, use 
the second table.  
Reagents Volume per reaction (µ l) Final concentration – 1x (in 200-µ l reaction) (mM) 
Tris-Cl pH 8.0 (1 M) 1 5 
MgCl2 (1 M) 0.5 2.5 
DTT (0.1 M) 1 0.5 
KCl (4 M) 7.5 150 
DEPC-H2O 18  
 
 
Reagents Volume per reaction (µ l) Final concentration – 1x (in 200-µ l reaction) (mM) 
Tris-Cl pH 7.7 (1 M) 4 20 
MgCl2 (1 M) 6.4 32 
DTT (0.1 M) 1 0.5 
KCl (4 M) 10 200 
DEPC-H2O 6.6  
 
4. Depending on the type of run-on experiment (see Experimental Design 
section), prepare a 2x reaction mix according to Option A (single biotin 
run-on), Option B (4 biotin run-on), Option C (2 biotin run-on) or Option D 
(1 biotin run-on). If processing multiple libraries at once, scale up 
accordingly (Supplementary Table 1). 
A. Individual-biotin run-on 2x reaction mix 
i. Transfer a 28 µl aliquot of NRO master mix to each of 4 separate 
microcentrifuge tubes. 
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ii. Add 5 µl of biotin-11-ATP (1 mM) to one of the tubes containing NRO 
master mix. Label this mix “A”  
iii. Repeat step ii for the remaining 3 biotin-11-NTPs (1 mM each) and 
the 3 remaining tubes containing NRO master mix and label them “C”, 
“G”, “U” accordingly. 
iv. Add 15 µl DEPC H2O to all 4 tubes. 
v. Add 2 µl of RNase inhibitor and 50 µl of 2% Sarkosyl to all 4 tubes. 
From step 5, each tube will be processed as a separate sample. 
B. 4-Biotin run-on 2x reaction mix 
i. Transfer a 28 µl aliquot of NRO master mix to a microcentrifuge tube. 
ii. Add 5 µl each of all 4 biotin-11-NTPs (1 mM each) to the NRO master 
mix aliquot. 
iii. Add 2 µl of RNase inhibitor and 50 µl of 2% Sarkosyl. 
C. 2-Biotin run-on 2x reaction mix 
i. Transfer a 28 µl aliquot of NRO master mix to a microcentrifuge tube. 
ii. Add 5 µl each of biotin-11-CTP (1 mM) and biotin-11-UTP (1 mM) to 
the NRO master mix aliquot. 
iii. Add 2.5 µl each of ATP (10 mM) and GTP (10 mM) to the mix. 
iv. Add 5 µl DEPC H2O. 
v. Add 2 µl of RNase inhibitor and 50 µl of 2% Sarkosyl. 
D. 1-Biotin run-on 2x reaction mix 
i. Transfer a 28 µl aliquot of NRO master mix to a microcentrifuge tube. 
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ii. Add 5 µl of biotin-11-CTP (1 mM) to the NRO master mix aliquot. 
iii. Add 1 µl of CTP (0.05 mM) to the mix. 
iv. Add 2.5 µl each of ATP (10 mM), GTP (10 mM), and UTP (10 mM) to 
the mix. 
v. Add 6.5 µl DEPC H2O. 
vi. Add 2 µl of RNase inhibitor and pipette up and down several times. 
vii. Add 50 µl of 2% Sarkosyl and pipette up and down 15 times. 
5. Preheat 100 µl of the appropriate 2x reaction mix prepared in step 4 to 
37°C for mammalian cells or 30°C for yeast and insect cells. 
6. Using a cut-off P200 pipette tip, add 100 µl nuclei or permeabilized cells 
(in storage buffer from step 2) to 100 µl of preheated 2x reaction mix, 
gently but thoroughly pipette the reaction 15 times, and place in a heat 
block at the appropriate temperature. 
CRITICAL STEP: Sarkosyl in the 2x reaction mix causes the run-on 
reaction to become viscous (except for yeast). When adding the nuclei or 
permeabilized cells to the reaction mix and when mixing by pipetting up 
and down, use a wide bore pipette tip or cut the last cm off a normal one 
with ethanol wiped clean scissors or razor blade.  
7. Incubate for 3 min (5 min for yeast cells), with gentle tapping at the 
incubation midpoint. 
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RNA extraction | TIMING: 1 h 
8. Extract RNA using Option A for non-yeast nuclei or permeabilized cells 
or Option B for yeast. 
A. RNA extraction from non-yeast nuclei or permeabilized cells 
i. Add 500 µl Trizol LS and mix well by vortexing to stop the reaction. 
ii. Incubate the homogenized sample for 5 min at room temperature 
(250C) to allow the complete dissociation of nucleoprotein complexes 
and add 130 µl Chloroform.  
iii. Vortex sample vigorously for 15 s and incubate at room temperature 
for 2 to 3 min. 
iv. Centrifuge at 14,000 g for 5 min at 4°C, transfer the aqueous phase to 
a new tube, and add 1 µl GlycoBlue. 
B. RNA extraction from yeast cells or nuclei 
i. Pellet cells or nuclei after the run-on reaction at 400 g for 5 mins at 
4 °C and quickly resuspend in 500 μl phenol. 
ii. Add an equal volume of AES buffer and incubate it at 65°C for 5 min 
with periodic vortexing. Let the mixture rest on ice for 5 min, and then 
add 200 μl of chloroform. 
iii. Vortex sample vigorously for 15 s and incubate at room temperature 
for 2 to 3 min. 
iv. Centrifuge at 14,000 g for 5 min at 4°C, transfer the aqueous phase to 
a new tube, and add 1 µl GlycoBlue and NaOAc to 200 mM final conc. 
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9. Add 2.5x volume of 100% room temperature ethanol & vortex for 10 s. 
10. Incubate samples at room temperature for 10 min.   
11. Centrifuge at 14,000 g for 20 min at 4°C. The RNA precipitate forms a 
gel-like pellet on the side and bottom of the tube. 
12. Remove supernatant completely. 
13. Add 750 µl of 75% ethanol. 
PAUSE POINT: The RNA pellet in 75% ethanol can be stored up to a 
week at -80°C. 
14. Mix by vortexing and centrifuge at 14,000 g for 5 min at 4°C. 
15. Remove all supernatant. 
16. Air-dry the RNA pellet for 5-10 min. 
CRITICAL STEP: It is important not to let the RNA pellet dry completely 
as this will greatly decrease its solubility. 
17. For PRO-seq, re-dissolve the RNA pellet in 20 µl DEPC H2O and 
proceed to step 18. For PRO-cap, re-dissolve the RNA pellet in 50 µl 
DEPC H2O and proceed to step 23. 
 
RNA fragmentation by base hydrolysis (PRO-seq only) | Timing: 0.5 h 
18. Heat denature the RNA at 65°C on a heat block for 40 s and then place 
the tubes on ice. 
19. Add 5 µl of cold 1 N NaOH and incubate the mixture on ice for 10 min. 
20. Add 25 µl of 1 M Tris-HCl pH 6.8. 
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21. Perform buffer exchange once by running the 50-µl base-hydrolyzed 
RNA through a P-30 column following manufacturer’s instructions. 
22. Add 1µl RNase inhibitor. 
 
Biotin RNA enrichment | Timing: 3 h 
23. Mix ~50 µl of the RNA sample from step 22 for PRO-seq or from step 17 
for PRO-cap with 50 µl of pre-washed Streptavidin beads. 
24. Incubate at room temperature on a rotator set at 8 rpm for 20 min. 
25. Place on magnet for 1 min and remove the liquid. 
26. Resuspend the beads in 500 μl ice cold High salt wash buffer for a 1 min 
wash using rotator. 
27. Place on magnet for 1 min and remove the buffer. 
28. Repeat steps 26-27 once more. 
29. Wash two times with 500 μl Binding buffer for a minute and use the 
magnet to facilitate removal of buffer. 
30. Wash once with 500 μl Low salt wash buffer. 
31. Resuspend the beads in 300 μl Trizol and vortex thoroughly. 
32. Incubate for 3 min at room temperature. 
33. Add 60 μl chloroform. 
CRITICAL STEP: Inaccurate pipetting of chloroform leads to incomplete 
phase separation of the Trizol when transferring a small volume. 
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34. Vortex thoroughly for more than 20 s and incubate the tubes for 3 min at 
room temperature. 
35. Centrifuge at 14,000 g for 5 min, 4°C. 
36. Transfer ~180 μl of the aqueous layer to a new tube. 
37. Remove and discard the organic phase, leaving the beads and the 
unpipetted aqueous phase. 
38. Extract RNA from the beads once more by repeating steps 31-35. 
39. Collect ~180 μl of the aqueous layer and combine with the sample from 
step 36. 
40. Add 360 μl chloroform to the pooled aqueous layer and vortex. 
41. Centrifuge at 14,000 g for 5 min, 4°C. 
42. Transfer ~350 μl of the aqueous layer to a clean tube. 
43. To the collected aqueous layer, add 1 μl of GlycoBlue, 900 μl of 100% 
ethanol and vortex. 
44. Incubate samples at room temperature for 10 min and centrifuge at 
14,000 g for 20 min, 4°C. 
TROUBLESHOOTING: 
45. Add 750 µl of 75% ethanol. 
PAUSE POINT: The RNA pellet in 75% ethanol can be stored up to a 
week at -80°C. 
46. Mix by vortexing and centrifuge at 14,000 g for 5 min, 4°C. 
47. Remove all residual liquid. 
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48. Air-dry the RNA pellet for 5-10 min. 
CRITICAL STEP: Do not re-dissolve in H2O without the RNA adaptor. 
The RNA pellet is dissolved in small volume of RNA adaptor-containing 
solution to minimize the adapter ligation reaction volume. 
 
3’ RNA adaptor ligation | Timing: 4.5 h 
49. Dilute 0.5 μl 100 μM 3’ RNA adaptor in 3.5 μl DEPC H2O. For PRO-seq, 
use VRA3 RNA adaptor. For PRO-cap, use RA3 RNA adaptor. For 
processing multiple samples, scale up accordingly. 
50. Redissolve the RNA from step 48 in 4 μl of 3’ RNA adaptor dilution. 
51. Heat denature at 65°C in a heat block for 20 s, then place on ice. 
52. Make the RNA ligation mix tabulated below. When processing multiple 
samples, scale up accordingly (Supplementary Table 2). 
Reagents Volume per reaction (µ l) Final concentration  
T4 RNA ligase buffer (10x) 1 1x 
ATP (10 mM) 1 1 mM 
50% PEG 2 10 % 
RNase inhibitor 1 4 units per µl 
T4 RNA ligase I 1 1 units per µl 
 
53. Add 6 μl of the mix to the 4 μl of RNA (10 μl final). 
CRITICAL STEP: GlycoBlue may form a precipitate in presence of high 
PEG conc, but is not reported to affect the ligation efficiency.  
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54. Incubate at 20°C for 4 hr then place at 4°C until ready to proceed to the 
next step. 
PAUSE POINT: The ligation reaction can be left at 4°C overnight. 
 
Second biotin RNA enrichment | Timing: 3 h 
55. Bring the volume of the adaptor ligated RNA from step 54 to 50 μl by 
adding 40 μl DEPC H2O. 
56. Perform a second biotin enrichment by repeating steps 23-48 with the 50 
μl ligated RNA sample. 
PAUSE POINT: The RNA pellet in 75% ethanol can be stored up to a 
week at -80°C. 
 
Enzymatic modification of the RNA 5’ ends | Timing: 3.5-4 h 
57. Re-dissolve the RNA pellet from step 56 in 5 μl DEPC H2O. 
58. Heat denature briefly at 65°C in a heat block for 20 secs, then place on 
ice. 
59. If performing PRO-cap, degrade the uncapped RNA containing 5’-
monophosphate and remove the 5’ triphosphate and monophosphate 
from uncapped RNA as described in Box 1 (Supplementary Table 3 & 4) 
before proceeding to step 60. For PRO-seq, continue directly to step 60.  
60. Prepare 5’ cap repair enzyme mix: depending on the availability of 
Tobacco acid pyrophosphatase (TAP) or RNA 5’ Pyrophosphohydrolase 
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(RppH). When using TAP, prepare the enzyme mix in the first table. 
When using RppH, prepare the enzyme mix in the second table. When 
processing multiple samples, scale up (Supplementary Table 5).  
Reagents Volume per reaction (µ l) Final concentration 
DEPC H2O 3  
TAP buffer (10x) 1 1x 
RNase inhibitor 0.5 2 units per µl 
TAP 0.5 0.5 units per µl 
 
 
Reagents Volume per reaction (µ l) Final concentration 
DEPC H2O 2.5  
ThermoPol Reaction buffer 
(10x) 1 1x 
RNase inhibitor 0.5 2 units per µl 
RppH 1 0.5 units per µl 
 
61. Add 5μl of the appropriate enzyme mix to the 5μl of RNA from step 58 for 
PRO-seq or 5μl of RNA from step 24 of Box 1 for PRO-cap.  
62. Incubate at 37°C for 1 hr. 
63. For PRO-seq, proceed to step 64 for hydroxyl repair. For PRO-cap, Add 
90μl of DEPC H2O to the 10μl of RNA from step 62 and proceed directly 
to step 67 
 
(PRO-seq only) Hydroxyl repair | TIMING: 2 h 
64. Prepare polynucleotide kinase (PNK) mix as tabulated below. When 
processing multiple samples, scale up accordingly (Supplementary Table 
6). 
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Reagents Volume per reaction (µ l) Final concentration 
DEPC H2O 65  
PNK buffer (10x) 10 1x 
ATP (10 mM) 10 1 mM 
RNase inhibitor 2.5 1 units per µl 
PNK 2.5 0.25 units per µl 
 
65. Add 90μl of the mix to the 10μl of RNA from step 62. 
66. Incubate at 37°C for 1 hr. 
67. Add 300 μl of Trizol and vortex for 5 s. 
68. Add 60 μl chloroform, vortex for 15 s, and incubate for 2 min at room 
temperature. 
69. Centrifuge at 14,000 g for 5 min at 4°C. 
70. Transfer ~280 μl aqueous layer to a clean microfuge tube. 
71. Add 280 μl chloroform to the aqueous layer from step 70 and vortex for 5 
s. 
72. Centrifuge at 14,000 g for 5 min at 4°C and transfer ~280 μl aqueous 
layer to a clean microfuge tube. 
73. Add 0.5 μl GlycoBlue and 700 μl of 100% ethanol to the aqueous layer 
from step 72, and pellet the RNA by centrifuging at 14,000 g for 20 min at 
4°C.  
74. Wash the RNA pellet in 75% ethanol by repeating steps 45-48. 
PAUSE POINT: The RNA pellet in 75% ethanol can be stored up to a 
week at -80°C. 
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CRITICAL STEP: Do not re-dissolve in H2O without the RNA adaptor. 
The RNA pellet is dissolved in a small volume of RNA adaptor-containing 
solution to minimize the adapter ligation reaction volume. 
 
5’ RNA adaptor ligation | Timing: 4.5 h 
75. Dilute 0.5 μl 100 μM 5’ RNA adaptor in 3.5 μl DEPC H2O. For PRO-seq, 
use VRA5 RNA adaptor. For PRO-cap, use RA5 RNA adaptor. For 
processing multiple samples, scale up accordingly. 
76. Redissolve the RNA pellet from step 74 in 4 μl of the 5’ RNA adaptor 
dilution. 
77. Heat denature at 65°C in a heat block for 20 s, then place on ice. 
78. Make the RNA ligation mix as described in step 52. When processing 
multiple samples, scale up accordingly (Supplementary Table 2). 
79. Add 6 μl of the RNA ligation mix to the 4 μl of RNA (10 μl final). 
CRITICAL STEP: GlycoBlue may precipitate in the presence of high PEG 
concentration, but is not reported to affect the ligation efficiency. 
80. Incubate at 20°C for 4 hr then place at 4°C until ready to proceed to the 
next step.  
PAUSE POINT: The ligation reaction can be left at 4°C overnight. 
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Third biotin RNA enrichment | Timing: 3 hr 
81. Bring the volume of the adaptor ligated RNA to 50 μl by adding 40 μl 
DEPC H2O. 82. Perform a third biotin enrichment by repeating steps 23-48 with the 50 μl 
ligated RNA sample. 
PAUSE POINT: The RNA pellet in 75% ethanol can be stored up to a 
week at -80°C.	
  
Reverse transcription | Timing: 2 h 
83. Re-dissolve the RNA pellet in 10 μl DEPC H2O. 
84. Make reverse transcription (RT) primer mix as shown in the table below. 
Component 
Amount per reaction (μl) Final conc. in 20-
μl volume (μM) PRO-seq PRO-cap 
RP1 reverse transcription 
primer (100 μM) 0.5 -- 2.5 
RTP reverse transcription 
primer (100 μM) -- 0.5 2.5 
12.5 mM dNTP mix 1 1 625 
DEPC-H2O 1 1  
 
 
85. Add 2.5 μl of the RT primer mix to the 10 μl of re-dissolved RNA. 
86. Heat to 70°C for 2 min, chill it on ice for 2 min and briefly spin at 500-
1,000g at 25°C for 5 s.  
87. Prepare the RT buffer mix as shown in table below. When processing 
multiple samples, scale up accordingly (Supplementary Table 7). 
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Reagents Volume per reaction (µ l) Final concentration 
First strand buffer (5x) 4  
DTT (0.1 M) 1 5 mM 
RNase inhibitor 1 2 units per µl 
 
88.  Add 6 μl of RT buffer mix to 12.5 ul of RNA-primer mix from step 86. 
89. Incubate for 5 min, 37°C. 
90. Add 1.5 μl Superscript III reverse transcriptase and mix (total 20 μl). 
91. Incubate for 15 min at 45°C, then 40 min at 50°C, 10 min at 55°C, and 15 
min at 70°C. 
92. Add 6 μl of DEPC H2O to the RT reaction (total 26 μl). 
PAUSE POINT: The reverse transcribed cDNA can be stored for a month 
at -20°C. 
 
Test PCR amplification | Timing: 2 h 
93. Prepare a series of 4-fold dilutions of the RT sample in H2O as tabulated 
below. Test PCR amplification (a total of 21 amplification cycles) of these 
dilutions will be used to determine the appropriate number of PCR cycles 
to use in full-scale amplification at step 105. The use of 2 μl RT sample 
in dilution 1 leaves 24 μl for full-scale amplification at step 105. 
Dilution Amount of cDNA 
Amount of H2O 
(μl) 
Equivalent full-scale 
PCR cycles (step 105) 
1 2 μl RT sample 6 17 
2 2 μl dilution 1 6 15 
3 2 μl dilution 2 6 13 
4 2 μl dilution 3 6 11 
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CRITICAL STEP: As only 6 μl out of the total 8 μl of Dilution 1 is used for 
PCR, this is equivalent to using 1.5 μl (6/8 x 2) of the original 26 μl RT 
sample, which is 16 fold less than the remaining 24 μl RT sample. Thus, 
to account for the 16-fold higher amount of starting material in the full-
scale amplification, the number of PCR cycles needs to be reduced by 4 
compared to test PCR of Dilution 1 i.e. 17 cycles instead of 21. Each 
remaining dilution in the 4-fold dilution series will need to be corrected by 
a further 2 cycles compared to the previous dilution i.e. 15, 13, and 11 
cycles for dilutions 2 to 4 respectively.  
94. Prepare a test PCR mix. One test PCR amplification will be performed for 
each dilution prepared in step 93 (Supplementary Table 8).  
Reagents Volume per reaction (µ l) Final concentration 
DEPC H2O 5  
HF buffer (5x) 4 1x 
Betaine (5 M) 4 1 M 
dNTP mix (12.5 mM each) 0.4 250 μM each 
RP1 primer (25 μM) 0.2 250 nM 
RPI-1 primer (25 μM) 0.2 250 nM 
Phusion DNA polymerase 0.2 0.02 units per µl 
 
95. Add 14 μl of the PCR mix to 6 μl of each diluted test sample.  
96. Use the following thermal cycling to perform test PCR amplification (a 
total of 21 amplification cycles). 
Cycle number Denature (95°C) Anneal Extend (72°C) 
1 2 min   
2 - 6 30 s 56°C for 30 s 30 s 
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7 - 22 30 s 65°C for 30 s 30 s 
23   10 min 
 
 
Gel analysis of test PCR | Timing: 2 h 
97. Add 2.2 μl 10x Orange G dye to the 20 μl PCR reactions and load 20 μl 
of the samples onto a 2.2% agarose gel in 1xTAE. 
98. Load 8 μl of 100 bp DNA ladder on a separate lane. 
99. Run the gel at 100 V for 15 min, then run it at 130 V for up to 45 min. 
CRITICAL STEP: Orange G dye runs at 50 bp. Stop the electrophoresis 
before the dye runs out of the gel. 
100. Add 15 μl of SYBRGold to 150 ml 1x TAE. Place the gel in this solution 
and stain for 30 min on a shaker. 
101. Image the gel with 485 nm illumination, or with UV light. Examine the gel 
and determine the dilution (and therefore the equivalent full-scale PCR 
amplification cycle) with desired amplification characteristics (sufficient 
amount of product, not over amplified, and having 50-75% of unused 
primers). For example, if the lane in the agarose gel with dilution 3 has 
the desired amplification characteristics, then the optimal number of PCR 
cycles (optimized cycle, OC) for full-scale amplification is 13 (see step 
93). See Figure A.2A and A.2B for an example gel image. 
TROUBLESHOOTING:  
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Figure A.2. Gel images of library products 
(A) PRO-seq libraries at the test amplification stage (step 101). 3 different 
samples are loaded on the agarose gel, each at 4 dilutions. From the left of 
each series, the 4 dilutions are equivalent to 17, 15, 13, and 11 cycles of full 
amplification. The gel image in left panel shows two successful PRO-seq 
libraries. Optimal amplification cycles are determined by comparing both the 
intensities of library products and the unused primers. Optimal amplification 
cycles are when 50-75% of the primers remain unused (13 cycles for this 
example). Gel image of a failed library preparation is shown on the right panel; 
only primer dimers are detected. 
(B) PRO-cap libraries at the test amplification stage (step 101). Library 
products are smaller in size and amount, because most PRO-cap RNA 
molecules are from paused RNA polymerase. 15 cycles were optimal for these 
samples. 
(C) Two PRO-seq libraries after full amplification analyzed by 8% PAGE (step 
118). Labels on the left indicate DNA sizes. Note the presence of unused 
primers around 50 bp and primer dimer bands ~120 bp. The library product is 
the smear above the primer dimer band. 
(D) Two PRO-seq libraries after the size selection analyzed by 8% PAGE 
(step 119). PRO-seq library on the left still has some residual primer dimer. 
(E) Two PRO-cap libraries after the full amplification analyzed by 8% PAGE 
(step 118). Note that there are additional primer and primer dimer bands 
compared to PRO-seq. 
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Full-scale PCR amplification | Timing: 2.5 h 
102. Prepare a full-scale amplification PCR mix according to the table below. 
For processing multiple samples, scale up accordingly (Supplementary 
Table 9). 
Reagents Volume per reaction (µ l) Final concentration 
DEPC H2O 3  
HF buffer (5x) 10 1x 
Betaine (5 M) 10 1 M 
dNTP mix (12.5 mM each) 1 250 μM each 
RP1 primer (25 μM) 0.5 250 nM 
Phusion DNA polymerase 1 0.04 units per µl 
 
103. Add 25.5 μl of the PCR mix to the 24 μl of the remaining reverse 
transcription product (from step 93). 
104. Add 0.5 μl of a different RPI-n (25 μM) primer to the different libraries so 
that each library is differentially barcoded. 
CRITICAL STEP Different barcodes are only needed if the libraries are to 
be pooled for sequencing. 
105. Use the following thermal cycling for full-scale PCR amplification, where 
OC stands for Optimized Cycle as determined in step 101.  
Cycle number Denature (95°C) Anneal Extend (72°C) 
1 2 min   
2 - 6 30 s 56°C for 30 s 30 s 
7 - (OC + 1) 30 s 65°C for 30 s 30 s 
(OC + 1) - (OC + 2)   10 min 
 
PAUSE POINT: The PCR product can be stored up to a month at -20°C. 
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106. Add 231 μl H2O, 18 μl 5 M NaCl, 1 μl GlycoBlue to the 50 μl full 
amplification PCR product. 
107. Add 750 μl 100% ethanol and vortex thoroughly. 
108. Centrifuge at 14,000 g for 20 min, 4°C. 
109. Remove liquid and the wash the pellet once in 75% ethanol by repeating 
steps 45-48. 
PAUSE POINT: The DNA pellet in 75% ethanol can be stored up to 
several months at -80°C. 
110. Re-dissolve the DNA pellet in 18 μl H2O. 
 
Library size selection by PAGE | Timing: 5 h to 1 day 
CRITICAL: we describe PAGE purification for size selection of the library. 
However, a Pippin Prep (Sage Science) can also be used in place of steps 
111-130; follow the manufacturer’s instruction for selecting a size range of 
140-350 bp. 
111. Add 2 μl of 10× Orange G loading dye to 18 μl DNA from step 110. 
112. Prepare a medium size (10 cm running length) Native PAGE gel as 
below. 
Reagents Volume Final concentration 
DEPC-H2O 31.67 ml  
Acrylamide (30%) 13.3 ml 8% 
TBE (5x) 5 ml 0.5x 
APS (10%) 500 µl 0.1% 
TEMED 50 µl  
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113. Pre-run the gel for 15 min at a constant current of 30 mA. 
114. Load samples. Also load 2 μl 10 bp DNA ladder and 8 μl of 100 bp DNA 
ladder. 
115. Run gel at 15 mA for 30 min until the DNA has entered the gel, and then 
run at 30 mA for 1.5 hr. Stop electrophoresis 10 minutes after the Orange 
G dye has run off the gel. 
116. During the electrophoresis, puncture the bottom of a sterile, nuclease-
free, 0.5 ml centrifuge tube using a 21-gauge needle (heated in a bunsen 
flame) to create a hole or several holes in the bottom of the tube. Place 
the 0.5 ml microtube into a sterile, round-bottom, nuclease-free, 2 ml 
microtube. 
117. After the electrophoresis, pry apart the gel cassette and stain the gel with 
SYBR Gold (10 μl SybrGold per 100 ml 1× TBE buffer) in a clean 
container for 5-10 min. 
118. Visualize the gel on a Dark Reader transilluminator. 
119. Using a clean scalpel or razor, cut the gel from 140 bp (20 bp just above 
the 120 bp adapter dimer) up to 350 bp (see Figure A.2C, A.2D, and 
A.2E). 
120. Split the gel fragment vertically and place the pieces into the 0.5 ml 
microtube. 
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121. Centrifuge the stacked tubes at 10,000 g for 2 min at room temperature 
to shred the gel through the holes into the 2 ml tube (there is no liquid at 
this point). 
122. If some gel remains in the top tube, add 100 μl of Gel Elution Buffer and 
spin at 10,000g again for another 2 min. 
123. Add 600 μl of Gel Elution Buffer and incubate for 2 hr in a rotating 
incubator, 37°C.  
PAUSE POINT: The elution can continue overnight. 
124. Spin down gel pieces for 1 min at max speed in a benchtop centrifuge.  
125. Transfer all liquid possible to a new tube. 
126. Add 400 μl of Gel Elution Buffer to the remaining gel pieces. 
127. Incubate for 1 hr in a rotating incubator, 37°C. 
128. After 1 h incubation, spin at the maximum speed in a benchtop centrifuge 
for 1 min; take the supernatant and pool with the first elution from step 
125. 
129. Rinse gel pieces with 250 μl H2O, spin and add the rinsed liquid to the 
pool. 
130. Transfer the pooled eluate which may contain small pieces of gel debris, 
to the top of a Spin-X filter. 
131. Centrifuge the filter for 1-2 min at 6,000-7,000 g, room temperature. 
Collect the filtrate. If the volume exceeds the filter capacity, use multiple 
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filters or split into batches and repeat filtering a couple of times and pool 
the filtrates. 
132. Lyophilize (on medium setting) the sample using a Speed Vac dryer 
reduce the volume to ~400 μl (takes 45 min-2 hr). If the volume 
decreases below 400 μl, bring the volume up to 400 μl by adding DEPC-
H2O. 
133. Add an equal volume of buffered phenol:chloroform, and vortex 
thoroughly. 
134.  Centrifuge at 14,000 g for 5 min, 4°C. 
135. Collect the aqueous layer in a clean tube. 
136. Add an equal volume of chloroform to the aqueous layer, and vortex 
thoroughly. 
137. Centrifuge at 14,000 g for 5 min, 4°C. 
138. Collect the aqueous layer in a clean tube. 
139. Add 1 μl GlycoBlue to the aqueous layer. 
140. Add 2.5× volume of room temperature 100% ethanol. 
141. Vortex thoroughly and incubate at room temperature for 10 min. 
142. Centrifuge at 14,000 g for 20 min, 4°C. 
143. Remove liquid, and wash the DNA pellet once in 75% ethanol by 
repeating steps 45-48. 
144. Re-dissolve the pellet in 12 μl H2O. 
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145. Use 2 μl of the library DNA for quantification using Qubit or Bioanalyzer. 
The expected concentration of the library is between 1-20 ng/μl. 
146. If required, dilute the samples to 5 ng/μl. Send ~10 ng to the sequencing 
facility for sequencing. If the libraries are barcoded, pool the barcoded 
libraries that are to be sequenced simultaneously. 
 
High-throughput sequencing | Timing: 24 h 
147. Sequence pooled PRO-seq or PRO-cap libraries using an Illumina TRU-
seq compatible sequencing platform. Sequencing depth of ~20 million 
and ~50 million reads provides good coverage in insect cells and 
mammalian cells respectively.  
 
Data analysis | TIMING: variable 
CRITICAL. In PRO-seq, the 3’ end of the nascent RNA corresponds to the 
genomic position of the RNA polymerase active site. The modified RNA 
adaptors were designed to enable sequencing of the reverse complement of 
nascent RNAs. Therefore, the 3’ end of the reverse complement of the 
sequencing reads reflects the RNA polymerase active site position. In PRO-
cap, conventional RNA adaptors are used, and the 5’ ends of each sequence 
read reflects the transcription start sites in the same direction. Below, we 
outline the three major stages of a simple processing pipeline. 
148. Pre-process the raw sequence data. Filter out low quality reads and 
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trimming potential adaptor sequences (TGGAATTCTCGGGTGCCAAGG) 
from the sequence reads. Tools such as ‘cutadapt’ are publicly available 
for this purpose. Depending on the quality of the library, sequences 
containing only the adaptor sequences (adaptor dimers) may take up to 
5% of total reads. 
149. Map or align the sequence reads to the genomic sequence. Since most 
of the nascent RNA reads are captured before RNA processing and 
splicing, they do not contain large gaps in alignment. Therefore, many 
alignment programs based on the Burrows-Wheeler transformation 
algorithm such as ‘bwa’ or ‘bowtie’ work well. Reads with multiple 
alignments are usually discarded, unless they are used for studying 
specific target regions that are repeated more than once. Sometimes, 
reads aligning to the ribosomal DNA sequence can be pre-filtered since 
they can account for 30-40% of all the transcriptional activity. On 
average, about 55-70% of the raw sequence reads are aligned uniquely 
to the genome. The alignment results are commonly stored in ‘sam’ or 
‘bam’ formats. 
150. Generate the coverage of the aligned sequence reads. A common way 
to do this using publicly available tools is as follows: first, sort the ‘bam’ 
file using ‘samtools sort’; then process the sorted ‘bam’ file using 
‘bedtools genomecov’ with ‘-ibam’ (use bam file input), ‘-strand’ (strand 
specific coverage), and ‘-5’ (5’ position coverage’) options. For the PRO-
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seq data, swap the plus and minus strand data for the correct orientation. 
These data can be visualized in genome browsers (Figure A.3), and 
used in further downstream analyses. 
 
TROUBLESHOOTING 
Troubleshooting advice is provided in Table A.2. 
 
Table A.2. Troubleshooting PRO-seq library preparation 
Step Problem Possible reason Solution 
44 
Small or 
no pellet 
Incomplete 
precipitation. 
 
· Re-centrifuge using higher speed. 
· If the pellet is still not recovered, 
add 0.4× volume of isopropanol and 
re-centrifuge. 
Incomplete 
separation of the 
organic phase 
· Perform an additional chloroform 
extraction after step 42. 
Blue jelly 
ball-like 
pellet 
Incomplete 
separation of the 
organic phase. 
· Re-dissolve the pellet in 100 μl 
DEPC H2O and extract RNA once 
more using Trizol LS. 
· If the problem persists, add 
additional chloroform extraction after 
step 42. 
101 
No library 
product 
or the 
library 
product 
amplifies 
at later 
cycles. 
Insufficient amount 
or quality of the 
nuclei sample. 
· Adjust the nuclei amount and 
monitor the quality. A typical batch of 
active nuclei can incorporate 1-5% of 
total radioactive CTP [α-32P] under 
the nuclear run-on condition. 
RNA degradation. 
· Replace all reagents using RNA-
grade materials and carry out steps 
at low 40C. 
Incomplete RNA 
extraction during 
biotin RNA 
enrichment. 
· Resuspend the bead thoroughly in 
step 31. 
· Add additional RNA extraction by 
repeating step 38. 
Inefficient RNA 
modifying enzymes. 
· Monitor enzyme activities following 
the manufacturers’ instructions. 
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Figure A.3. Genome browser examples of PRO-seq and PRO-cap results 
(A) Sample of PRO-seq and PRO-cap data viewed on the University of 
California at Santa Cruz (UCSC) genome browser. A region on chromosome 
11 encompassing the MED17 gene showing PRO-seq (top), PRO-cap (mid), 
and Pol II ChIP-seq and Serine-2 phosphorylated Pol II (Pol II S2P) ChIP-seq 
(bottom) reads aligned to the human genome (hg19). PRO-seq and PRO-cap 
reads on the plus strand (left to right), red; PRO-seq and PRO-cap reads on 
the minus strand (right to left), light blue; RefSeq gene annotations, dark blue; 
and ChIP-seq reads, dark red. The Pol II and Pol II S2P ChIP-seq tracks are 
from the ENCODE public data on GM12878 cells using 8WG16 and ab5095 
antibodies respectively. Y-axis represents raw read counts displayed on the 
default setting of the UCSC genome browser. 
(B) Sample of PRO-seq and PRO-cap data view on the UCSC genome 
browser. A region on chromosome 5 encompassing the NPM1 gene showing 
PRO-seq (top) and PRO-cap (bottom) reads aligned to the human genome 
(hg19). Red boxes with arrowheads mark the region magnified in subsequent 
panels. 
(C) PRO-seq (top), PRO-cap (mid), and Pol II ChIP-seq and Pol II S2P ChIP-
seq (bottom) data across the gene body of NPM1 gene.  
(D) An up-close view around the annotated TSS of NPM1 gene. ENCODE 
RIKEN CAGE data (bottom) is shown to illustrate the position of mRNA cap 
site relative to the PRO-seq, PRO-cap, and Pol II ChIP-seq data around the 
annotated TSS of NPM1 gene.  
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Anticipated results 
 The final product of the PRO-seq or PRO-cap method is genome-wide 
maps of, respectively, RNA polymerase active sites or transcription start sites 
(Figure A.3). In general, PRO-seq profile of a gene exhibits several features 
such as: a) higher read density at the promoter-proximal pause site compared 
to the gene body representing paused Pol IIs, b) uniform read density across 
exons and introns, c) reads beyond the polyadenylation site, and d) divergent 
PRO-seq reads at the promoter of genes in mammals indicating divergent 
transcription. The enhancer regions, which are present in intergenic and 
intragenic regions, are also characterized by divergent PRO-seq reads. In 
PRO-cap, read density is very high at TSS and very low, almost at background 
level, in gene bodies.  
 An indication of whether library preparation has been successful can be 
obtained at the Test amplification stage (steps 93-101) through estimates of 
yield and quality (Figure A.2). Spiky PRO-seq read coverage along the gene 
body indicates lower complexity of the library, which may arise from use of 
fewer nuclei or permeabilized cells or by the use of higher number of PCR 
amplification cycles. Libraries that require fewer amplification cycles (less than 
13 cycles) provide high quality results, and those requiring between 14-18 
cycles provide meaningful results but with some potential for amplification 
biases. These amplification biases manifest as low library complexity in 
general and high repetition of certain sequence reads.  
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Box 1. Degradation of RNA containing 5’-monophosphate and removal of 
5’-triphosphate and -monophosphate from the RNA for PRO-cap | 
Timing: 4 h 
1. Prepare the 5’-phosphate-dependent exonuclease enzyme mix. When 
processing multiple samples, scale up accordingly (Supplementary Table 
3) 
Reagents Volume per reaction (µ l) Final concentration 
DEPC-H2O 2.5  
Buffer A (10x) 1 1x 
RNase inhibitor 0.5 2 units/µl 
5’-phosphate-dependent 
exonuclease 1 0.1 units/µl 
 
2. Add 5 μl of the mix to the RNA from step 58 of the main Procedure (10μl 
final) 
3.  Incubate at 30°C for 1 hr. 
4.  Add 300 μl of Trizol and vortex for 5 s. 
5.  Add 60 μl chloroform, vortex for 15 s, and incubate for 2 min at room 
temperature. 
6.  Centrifuge at 14,000 g for 5 min at 4°C. 
7.  Transfer ~180 μl aqueous layer to a clean microfuge tube. 
8.  Add 180 μl chloroform to the aqueous layer from step 7 and vortex for 5 s. 
9.  Centrifuge at 14,000 g for 5 min at 4°C and collect ~180 μl aqueous layer. 
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10.  Add 0.5 μl GlycoBlue and 450 μl of 100% ethanol to the aqueous layer 
from step 9, and pellet the RNA by centrifuging at 14,000 g for 20 min at 
4°C.  
11.  Wash the RNA pellet in 75% ethanol by repeating steps 45-48 of the main 
Procedure. 
PAUSE POINT: The RNA pellet in 75% ethanol can be stored up to a week 
at -80°C. 
12.  Re-dissolve the RNA pellet in 5 μl DEPC H2O, and heat denature briefly in 
65°C heat block for 20 s, then place on ice. 
 
13. Prepare the alkaline phosphatase enzyme mix. When processing multiple 
samples, scale up accordingly (Supplementary Table 4). 
Reagents Volume per reaction (µ l) Final concentration 
DEPC-H2O 3  
Alkaline phosphatase 
buffer (10x) 1 1x 
RNase inhibitor 0.5 2 units/µl 
Alkaline phosphatase 0.5 0.5 units/µl 
 
14. Add 5 μl of the mix to the RNA from step 12 (10μl final) 
15.  Incubate at 37°C for 1 hr. 
16.  Add 300 μl of Trizol and vortex for 5 s. 
17.  Add 60 μl chloroform, vortex for 15 s, and incubate for 2 min at room 
temperature. 
		
	
	
312	
18.  Centrifuge at 14,000 g for 5 min at 4°C. 
19.  Transfer ~180 μl aqueous layer to a clean microfuge tube. 
20.  Add 180 μl chloroform to the aqueous layer from step 19 and vortex for 5 
s. 
21.  Centrifuge at 14,000 g for 5 min at 4°C and collect ~180 μl aqueous layer. 
22.  Add 0.5 μl GlycoBlue and 450 μl of 100% ethanol to the aqueous layer 
from step 21, and pellet the RNA by centrifuging at 14,000 g for 20 min at 
4°C.  
23.  Wash the RNA pellet in 75% ethanol by repeating steps 45-48 of the main 
Procedure. 
PAUSE POINT: The RNA pellet in 75% ethanol can be stored up to a week 
at -80°C. 
24.  Re-dissolve the RNA pellet in 5 μl DEPC H2O, and heat denature briefly in 
65°C heat block for 20 s, then place on ice. Proceed from step 60 of the 
main Procedure. 
 
Timing 
Step 1, cell culture: 24 h 
Step 2, sample preparation (nuclei isolation/cell permeabalization): 1 h 
Steps 3-7, nuclear Run-On: 1.5 h 
Steps 8-17, RNA extraction: 1 h 
Steps 18-22, RNA fragmentation by base hydrolysis: 0.5 h 
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Steps 23-48, biotin RNA enrichment: 3 h 
Steps 49-54, 3’ RNA adaptor ligation: 0.5 h hands-on, 4.5 h to overnight total 
(suggested end of the first day) 
Steps 55 and 56, second biotin RNA enrichment: 3 h 
Steps 57–63, enzymatic modification of the RNA 5′ ends: 3.5–4 h   
Steps 64–74, hydroxyl repair (PRO-seq only): 2 h 
Steps 75-80, 5’ RNA adaptor ligation: 4.5 h (0.5 h hands-on and 4 h 
incubation; can be stored overnight (suggested end of the second day) 
Steps 81 and 82, third biotin RNA enrichment: 3 h 
Steps 83-92, reverse transcription: 2 h 
Steps 93-96, test PCR amplification: 2 h 
Steps 97-101, test PCR gel analysis: 2 h (Suggested end of the third day) 
Steps 102-110, full-scale PCR amplification: 2.5 h 
Steps 111-146, library size selection by PAGE: 5 h – 1 day 
Step 147, high-throughput sequencing, 24 h 
Steps 148–150, data analysis: variable 
Box 1, degradation of RNA containing 5′-monophosphate and removal of 5′-
triphosphate and monophosphate from the RNA for PRO-cap: 4 h 
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Supplementary Tables 
 
Supplementary Table 1. Nuclear Run-On reaction mix (step 4) 
Reagents 1× volume (μl) Scaled volume (μl) 
NRO master mix 28  
Biotin NTP mix (+rNTP/H2O) 20  
RNase inhibitor 2  
Sarkosyl (2%) 50  
Total 100  
 
Supplementary Table 2. RNA adaptor ligation mix (steps 52, 78) 
Reagents 1× volume (μl) Scaled volume (μl) 
T4 RNA ligase buffer (10x) 1  
ATP (10 mM) 1  
50 % PEG 2  
RNase inhibitor 1  
T4 RNA ligase I 1  
Total 6  
 
Supplementary Table 3. 5’-phosphate-dependent exonuclease enzyme mix 
(Box 1, step 1, for PRO-cap only) 
Reagents 1× volume (μl) Scaled volume (μl) 
DEPC H2O 2.5  
Buffer A (10x) 1  
RNase inhibitor 0.5  
5’-phosphate-dependent 
exonuclease 1  
Total 5  
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Supplementary Table 4. Alkaline phosphatase enzyme mix (Box 1, step 14, 
for PRO-cap only) 
Reagents 1× volume (μl) Scaled volume (μl) 
DEPC H2O 3  
Alkaline phosphatase buffer 
(10x) 1  
RNase inhibitor 0.5  
Alkaline phosphatase 0.5  
Total 5  
 
Supplementary Table 5. 5’ cap repair enzyme mix (step 60) 
Reagents 1× volume (μl) Scaled volume (μl) 
DEPC H2O 3/2.5  
TAP buffer/ThermoPol 
Reaction buffer (10x) 1  
RNase inhibitor 0.5  
TAP/RppH enzyme 0.5/1  
Total 5  
 
Supplementary Table 6. Polynucleotide kinase (PNK) enzyme mix (step 64, 
for PRO-seq only) 
Reagents 1× volume (μl) Scaled volume (μl) 
DEPC H2O 65  
10× PNK buffer 10  
ATP (10 mM) 10  
RNase inhibitor  2.5  
T4 PNK enzyme 2.5  
Total 90  
 
Supplementary Table 7. Reverse transcription buffer mix (step 87) 
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Reagents 1× volume (μl) Scaled volume (μl) 
First strand buffer (5x) 4  
DTT (0.1 M) 1  
RNase inhibitor 1  
Total 6  
 
Supplementary Table 8. Test PCR amplification mix (step 94) 
Reagents 1× volume (μl) Scaled volume (μl) 
H2O 5  
High Fidelity (HF) buffer (5x) 4  
Betaine (5 M) 4  
dNTP mix (12.5 mM each) 0.4  
RP1 primer (25 μM) 0.2  
RPI-1 primer (25 μM) 0.2  
Phusion DNA polymerase 0.  
Total 14  
 
Supplementary Table 9. Full-scale PCR amplification mix (step 102) 
Reagents 1× volume (μl) Scaled volume (μl) 
H2O 3  
High Fidelity (HF) buffer (5x) 10  
Betaine (5 M) 10  
dNTP mix (12.5 mM each) 1  
RP1 primer (25 μM) 0.5  
Phusion DNA polymerase 1  
Total 25  
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APPENDIX Be 
 
ENHANCED PRO-seq (ePRO-seq) FOR EFFICIENT AND HIGH-
THROUGHPUT LIBRARY PREPARATION WITHOUT PCR AND SIZE-
SELECTION BIASES 
 
Development of ePRO-seq 
PRO-seq maps the location of active RNA polymerases genome-wide 
at high resolution (Kwak et al., 2013). This assay has many attractive features 
over other genomic assays that also map RNA polymerases genome-wide. 
The recently published PRO-seq protocol (Mahat et al., 2016b) highlights 
advantages and limitations of this assay, and explains the procedure in great 
detail. However, PRO-seq can be laborious and takes 4 to 5 days. Library 
preparation of multiple samples is individually handled, increasing the 
likelihood of error. Once RNA adaptors on both ends of nascent RNA are 
ligated, PRO-seq library is amplified using PCR to generate quantifiable 
amount for optimal loading in the sequencing machine and size-selected using 
PAGE gel for optimal cluster generation and sequencing.  
																																																						
e Sections similar to PRO-seq are adapted from Mahat, D. B.*, Kwak, H.*, 
Booth, G. T., Jonkers, I. H., Danko, C. G., Patel, R. K., Waters, C.T., Munson, 
K., Core, L.J., & Lis, J.T. (2016). Base-pair-resolution genome-wide mapping 
of active RNA polymerases using precision nuclear run-on (PRO-seq). Nature 
Protocols, 11(8), 1455–1476. *denotes equal contribution. Reprinted with 
permission from Nature Publishing. 
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 The long library-preparation procedure and the likelihood of error due to 
extensive handling have been a source of intimidation for many young 
scientists who want to use this highly sensitive and robust genomic assay. The 
biases associated with PCR (Aird et al., 2011; Jones et al., 2015) has limited 
the ability of POR-seq assay to detect the transcription regulation in gene body 
manifested through pause. Similarly, size-selection bias (Poptsova et al., 
2014) restrict the detection and interpretation of shorter promoter-proximal-
paused reads. To address these limitations and simplify library preparation 
procedure, we developed an enhanced version of PRO-seq called ePRO-seq. 
This new method supports high-throughput library preparation by enabling 
sample mixing on the beginning of second day and reduces the library 
preparation time to 2.5 days. ePRO-seq library does not require PCR 
amplification and size selection, and thus eliminates the biases associated 
with these two steps common in genomic library preparation. By reducing time 
and minimizing handling, ePRO-seq saves reagents and reduces cost of 
library preparation making the enhanced version of PRO-seq a relatively easy, 
efficient, and rigorous genomic assay to map the transcriptionally engaged 
RNA polymerases genome-wide at base-pair resolution. 
 
Overview of ePRO-seq 
The major steps in ePRO-seq are similar to PRO-seq. Cell-culture, 
sample preparation, nuclear-run-on, RNA extraction and fragmentation by 
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base hydrolysis, and first biotin enrichment is identical. The process of 3’ RNA 
adaptor ligation at the end of the first day is similar except for the difference in 
sequence. Unlike the 3’ RNA adaptor VRA3 in PRO-seq, ePRO-seq uses 
PCRfreeRC3_BRn (n stands for barcode index), which contains in-line TRU-
seq small RNA barcode with an additional G nucleotide at the very end of the 
5’ end. The presence of in-line barcode in 3’ RNA adaptor allows for 
multiplexing of libraries on the second day and eliminates the necessity to 
carry each library in individual tube for multiple days. During library 
sequencing, the sequencing primer anneals upstream of the in-line barcode. 
Thus, the first six nucleotides of each read is the barcode sequence, which is 
used at post-processing step to parse sequences into individual libraries. The 
addition of a G nucleotide as the first base on the 5’ end of 3’ RNA adaptor in 
front of the barcode, which is also the nucleotide that gets directly ligated to 
the 3’ end of nascent RNA, ensures uniformity in the ligating nucleotide as in 
PRO-seq and eliminates ligation bias that could be caused by different end-
nucleotide of barcodes. This G is also removed at post-processing step prior 
to mapping of the reads to the genome. 
 The procedures on the second day of ePRO-seq are also similar to 
PRO-seq. One significant improvement in ePRO-seq is the ability to pool 
differentially barcoded libraries after the second biotin RNA enrichment step. 
For example, 48 ePRO-seq libraries made by using 12 barcodes can be 
pooled into 4 tubes (12 differentially barcodes libraries in each tube). The 
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steps of de-capping and hydroxyl-repair are identical, although the reaction 
volume may be scaled up to match the number of libraries pooled. The 5’ RNA 
adaptor used in ePRO-seq (PCRfreeRC5 for single-end sequencing and 
5Adapt_Paired_ePROseq for paired-end sequencing) is also different from 
VRA5 used in PRO-seq, however, the reaction is carried out similarly. 
 On the third day, the third biotin RNA enrichment and reverse 
transcription is carried out just like in PRO-seq. However, degradation of RNA 
after reverse transcription is critical in ePRO-seq. The resulting cDNA is ready 
for sequencing and is submitted to sequencing facility without further 
processing. All subsequent steps in PRO-seq such as test PCR amplification, 
gel analysis of test PCR, full-scale PCR amplification, and library-size 
selection by PAGE are eliminated in ePRO-seq. The removal of these steps 
significantly reduces the library preparation time (from 4-5 days to 2.5 days), 
saves reagents, and cuts cost. More importantly, it eliminates the biases 
associated with PCR amplification of genomic library and size selection for 
optimal sequencing. 
A schematic of steps involved in ePRO-seq and their comparison with 
steps involved in PRO-seq is shown in Figure B.1. Major differences remain in 
RNA adaptors sequence and the placement of barcode.   
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Figure B.1. Overview of ePRO-seq and its comparison to PRO-seq 
Steps in PRO-seq that correspond to steps in ePRO-seq are shown side-by-
side. PRO-seq steps in green boxes are present in ePRO-seq and PRO-seq 
steps in red box are eliminated from ePRO-seq. Compared to 4-5 days 
required for PRO-seq library preparation, ePRO-seq library can be prepared in 
2.5 days. The RNA adaptors sequences are different between PRO-seq and 
ePRO-seq and the multiplesing barcode in ePRO-seq is present as in-line 
barcode in 3’ RNA adaptor. 
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Experimental Design 
Cells 
We have successfully made ePRO-seq libraries with MEFs. However, 
PRO-Seq libraries are routinely made from plant (unpublished, G.T.B.), yeast 
(unpublished, G.T.B.), Drosophila (Kwak et al., 2013), and mammalian cells 
(Core et al., 2014; Mahat et al., 2016a), and ePRO-seq should be easily 
adaptable to these cells. In general, the higher the number of cells the better 
the ePRO-seq read coverage of the genome. Although a minimum of 5-10 
million nuclei or permeabilized cells is recommended for a single ePRO-seq 
library regardless of cell type, the option of pooling of multiple differentially 
barcoded libraries after second bead binding may tolerate lower number of 
cells in individual library. The number of barcodes available is the only factor 
that limits the extent of library pooling. In principle, the application of PRO-seq 
and ePRO-seq in yeast, including S. pombe and S. cerevisiae, is very similar 
to that of other organisms; however, some alterations are required in yeast cell 
permeabilization (García-Martínez et al., 2004), run-on reaction, and post run-
on RNA extraction procedures (Collart and Oliviero, 2001); required 
modifications for yeast are indicated in the appropriate steps of the Procedure. 
Sample preparation 
Isolation of nuclei for nuclear run-on is a critical step in the procedure 
not only to preserve the enzymatic activity of the RNA polymerase, but also to 
capture the precise position of the RNA polymerase on genes. Starting with 
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10-20 million cells per library is recommended considering the efficiency of 
nuclei isolation process (~50%). The whole process should take place in the 
cold room on ice as far as is possible. Isolated nuclei can be resuspended in 
the glycerol-containing storage buffer, and quickly frozen in liquid nitrogen for 
long term storage at -80°C. We have used permeabilized cells in PRO-seq 
and ePRO-seq as an alternative to isolating nuclei, making handling easier 
and reducing loss of sample; cell permeabilization has a much higher 
efficiency (~90%) than nuclei isolation. Cell permeabilization conditions may 
differ between cell types and may need to be optimized; we provide a general 
method for permeabilization in the Procedure as well as a version optimized 
for yeast cells. 
Spike-in for library normalization 
Disproportionate loss of RNA and/or cDNA can occur during multiple 
stages of the PRO-seq library preparation, which spans 4-5 days and involves 
several handling steps. Even with the use of identical starting material, uneven 
loss of libraries could affect the genome-wide RNA polymerase density 
between libraries. To control for handling effects on library yield, a small 
fraction (1-5%) of cells with a distinct genome can be added during library 
preparation; adding an identical number of spike-in cells to different libraries 
enables normalization between different conditions. We have used 
Schizosaccharomyces pombe to normalize Saccharomyces cerevisiae and 
vice versa, and Drosophila cells to normalize mammalian cells and vice versa. 
		
	
	
329	
When using the cell-permeabilization approach, spike-in cells should be added 
and permeabilized together with the experimental cells. For the nuclei isolation 
approach, spike-in cells should be added to the experimental cells prior to 
nuclei isolation and dounced together. 
Nuclear run-on 
In PRO-seq, biotin-NTPs are used as the nuclear run-on substrates. The 
Km of each of the NTPs as substrates for RNA polymerase lie in the range of 
1–20 µM (Job et al., 1984). Therefore, final substrate concentration greater 
than 1-20 µM range (~25 µM) is, in general, sufficient for each biotin-NTP 
substrate. Depending on the purpose of the experiment, biotin-NTP substrates 
can be supplied in different combinations: individual biotin run-on, 4 biotin run-
on, 2 biotin run-on or 1 biotin run-on.  
• Individual-biotin run-on: To obtain the most precise mapping of the RNA 
polymerase, four separate PRO-seq libraries are made, each supplied with 
only one type of biotin-NTP in the nuclear run-on reaction. This ensures 
that the RNA polymerase adds only one, or at most a few (when the 
polymerase is positioned at multiple stretches of same nucleotide) biotin-
NTPs to the nascent RNA. In this case, 4 times more sample is required. 
• 4-Biotin run-on: we found that all 4 biotin-NTPs can be supplied in a single 
reaction and the Pol II only incorporates one or at most a few bases, giving 
an equivalent resolution to Individual-biotin run-on. The reason for this is 
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unclear, but we speculate that steric hindrance in the active site of RNA 
polymerase prevents incorporation of multiple biotinylated nucleotides. 
• 2-Biotin run-on: When the amount of sample or the cost is limiting, 
unlabeled NTPs can be used in combination with biotin NTPs. Use of 
biotinylated purine nucleotides (biotin-ATP, biotin-GTP) is more costly than 
that of the pyrimidine nucleotides (biotin-CTP, biotin-UTP). A combination 
of biotin-CTP, biotin-UTP, ATP, and GTP can be used in run-on reaction, 
providing reasonable resolution and cost.  
• 1-Biotin run-on: If a longer run-on RNA is preferred, combinations of biotin-
CTP with unlabeled CTP, UTP, ATP, and GTP can be used effectively in a 
biotin-NTP form of GRO-seq. This approach can be useful for increasing 
sequencing coverage of RNA polymerases that reside near the TSSs. 
While most transcriptionally-engaged RNA polymerases near the 5’ ends 
reside between 30-60 nucleotides from the TSS (Kwak et al., 2013), RNA 
polymerases closer to the TSS may fail to map uniquely. Additionally, the 
longer run-on of nascent RNAs may be desired for distinguishing allele-
specific nascent transcription. 
Multiplexing 
The presence of multiplexing barcodes in the 3’ RNA adaptor enables 
pooling of libraries after the second bead binding (first step on Day 2). This 
significantly reduces the number of tubes and simplifies handling. Only the 
number of barcodes being used dictates the extent of pooling. 
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Materials 
Reagents 
CRITICAL: Extreme care should be taken to avoid nuclease contamination. 
Use nuclease-free reagents and change gloves routinely. 
• Appropriate cell line(s) e.g. K562, GM12878, MCF7, Hela, embryonic stem 
cells, mouse embryonic fibroblasts, mouse 3T3 cells, Drosophila S2, yeast. 
CAUTION: Before use, cells should be checked for contamination. 
Chemical stocks 
• Diethyl pyrocarbonate (DEPC; Sigma-Aldrich, cat. no. D5758)  
CAUTION: DEPC is toxic and harmful. Proper eyeshield, faceshield, full-
face respirator, and gloves are required while handling DEPC. 
• Sodium chloride, NaCl (Sigma-Aldrich, cat. no. S9888)  
• Potassium chloride, KCl (Avantor, cat. no. 6858-04)  
• Magnesium chloride, MgCl2 (Avantor, cat. no. 5958-04)  
• Sucrose (Sigma-Aldrich, cat. no. S0389)  
• Calcium chloride, CaCl2 (Sigma-Aldrich, cat. no. C1016)  
• Magnesium acetate, MgAc2 (Sigma-Aldrich, cat. no. M5661)  
• Ammonium acetate, NH4Ac (Sigma-Aldrich, cat. no. A1542)  
• Sodium acetate NaOAc (Sigma-Aldrich, cat. no. S2889)  
• EDTA (Sigma-Aldrich, cat. no. E9884) 
• EGTA (Sigma-Aldrich, cat. no. E3889) 
• Protease inhibitor cocktail, EDTA-free (Roche, cat. no. 11873580001) 
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• Sodium hydroxide, NaOH (Avantor, cat. no. 7708-10) 
• Triton X-100, (Calbiochem, cat. no. 9410)  
• Nonidet P40 (NP40) Substitute, (Sigma-Adlrich, cat. no. 11332473001)  
• Sarkosyl (Sigma-Aldrich, cat. no. L5125)  
• Tween-20 (Sigma-Aldrich, cat. no. P9416) 
• Phosphate buffer saline, PBS pH 7.4 (Gibco, cat. no. 10010031). 
• TRIS (Avantor, cat. no. 4109-02)  
• Hydrochloric acid, HCl (Avantor, cat. no. 4613-05)  
• DTT (Sigma-Aldrich, cat. no. D0632) 
• Glycerol (Sigma-Aldrich, cat. no. G5516) 
Biotin Nuclear Run-On and enrichment 
• Biotin-11-ATP (PerkinElmer, cat. no. NEL544001EA) 
• Biotin-11-CTP (PerkinElmer, cat. no. NEL542001EA) 
• Biotin-11-GTP (PerkinElmer, cat. no. NEL545001EA) 
• Biotin-11-UTP (PerkinElmer, cat. no. NEL543001EA)  
• ATP, 10mM (Roche, cat. no. 11 277 057 001) 
• GTP, 10mM (Roche, cat. no. 11 277 057 001) 
• UTP, 10mM (Roche, cat. no. 11 277 057 001) 
• P-30 column, RNase free (BIORAD, cat. no. 732-6250) 
• Streptavidin M280 beads (Invitrogen, cat. no. 112.06D) 
Reagents for nucleic acid extraction 
• Trizol (Ambion, cat. no. 115596018)  
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CAUTION: Trizol is harmful and contact with skin, eye or inhalation should 
be avoided. Use it inside a fume hood. 
• Trizol LS (Ambion, cat. no. 10296028)  
CAUTION: Trizol is harmful and contact with skin, eye or inhalation should 
be avoided. Use it inside a fume hood. 
• Chloroform (Calbiochem, cat. no. 3150) 
• GlycoBlue (Ambion, cat. no. AM9515) 
• Ethanol, 100% (PHARMCO-AAPER, cat. no. 111000200) 
• Ethanol, 75%(vol/vol) 
• Phenol:Chloroform, Tris buffered (Thermo Scientific, cat. no. 17909) 
CAUTION: Phenol:Chloroform is harmful and contact with skin, eye or 
inhalation should be avoided. Use it inside a fume hood. 
• Phenol, (Ambion, cat. no. 9700).  
CAUTION: Phenol is harmful and contact with skin, eye or inhalation 
should be avoided. Use it inside a fume hood. 
Enzymes and recombinant protein reagents 
• RNase inhibitor, 40 units/µl (Ambion, cat. no. AM2696) 
• T4 RNA ligase I, 10 units/µl (NEB, cat. no. M0204). Supplied with 10× T4 
RNA ligase buffer, 10 mM ATP, and PEG, 50%(wt/vol). 
• 5´-phosphate-dependent exonuclease, 1 unit/μl (Epicenter, cat. no. 
TER51020) (required for PRO-cap only). Supplied with 10× reaction buffer 
A. 
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• Alkaline phosphatase, 10 units/µl (NEB, cat. no. M0290) (required for PRO-
cap only). Supplied with 10× Alkaline phosphatase buffer. Alternatively, 
Antarctic phosphatase, 5 units/µl (NEB, cat. no. M0289) can be used.  
• Tobacco acid pyrophosphatase, 10 units/µl (TAP) (Epicenter, cat. no. 
T19500). Supplied with 10× TAP buffer. Alternatively, RNA 5’ 
Pyrophosphohydrolase, 5 units/µl (RppH) (NEB, cat. no. M0356S) can be 
used with ThermoPol Reaction buffer (NEB, cat. no. B9004S). 
• T4 polynucleotide kinase, 10 units/µl (PNK) (NEB, cat. no. M0201) 
(required for PRO-seq only). Supplied with10× PNK buffer.  
• Superscript III reverse transcriptase (Invitrogen, cat. no. 56575). Supplied 
with 5× first strand buffer, and 0.1M DTT.  
• dNTP mix, 12.5 mM each (Roche, cat. no. 03 622 614 001) 
• RNase cocktail, 0.5 U/μl of RNase A and 20 U/μl of RNase T1 (Ambion, 
AM2286)  
• RNase H, 5 U per μl (NEB, cat. no. M0297S) 
• RNA and DNA oligos. (Custom synthesis from IDT DNA, RNase-free HPLC 
purified) See Table 1 and Reagent Setup for details. Further information 
about barcoding and sequencing indexes can be found at 
http://support.illumina.com/content/dam/illumina-
support/documents/documentation/chemistry_documentation/samplepreps
_truseq/truseqsampleprep/truseq-library-prep-pooling-guide-15042173-
01.pdf  
		
	
	
335	
Equipment 
• 2 heat blocks, one set at 37°C and the other at 65°C, each filled with water 
equilibrated at the appropriate temperature. 
• Dounce homogenizer (Wheaton scientific, cat. no. 357546) (for nuclei 
isolation) 
• Magnetic stand for Streptavidin magnetic beads (Invitrogen, cat. no. 
K1585-01) 
• Rotating stand (Thermo Barnstead Labquake rotator, cat. no. 415110) 
• Refrigerated centrifuge (Eppendorf, cat. no. 5417R) 
• Microcentrifuge (Eppendorf, cat. no. 5415D) 
Reagent Setup 
CRITICAL: All reagents, solutions, and buffers should be made with DEPC-
treated water 
• DEPC-H2O Add 0.1%(vol/vol) DEPC to H2O. Mix overnight then autoclave 
and filter-sterilize the solution with a 0.22 µm filter. DEPC-H2O can be 
prepared in advance and stored at room temperature (250C) for up to a 
year. 
CAUTION: DEPC is toxic and harmful. Proper eyeshield, faceshield, full-
face respirator, and gloves are required while handling DEPC. 
• 5M NaCl Dissolve 14.61 g NaCl in 50 ml H2O with 0.1%(vol/vol) DEPC. Mix 
overnight and then autoclave and filter.  
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CRITICAL: 5M NaCl can be stored at room temperature (250C) for up to a 
year. 
• 4M KCl Dissolve 3.73 g KCl in 50 ml H2O with 0.1%(vol/vol) DEPC, mix 
overnight then autoclave and filter-sterilize.  
CRITICAL: 4M KCl can be stored at room temperature for up to a year. 
• 1M MgCl2 Dissolve 4.76 g MgCl2 in 50 ml H2O with 0.1%(vol/vol) DEPC, 
mix overnight then autoclave and filter-sterilize.  
CRITICAL: 1M MgCl2 can be stored at room temperature for up to a year. 
• 1M Sucrose Dissolve 171.15 g Sucrose in 500 ml H2O with 0.1%(vol/vol) 
DEPC, mix overnight then autoclave and filter-sterilize.  
CRITICAL: 1M Sucrose can be stored at room temperature for up to a 
year. 
• 1M CaCl2 Dissolve 5.55 g CaCl2 in 50 ml H2O with 0.1%(vol/vol) DEPC, 
mix overnight then autoclave and filter-sterilize.  
CRITICAL: 1M CaCl2 can be stored at room temperature for up to a year. 
• 1M MgAc2 Dissolve 7.12 g MgAc2 in 50 ml H2O with 0.1%(vol/vol) DEPC, 
mix overnight then autoclave and filter-sterilize.  
CRITICAL: 1M MgAc2 can be stored at room temperature for up to a year. 
• 1M NH4Ac Dissolve 3.85 g NH4Ac in 50 ml H2O with 0.1%(vol/vol) DEPC, 
mix overnight then autoclave and filter-sterilize.  
CRITICAL: 1M NH4Ac can be stored at room temperature for up to a year. 
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• 1M NaOAc, pH 5.3 Dissolve 4.1 g NaOAc in 50 ml H2O and pH to 5.3, add 
0.1%(vol/vol) DEPC, mix overnight then autoclave and filter-sterilize.  
CRITICAL: 1M NaOAc can be stored at room temperature for up to a year. 
• 0.5M EDTA Dissolve 29.22 g EDTA in 100 ml DEPC treated H2O, then 
autoclave and filter-sterilize.  
CRITICAL: 0.5M EDTA can be stored at room temperature for up to a year. 
• 0.1M EGTA Dissolve 19.02 g EGTA in 50 ml DEPC treated H2O, then 
autoclave and filter-sterilize. 
CRITICAL: 0.1M EGTA can be stored at room temperature for up to a year. 
• 1N NaOH Dissolve 2 g NaOH in 50 ml DEPC treated H2O, filter-sterilize. 
CRITICAL: 1N NaOH can be prepared in advance in 50 ul aliquots, stored 
at -80°C for up to a year. Use freshly thawed aliquot each time.  
CAUTION: NaOH is corrosive and contact with skin, eye or inhalation 
should be avoided.  
• 10% Triton X-100 Dissolve 5 ml of Triton X-100 in 45 ml DEPC H2O and 
filter-sterilize.  
CRITICAL: 10% Triton X-100 can be stored at room temperature for up to a 
year. 
• 10% NP40 Dissolve 5 ml of NP40 in 45 ml DEPC H2O and filter-sterilize. 
CRITICAL: 10% NP40 can be stored at room temperature for up to a year. 
• 2% Sarkosyl Dissolve 1 g of Sarkosyl in 50 ml DEPC H2O and filter-
sterilize. CRITICAL: 2% Sarkosyl can be stored at room temperature for up 
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to a year. CAUTION: Sarkosyl is an irritant and contact with skin, eye or 
inhalation should be avoided. 
• 1% Tween-20 Dissolve 1 ml of Tween-20 in 49 ml DEPC H2O and filter-
sterilize. CRITICAL: 1% Tween-20 can be stored at room temperature for 
up to a year. 
• 1M Tris-HCl, pH 6.8 Dissolve 6.06 g TRIS base in 50 ml DEPC H2O, pH to 
6.8 with HCl then autoclave and filter-sterilize.  
CRITICAL: The buffer can be stored at room temperature for up to a year. 
• 1M Tris-HCl, pH 7.4 Dissolve 6.06 g TRIS base in 50 ml DEPC H2O, pH to 
7.4 with HCl then autoclave and filter-sterilize.  
CRITICAL: The buffer can be stored at room temperature for up to a year. 
• 1M Tris-HCl, pH 8.0 Dissolve 6.06 g TRIS base in 50 ml DEPC H2O, pH to 
8.0 with HCl then autoclave and filter-sterilize.  
CRITICAL: The buffer can be stored at room temperature for up to a year. 
• 1M DTT Dissolve 1.54 g DTT in 10 ml DEPC H2O and filter-sterilize.  
CRITICAL: 1M DTT can be prepared and stored at -200C for up to a year. 
• 1mM Biotin-11-CTP Mix 10 µl of 10 mM stock in 90 µl DEPC H2O to get 1 
mM dilution.  
CRITICAL: The buffer can be stored at 40C for up to a year. 
• 1mM Biotin-11-UTP Mix 10 µl of 10 mM stock in 90 µl DEPC H2O to get 1 
mM dilution.  
CRITICAL: The buffer can be stored at 40C for up to a year. 
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• Douncing buffer (for nuclei isolation) 10 mM Tris-HCl pH 7.4, 300mM 
sucrose, 3 mM CaCl2, 2 mM MgCl2, 0.1% Triton X-100, 0.5 mM DTT, 1 
tablet of protease inhibitors cocktail per 50ml, 4 u/ml RNase inhibitor.  
CRITICAL: The buffer without DTT, protease inhibitors, and RNase 
inhibitor can be prepared and stored at 40C for up to a month. Add DTT, 
protease inhibitors, and RNase inhibitor immediately before use. 
• Permeabilization buffer (for non-yeast cells) 10mM Tris-HCl pH 7.4, 
300mM sucrose, 10mM KCl, 5mM MgCl2, 1mM EGTA, 0.05% Tween-20, 
0.1% Nonidet P40 substitute, 0.5 mM DTT, 1 tablet of protease inhibitors 
cocktail per 50ml, 4 u/ml RNase inhibitor.  
CRITICAL: The buffer without DTT, protease inhibitors, and RNase 
inhibitor can be prepared and stored at 40C for up to a month. Add DTT, 
protease inhibitors, and RNase inhibitor immediately before use. 
• Permeabilization buffer (for yeast cells) 0.5% Sarkosyl, 0.5 mM DTT, 1 
tablet of protease inhibitors cocktail per 50ml, 4 u/ml RNase inhibitor.  
CRITICAL: The buffer without DTT, protease inhibitors, and RNase 
inhibitor can be prepared and stored at 40C for up to a month. Add DTT, 
protease inhibitors, and RNase inhibitor immediately before use. 
• Storage buffer 10 mM Tris-HCl pH 8.0, 25%(vol/vol) glycerol, 5 mM 
MgCl2, 0.1 mM EDTA, 5 mM DTT.  
CRITICAL: The buffer without DTT can be prepared and stored at 40C for 
up to a month. Add fresh DTT immediately before use. 
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• 2x Nuclear run-on master mix (for non-yeast cells) 10 mM Tris-HCl pH 
8.0, 5 mM MgCl2, 300 mM KCl, and 1 mM DTT.  
CRITICAL: The buffer without DTT can be prepared and stored at 40C for 
up to a month. Add fresh DTT immediately before use. 
• 2x NRO master mix (for yeast cells) 40 mM Tris-HCl, pH 7.7, 400 mM 
KCl, 64 mM MgCl2, 1 mM DTT.)  
CRITICAL: The buffer without DTT can be prepared and stored at 40C for 
up to a month. Add fresh DTT immediately before use. 
• AES buffer (for yeast cells only) 50 mM NaOAc pH 5.3, 10 mM EDTA, 
1% SDS. 
• High-salt wash buffer 50 mM Tris-HCl pH 7.4, 2 M NaCl, 0.5%(vol/vol) 
Triton X-100 in DEPC H2O. 
CRITICAL: The buffer can be stored at 40C for up to a month.  
• Binding buffer 10 mM Tris-HCl pH 7.4, 300 mM NaCl, 0.1%(vol/vol) Triton 
X-100 in DEPC H2O. 
CRITICAL: The buffer can be stored at 40C for up to a month. 
• Low-salt wash buffer 5 mM Tris-HCl pH 7.4, 0.1%(vol/vol) Triton X-100 in 
DEPC H2O.  
CRITICAL: The buffer can be stored at 40C for up to a month. 
• Pre-washed streptavidin-coated magnetic beads Take 90 μl of 
Streptavidin M280 beads per library. Place the beads on the magnetic 
separator for 1 min and discard the supernatant. Pre-wash by 
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resuspending in 0.1 N NaOH + 50 mM NaCl in DEPC H2O for 1 min, place 
on the magnetic separator for 1 min, remove supernatant. Wash beads 
twice with 100 mM NaCl in DEPC H2O. After removing the wash buffer, 
resuspend the beads in 150 μl of the Binding Buffer and make 3 aliquots of 
50 μl each. Scale up accordingly when processing multiple samples.  
CRITICAL: The washed beads can be stored at 40C for up to a week. 
• DNA and RNA oligos Oligos for PRO-seq and PRO-cap (Table B.1) 
should be dissolved in DEPC H2O at a concentration of 100 mM. PCR 
primers should be dissolved in DEPC H2O at a concentration of 25 mM. 
CRITICAL: The DNA and RNA oligos can be stored at -800C for years. 
 
Software for data analysis 
• Barcode splitter, sequence trimmer, adaptor clipper, and reverse 
complement software as a part of ‘fastx’ toolkit 
(http://hannonlab.cshl.edu/fastx_toolkit/commandline.html) 
• Mapping or alignment software, such as ‘bwa’(Li and Durbin, 2009) 
(https://sourceforge.net/projects/bio-bwa/files/) or ‘bowtie’(Langmead et al., 
2009) (https://sourceforge.net/projects/bowtie-bio/files/)  
• Tools to generate coverage information, such as SAMtools(Li et al., 2009) 
(https://sourceforge.net/projects/samtools/files/) and BEDTools(Quinlan 
and Hall, 2010) 
(https://sourceforge.net/projects/bedtools/files/) 
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Table B.1. Oligonucleotides required for ePRO-seq. 
Oligo 
name 
Sequence 
(5’ to 3’) 
Purpose Comments 
PCRfre
eRC3_
BRn 
GNNNNNN
GAUCGUC
GGACUGU
AGAACUCU
GAAC-
/Inverted dT/ 
RNA adaptor for 
ligation to the 3’ 
end of nascent 
RNA  
Reverse complement of 
sequencing primer for 
TRUseq Small RNA (26bp), 
with TRUseq indexes on 5’ 
end plus a terminal G. The six 
Ns is in-line barcode (reverse 
complement of Illumina TRU-
seq index). The 5’ end of the 
adaptor is phosphorylated and 
the 3’ end is protected by an 
inverted dT.   
PCRfre
eRC5 
CAAGCAGA
AGACGGC
AUACGAGA
U 
RNA adaptor for 
ligation to the 5’ 
end of nascent 
RNA for single-
end sequencing. 
RNA version of one of the 
primers in flow-cell (with the 
G’). The 5’ end of the adaptor 
is not phosphorylated. 
5Adapt
_Paire
d_ePR
O 
CAAGCAGA
AGACGGC
AUACGAGA
UGUCUCG
UGGGCUC
GGAGAUG
UGUAUAAG
AGACAG 
RNA adaptor for 
ligation to the 5’ 
end of nascent 
RNA for paired-
end sequencing. 
Designed by 
Jacob M. Tome. 
The first 24 bp is the RNA 
version of one of the primers 
in flow-cell (with the G’) and 
the remaining 34 bp is the 
RNA version of the Read 2 
sequencing primer in paired-
end sequencing. The 5’ end of 
the adaptor is not 
phosphorylated. 
RP1 AATGATAC
GGCGACC
ACCGAGAT
CTACACGT
TCAGAGTT
CTACAGTC
CGA 
DNA oligo for 
reverse 
transcription of 
adaptors-ligated 
nascent RNA  
Same RP1 primer used in 
PRO-seq. 
TestA
mp3 
CAAGCAGA
AGACGGC
AUACGAGA
U 
DNA oligo for 
amplification of 
both single-end 
and paired-end 
libraries (test 
amplification or 
emergency 
amplification) 
One of the primers in flow-cell 
(with the G’) with exact 
sequence. 
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Procedure 
Cell culture | TIMING 24 h 
1. Seed cells at a concentration that will enable them to reach ~80% 
confluency in 24 hours. For a PRO-seq experiment using adherent 
fibroblasts, 4-6 150mm cell culture dishes yield sufficient cells (~107 
cells, see Experimental Design for further details). For yeast cells, plate 
them to ensure they are in the exponential phase of growth (OD600 = 0.5) 
at the time of harvest. 
CAUTION: Check cell lines for mycoplasma contamination before setting 
up the experiment. 
 
Sample preparation | TIMING: 1 h 
CRITICAL: Samples should be prepared in 40C to avoid unsolicited run-on. 
2. Prepare samples by isolating nuclei (Option A) or by cell permeabilization 
(use Option C for yeast cells and Option B for other cell types). All 
centrifugation steps for sample preparation are performed in a cold 
centrifuge (40C) at 1000 g (unless stated otherwise) for 5 min. 
A. Nuclei isolation  
a. Harvest adherent cells by scraping and centrifuging, and non-adherent 
cells by centrifuging.  
b. Resuspend the cell pellet in 10 ml ice-cold PBS and centrifuge. 
c. Resuspend the cell pellet in ice-cold douncing buffer (1x106 cells/ml).  
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d. CRITICAL STEP: If using spike-in cells, add them at this point to the 
cells resuspended in douncing buffer.  
e. Incubate for 5 min on ice and dounce 25 times using a dounce 
homogenizer.  
f. Transfer the dounced nuclei to either a 15 or 50 ml conical tube and 
centrifuge the nuclei. 
g. Wash twice by resuspending the pellet in 5 ml douncing buffer and 
centrifuging. 
h. Resuspend the pellet in storage buffer (5-10x106 nuclei per 100 µl of 
storage buffer), flash freeze in liquid nitrogen, and store at -800C. 
PAUSE POINT: The nuclei in storage buffer can be stored at -800C for 
up to 5 years. 
B. Cell permeabilization (non-yeast cells) 
a. Harvest adherent cells by scraping and centrifuging, and non-adherent 
cells by centrifuging.   
b. Resuspend the cell pellet in 10 ml ice-cold PBS and centrifuge. 
c. Resuspend the cell pellet in ice-cold permeabilization buffer (1x106 
cells/ml).  
CRITICAL STEP: Spike-in cells, if used, should be added to the cells 
resuspended in permeabilization buffer.  
d. Incubate for 5 min on ice and centrifuge the permeabilized cells.  
		
	
	
345	
e. Wash twice by resuspending in 5 ml permeabilization buffer and 
centrifuging. 
f. Resuspend the cell pellet in storage buffer (5-10x106 permeabilized 
cells per 100 µl of storage buffer), flash freeze in liquid nitrogen, and 
store in -800C.  
PAUSE POINT: The permeabilized cells in storage buffer can be stored 
at -800C for up to 5 years. 
C. Cell permeabilization (optimized for yeast) 
a. Harvest exponentially growing yeast cells by centrifugation at 400 g. 
b. Resuspend the cell pellet in 10 ml ice-cold PBS and centrifuge. 
c. Resuspend the cell pellet in ice-cold yeast permeabilization buffer 
(1x106 cells/ml). 
CRITICAL STEP: Spike-in cells, if used, should be added to the cells 
resuspended in yeast permeabilization buffer.  
d. Incubate for 20 min on ice and centrifuge the cells at 400 g.  
e. Resuspend the cell pellet in storage buffer (25-50x106 permeabilized 
cells per 100 µl of storage buffer), flash freeze in liquid nitrogen, and 
store in -800C. 
PAUSE POINT: The permeabilized cells in storage buffer can be stored 
at -800C for up to 5 years. 
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Nuclear run-on | TIMING: 1.5 h 
3. Prepare a 2x nuclear run-on (NRO) master mix; for non-yeast cells, 
prepare the master mix according to the first table, for yeast cells, use 
the second table. 
Reagents Volume per reaction (µ l) 
Final concentration – 1x 
(in 200-µ l reaction) (mM) 
Tris-Cl pH 8.0 (1 M) 1 5 
MgCl2 (1 M) 0.5 2.5 
DTT (0.1 M) 1 0.5 
KCl (4 M) 7.5 150 
DEPC-H2O 18  
 
Reagents Volume per reaction (µ l) 
Final concentration – 1x 
(in 200-µ l reaction) (mM) 
Tris-Cl pH 7.7 (1 M) 4 20 
MgCl2 (1 M) 6.4 32 
DTT (0.1 M) 1 0.5 
KCl (4 M) 10 200 
DEPC-H2O 6.6  
 
4. Depending on the type of run-on experiment (see Experimental Design 
section), prepare a 2x reaction mix according to Option A (single biotin 
run-on), Option B (4 biotin run-on), Option C (2 biotin run-on) or Option D 
(1 biotin run-on). If processing multiple libraries at once, scale up 
accordingly. 
A. Individual-biotin run-on 2x reaction mix 
a. Transfer a 28 µl aliquot of NRO master mix to each of 4 separate 
microcentrifuge tubes. 
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b. Add 5 µl of biotin-11-ATP (1 mM) to one of the tubes containing NRO 
master mix. Label this mix “A”  
c. Repeat step b for the remaining 3 biotin-11-NTPs (1 mM each) and the 
3 remaining tubes containing NRO master mix and label them “C”, “G”, 
“U” accordingly. 
d. Add 15 µl DEPC H2O to all 4 tubes. 
e. Add 2 µl of RNase inhibitor and 50 µl of 2% Sarkosyl to all 4 tubes. 
From step e, each tube will be processed as a separate sample. 
B. 4-Biotin run-on 2x reaction mix 
a. Transfer a 28 µl aliquot of NRO master mix to a microcentrifuge tube. 
b. Add 5 µl each of all 4 biotin-11-NTPs (1 mM each) to the NRO master 
mix aliquot. 
c. Add 2 µl of RNase inhibitor and 50 µl of 2% Sarkosyl. 
C. 2-Biotin run-on 2x reaction mix 
a. Transfer a 28 µl aliquot of NRO master mix to a microcentrifuge tube. 
b. Add 5 µl each of biotin-11-CTP (1 mM) and biotin-11-UTP (1 mM) to the 
NRO master mix aliquot. 
c. Add 2.5 µl each of ATP (10 mM) and GTP (10 mM) to the mix. 
d. Add 5 µl DEPC H2O. 
e. Add 2 µl of RNase inhibitor and 50 µl of 2% Sarkosyl. 
D. 1-Biotin run-on 2x reaction mix 
a. Transfer a 28 µl aliquot of NRO master mix to a microcentrifuge tube. 
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b. Add 5 µl of biotin-11-CTP (1 mM) to the NRO master mix aliquot. 
c. Add 1 µl of CTP (0.05 mM) to the mix. 
d. Add 2.5 µl each of ATP (10 mM), GTP (10 mM), and UTP (10 mM) to 
the mix. 
e. Add 6.5 µl DEPC H2O. 
f. Add 2 µl of RNase inhibitor and pipette up and down several times. 
g. Add 50 µl of 2% Sarkosyl and pipette up and down 15 times. 
 
5. Preheat 100 µl of the appropriate 2x reaction mix prepared in step 4 to 
37°C for mammalian cells or 30°C for yeast and insect cells. 
6. Using a cut-off P200 pipette tip, add 100 µl nuclei or permeabilized cells 
(in storage buffer from step 2) to 100 µl of preheated 2x reaction mix, 
gently but thoroughly pipette the reaction 15 times, and place in a heat 
block at the appropriate temperature. 
CRITICAL STEP: Sarkosyl in the 2x reaction mix causes the run-on 
reaction to become very viscous (except for yeast). When adding the 
nuclei or permeabilized cells to the reaction mix and when mixing by 
pipetting up and down, use a wide bore pipette tip or cut the last 
centimeter off a normal one with ethanol wiped clean scissors or razor 
blade.  
7. Incubate for 3 min (5 min for yeast cells), with gentle tapping at the 
incubation midpoint. 
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RNA extraction | TIMING: 1 h 
8. Extract RNA using Option A for non-yeast nuclei or permeabilized cells 
or Option B for yeast. 
A. RNA extraction from non-yeast nuclei or permeabilized cells 
a. Add 500 µl Trizol LS and mix well by vortexing to stop the reaction. 
b. Incubate the homogenized sample for 5 min at room temperature 
(250C) to allow the complete dissociation of nucleoprotein complexes 
and add 130 µl Chloroform.  
c. Vortex sample vigorously for 15 s and incubate at room temperature for 
2 to 3 min. 
d. Centrifuge at 14,000 g for 5 min at 4°C, transfer the aqueous phase to a 
new tube, and add 1 µl GlycoBlue. 
B. RNA extraction from yeast cells or nuclei 
a. Pellet cells or nuclei after the run-on reaction at 400 g for 5 mins at 4 °C 
and quickly resuspend in 500 μl phenol. 
b. Add an equal volume of AES buffer and incubate it at 65°C for 5 min 
with periodic vortexing. Let the mixture rest on ice for 5 min, and then 
add 200 μl of chloroform. 
c. Vortex sample vigorously for 15 s and incubate at room temperature for 
2 to 3 min. 
d. Centrifuge at 14,000 g for 5 min at 4°C, transfer the aqueous phase to a 
new tube, and add 1 µl GlycoBlue and NaOAc to 200 mM final conc. 
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9. Add 2.5x volume of 100% room temperature ethanol & vortex for 10 s. 
10. Incubate samples at room temperature for 10 min.   
11. Centrifuge at 14,000 g for 20 min at 4°C. The RNA precipitate forms a 
gel-like pellet on the side and bottom of the tube. 
12. Remove supernatant completely. 
13. Add 750 µl of 75% ethanol. 
PAUSE POINT: The RNA pellet in 75% ethanol can be stored up to a 
week at -80°C. 
14. Mix by vortexing and centrifuge at 14,000 g for 5 min at 4°C. 
15. Remove all supernatant. 
16. Air-dry the RNA pellet for 5-10 min. 
CRITICAL STEP: It is important not to let the RNA pellet dry completely 
as this will greatly decrease its solubility. 
17. Re-dissolve the RNA pellet in 20 µl DEPC H2O. 
 
RNA fragmentation by base hydrolysis | Timing: 0.5 h 
18. Heat denature the RNA at 65°C on a heat block for 40 s and then place 
the tubes on ice. 
19. Add 5 µl of ice cold 1 N NaOH & incubate the mixture on ice for 10 min. 
20. Neutralize with 25 µl of 1 M Tris-HCl pH 6.8. 
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21. Perform buffer exchange once by running the 50 µl base-hydrolyzed 
RNA sample through a P-30 column according to the manufacturer’s 
instructions. 
a. Invert the column sharply several times to resuspend the settled gel 
and remove any bubbles. 
b. Snap off the tip and place column in a 2.0 ml microcentrifuge tube 
(included).  
c. Remove cap. Allow the excess packing buffer to drain by gravity to top 
of gel bed. (If column does not begin to flow, push cap back into column 
and remove).  
d. Discard the drained buffer, then place the column back into 2 ml tube.  
e. Centrifuge for 2 min at 1,000 x to remove the packing buffer.  
f. Discard the buffer.  
g. Place the column in a clean 1.5 ml microcentrifuge tube.  
h. Carefully apply the sample (20 - 100 µl) directly to the center of the 
column. Application of more or less than the recommended sample 
volume may decrease column performance.  
i. After loading sample, centrifuge the column for 4 min at 1,000 x g.  
j. Following centrifugation, the purified sample is now in Tris or SSC 
buffer. Molecules smaller than the column’s exclusion limit (20 bp) will 
be retained. 
22. Add 1µl RNase inhibitor to the elution (base-hydrolyzed nascent RNA). 
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First biotin RNA enrichment | Timing: 3 h 
23. Prepare the buffers for bead binding and washing. The buffer recipe 
provided below would suffice for three bead binding and wash steps of 
ePRO-seq for 12 libraries. 
Buffer NaCl (5 M) NaOH (1 N) DEPC H2O 
NaOH Wash 50 µl (50 mM) 500 µl (0.1 N) 4.45 ml 
NaCl Wash 200 µl (100 mM) - 9.8 ml 
 
Buffer Tris-Cl 7.4 (1 M) NaCl (5 M) 
Triton X-100 
(10%) DEPC H2O 
High Salt 
Wash 1 ml (50mM) 8 ml (2M) 1 ml (0.5%) 10 mL 
Binding 
Buffer 
200µl 
(10mM) 
1.2 ml 
(300mM) 200 µl (0.1%) 18.4 mL 
Low Salt 
Wash 50µl (5mM) - 100 µl (0.1%) 9.85 mL 
 
24. Take 30 µl of Streptavidin coated magnetic beads per library. 
25. Place the beads on the magnetic separator for 1 min and discard the 
supernatant.  
26. Pre-wash the beads in 1 ml NaOH Wash buffer for 2 min. 
27. Place on the magnetic separator for 2 min and remove supernatant.  
28. Wash beads twice with 1 ml NaCl Wash buffer.  
29. Resuspend the beads in 50 µl of the Binding Buffer per library.  
30. Mix the RNA sample from step 22 with 50 µl of pre-washed Streptavidin 
beads. 
31. Incubate at room temperature on a rotator set at 8 rpm for 20 min. 
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32. Place on magnet for 2 min and remove the liquid. 
33. Resuspend the beads in 500 μl ice cold High Salt Wash. 
34. Wash for 2 min using rotator. 
35. Place on magnet for 2 min and remove the buffer. 
36. Repeat High Salt Wash by following steps 33-35. 
37. Wash twice with 500 μl Binding Buffer. 
38. Wash once with 500 μl Low Salt Wash. 
39. Resuspend the beads in 300 μl Trizol and vortex thoroughly. 
40. Incubate for 3 min at room temperature. 
41. Add 60 μl chloroform, vortex thoroughly for 20 s, and incubate for 3 min 
at room temperature 
42. Centrifuge at 20,000 g for 5 min at 4°C. 
43. Transfer the aqueous layer to a new tube. 
44. Remove and discard the organic phase, leaving the beads and the 
unpipetted aqueous phase. 
45. Extract RNA from the beads once more by repeating steps 38-41. 
46. Collect the aqueous layer and combine with the sample from step 43. 
47. Add 1 μl of GlycoBlue and 900 μl of 100% ethanol and vortex thoroughly. 
48. Incubate samples at room temperature for 10 min. 
49. Centrifuge at 20,000 g for 20 min at 4°C. 
50. Discard the supernatant from the tube, leaving only the RNA pellet. 
51. Wash the RNA pellet with 750 µl of 75% ethanol. 
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PAUSE POINT: The RNA pellet in 75% ethanol can be stored up to a 
week at -80°C. 
52. Mix by vortexing and centrifuge at 20,000 g for 5 min at 4°C. 
53. Discard the supernatant and remove all residual liquid. 
54. Air-dry the RNA pellet for 5-10 min. 
55. Dissolve the RNA pellet in 3.5 µl DEPC H2O. 
 
3’ RNA adaptor ligation | Timing: 4.5 h 
56. In ePRO-seq, the barcode for multiplexing is present in the 3’ RNA 
adaptor PCRfreeRC3_BRn. Therefore, differently barcoded 3’ RNA 
adaptors (PCRfreeRC3_BR1, PCRfreeRC3_BR2…) should be used for 
different libraries that will be pooled together for sequencing.  
The 5’ adaptors are at 100 µM concentration in -800C (Lis Lab -800C I) 
57. Add 0.5 μl of the appropriate 3’ RNA adaptor into the 3.5 µl of RNA. 
58. Mix gently, heat denature at 65°C for 20 s, then place on ice. 
59. Make the RNA ligation mix tabulated below. When processing multiple 
samples, scale up accordingly. 
Reagents Volume per reaction (µ l) 
Final 
concentration  
T4 RNA ligase buffer (10x) 1 1x 
ATP (10 mM) 1 1 mM 
50% PEG 2 10 % 
RNase inhibitor 1 4 units per µl 
T4 RNA ligase I 1 1 units per µl 
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60. Add 6 μl of the mix to the 4 μl of RNA (10 μl final). 
CRITICAL STEP: GlycoBlue may form a precipitate in the presence of 
high PEG concentration, but is not reported to affect the ligation 
efficiency.  
61. Incubate at 20°C for 4 hr then place at 4°C until ready to proceed to the 
next step. 
PAUSE POINT: The ligation reaction can be left at 4°C overnight. 
 
Second biotin RNA enrichment | Timing: 3 h 
62. Bring the volume of the adaptor ligated RNA to 50 μl by adding 40 μl 
DEPC H2O. 
63. Perform a second biotin enrichment by repeating steps 24-32. 
64. Resuspend the beads in 200 μl ice cold High Salt Wash and pool into 
two tubes. 
CRITICAL: Libraries with different in-line barcodes can be pooled at this 
step.  
Pooling into even number of tubes is recommended for easier handling 
and centrifuge balancing. 
I usually pool six libraries per tube and the reaction volumes hereon are 
optimized accordingly. 
65. Wash the magnetic beads twice with High Salt Wash, twice with Binding 
Buffer, and once with Low Salt Wash following steps 34-38. 
		
	
	
356	
66.  Trizol extract RNA following steps 39-54. 
67. Re-dissolve the RNA pellet in 10 μl DEPC H2O. 
68. Heat denature briefly at 65°C for 20 s and place in ice. 
 
Enzymatic modification of the RNA 5’ ends | Timing: 3.5-4 h 
69. Prepare 5’ cap repair enzyme mix: depending on the availability of 
Tobacco acid pyrophosphatase (TAP) or RNA 5’ Pyrophosphohydrolase 
(RppH). When using TAP, use the first table. When using RppH, prepare 
the enzyme mix in the second table. When processing multiple samples, 
scale up accordingly. 
Reagents Volume per reaction (µ l) Final concentration 
DEPC H2O 6  
TAP buffer (10x) 2 1x 
RNase inhibitor 1 2 units per µl 
TAP 1 0.5 units per µl 
 
Reagents Volume per reaction (µ l) Final concentration 
DEPC H2O 5  
ThermoPol Reaction buffer 
(10x) 2 1x 
RNase inhibitor 1 2 units per µl 
RppH 2 0.5 units per µl 
 
70. Add 10 μl of the appropriate enzyme mix to the 10 μl of RNA from step 
68. 
71. Incubate at 37°C for 1 hr. 
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Hydroxyl repair | TIMING: 2 h 
72. Prepare PNK mix as tabulated below. When processing multiple 
samples, scale up accordingly. 
Reagents Volume per reaction (µ l) Final concentration 
DEPC H2O 55  
PNK buffer (10x) 10 1x 
ATP (10 mM) 10 1 mM 
RNase inhibitor 2.5 1 units per µl 
Polynucleotide kinase (PNK) 2.5 0.25 units per µl 
 
73. Add 80 μl of the mix to the 20 μl of RNA from step 71. 
74. Incubate at 37°C for 1 hr. 
75. Add 300 μl of Trizol and vortex for 5 s. 
76. Add 60 μl chloroform, vortex for 15 s, and incubate for 2 min at room 
temperature. 
77. Centrifuge at 20,000 g for 5 min at 4°C. 
78. Transfer aqueous layer to a clean microfuge tube. 
79. Add 1 μl GlycoBlue and 2.5x volume of 100% ethanol. 
80. Pellet the RNA by centrifuging at 20,000 g for 20 min at 4°C.  
81. Discard the supernatant from the tube, leaving only the RNA pellet. 
82. Wash the RNA pellet in 75% ethanol. 
PAUSE POINT: The RNA pellet in 75% ethanol can be stored up to a 
week at -80°C. 
83. Mix by vortexing and centrifuge at 20,000 g for 5 min at 4°C. 
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84. Discard the supernatant and remove all residual liquid. 
85. Air-dry the RNA pellet for 5-10 min. 
86. Dissolve the RNA pellet in 6 µl DEPC H2O. 
 
5’ RNA adaptor ligation | Timing: 4.5 h 
87. ePRO-seq uses PCRfreeRC5 for single end sequencing and 
5Adapt_Paired_ePRO for paired end sequencing. The 5’ adaptors are at 
100 µM concentration in -800C (Lis Lab -800C I) 
88. Add 2 μl of the 100 µM 5’ RNA adaptor. 
89. Mix gently, heat denature at 65°C for 20 s, then place on ice. 
90. Make the RNA ligation mix as described below.  
Reagents Volume per pool (µ l) 
Final 
concentration  
T4 RNA ligase buffer (10x) 2 1x 
ATP (10 mM) 2 1 mM 
50% PEG 4 10 % 
RNase inhibitor 1 2 units per µl 
T4 RNA ligase I 3 1.5 units per µl 
 
91. Add 12 μl of the RNA ligation mix to the 8 μl of RNA (20 μl final). 
CRITICAL STEP: GlycoBlue may form precipitate in the presence of high 
PEG concentration, but is not reported to affect the ligation. 
92. Incubate at 20°C for 4 hr then place at 4°C until ready to proceed to the 
next step.  
PAUSE POINT: The ligation reaction can be left at 4°C overnight. 
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Third biotin RNA enrichment | Timing: 3 hr 
93. Bring the volume of the adaptor ligated RNA to 50 μl with 30 μl DEPC 
H2O. 
94. Take 90 µl of Streptavidin coated magnetic beads per pool. 
95. Perform third biotin enrichment of RNA by repeating steps 25-54. 
96. Dissolve the RNA pellet in 10 µl DEPC H2O. 
  
Reverse transcription | Timing: 2 h 
97. Make reverse transcription (RT) primer mix as shown below. 
Reagents Amount per pool (μl) 
Final 
concentration 
RP1 reverse transcription 
primer (100 μM) 2 8 uM 
dNTP mix (12.5 mM) 2 1 mM 
 
98. Add 4 μl of the RT primer mix to the 10 μl of re-dissolved RNA. 
99. Heat to 65°C for 5 min, chill on ice for 2 min, and briefly spin at 1,000g 
for 30 s.  
100. Prepare the RT reaction mix as tabulated below.  
When processing multiple samples, scale up accordingly. 
Reagents Volume per pool (µ l) 
Final 
concentration 
First strand buffer (5x) 5 1x 
DTT (0.1 M) 1.5 6 mM 
RNase inhibitor 1.5 1 units per µl 
Superscript III 3 24 U/µl 
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101.  Add 11 μl of the RT reaction mix to the 14 ul of RNA-primer mix and 
incubate for 5 min at RT. 
102. Transfer the reaction to 0.5 ml tubes. 
103. Reverse transcribe the RNA in PCR block for 15 min at 45°C, 40 min at 
50°C, 10 min at 55°C, and 15 min at 70°C. 
PAUSE POINT: The reverse transcribed cDNA can be stored for a month 
at -20°C. 
 
RNA degradation and cDNA purification | Timing: 2 h 
104. Degradation of RNA and purification of cDNA is critical in ePRO-seq 
because the cDNA is directly used for sequencing without further 
manipulation. Prepare RNase reaction mix as tabulated below.  
Reagents Volume per pool (µ l) Final concentration 
RNase H reaction buffer 
(10x) 3.5 1x 
RNase cocktail (0.5 U/μl 
of RNAse A, 20 U/μl of 
RNase H)  
3 0.04 unit/μl of RNase A & 1.7 U/μl of RNase T1 
RNase H (5 U/μl) 3.5 0.5 unit per µl 
 
105. Add 10 ul of the RNase reaction mix to 25 ul of RT reaction. 
106. Incubate the reaction for 20 min at 370C for RNA degradation. 
107. Incubate another 20 min at 650C for heat inactivation of the enzymes.  
108. Once the RNA digestion is complete, purify the cDNA by phenol 
chloroform extraction as below. 
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a. Add 215 μl DEPC H2O to 35 μl of RNase reaction to bring the final 
volume to 250 μl. 
b. Add an equal volume of buffered phenol:chloroform, and vortex 
thoroughly. 
c. Centrifuge at 20,000 g for 5 min at 4°C. 
d. Collect the aqueous layer in a clean tube. 
e. Follow steps 79-85. 
109. Re-dissolve the pellet in appropriate volume.  
For example, when making 12 libraries, pooling 6 libraries each in two 
tubes, resuspend cDNA in each tube in 20 μl DEPC H2O. Of the 40 μl 
after combining the cDNA from two tubes, keep 20 μl as backup and 
send 20 μl to sequencing facility.  
CRITICAL: The 20 μl backup cDNA can be PCR amplified using RP1 
and TestAmp3 primers if the amount of ePRO-seq library is not sufficient 
for sequencing. 
110. Quantification of the library is performed by the facility using digital PCR. 
Request the sequencing facility to use TRU-seq small RNA primers for 
digital PCR. 
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Test PCR amplification | Timing: 2 h 
Eliminated in ePRO-seq. 
However, it can be done using RP1 and TestAmp3 primers. Follow PRO-seq 
protocol for steps. 
 
Gel analysis of test PCR | Timing: 2 h 
Eliminated in ePRO-seq.  
However, if Test PCR amplification is performed, gel analysis of test PCR can 
be performed following PRO-seq protocol. 
 
Full-scale PCR amplification | Timing: 2.5 h 
Eliminated in ePRO-seq. 
However, if the library concentration measured using digital PCR is insufficient 
for sequencing, libraries can be amplified usig RP1 and TestAmp3 primers. 
 
Library size selection by PAGE | Timing: 5 h to 1 day 
Eliminated in ePRO-seq. 
If full-scale amplification is performed, libraries should be size-selected 
following steps in PRO-seq protocol. 
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High-throughput sequencing | Timing: 24 h 
111. Sequencing of ePRO-seq requires slight modification. Since the library is 
single-stranded DNA, quantification by intercalating dye-based methods 
such as Qubit may not be accurate. We recommend digital PCR for 
quantification of cluster-generating DNA molecules in the library. Many 
sequencing facilities provide this service with a small additional cost 
(~$20). Once the library concentration is quantified, we recommend 
loading twice the concentration of normal double-stranded library. For 
example, the concentration of PRO-seq dsDNA library loaded into 
Illumina NextSeq500 is 2 nM and we recommend loading 4 nM of ePRO-
seq library. 
 
Data analysis | TIMING: variable 
In both ePRO-seq & PRO-seq, the modified RNA adaptors were designed to 
enable sequencing of the reverse complement of nascent RNAs. Therefore, 
the 3’ end of the reverse complement of the sequencing reads reflects the 
RNA polymerase active site position. Below, we outline the three major stages 
of a simple processing pipeline. 
112. Pre-process the raw sequence data. Filter out low quality reads. 
Separate the barcoded reads based on the first six bp of the sequences.  
Once individual libraries are separated, trim the first seven bps of the 
reads (six bp barcode + 1 one G that was a part of 3’ adaptor) and clip 
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the potential adaptor sequences (ATCTCGTATGCCGTCTTCTGCTTG 
for single-end sequencing) from the sequence reads. Tools such as 
‘fastx_trimmer’ and ‘fastx_clipper’ are publicly available for this purpose. 
Depending on the quality of the library, sequences containing only the 
adaptor sequences (adaptor dimers) may take up to 5% of total reads. 
Once the sequences are cleaned up, make reverse complements of 
sequences and the sequences are ready for mapping. 
113. Map or align the sequence reads to the genomic sequence. Since most 
of the nascent RNA reads are captured before RNA processing and 
splicing, they do not contain large gaps in alignment. Therefore, many 
alignment programs based on the Burrows-Wheeler transformation 
algorithm such as ‘bwa’ or ‘bowtie’ work well. Reads with multiple 
alignments are usually discarded, unless they are used for studying 
specific target regions that are repeated more than once. On average, 
about 55-70% of the raw sequence reads are aligned uniquely to the 
genome. The alignment results are commonly stored in ‘sam’ or ‘bam’ 
formats. 
114. Generate the coverage of the aligned sequence reads. A common way to 
do this using publicly available tools is as follows: first, sort the ‘bam’ file 
using ‘samtools sort’; then process the sorted ‘bam’ file using ‘bedtools 
genomecov’ with ‘-ibam’ (use bam file input), ‘-strand’ (strand specific 
coverage), and ‘-5’ (5’ position coverage’) options. For the PRO-seq 
		
	
	
365	
data, swap the plus and minus strand data for the correct orientation. 
These data can be visualized in genome browsers (Figure A.3), and 
used in further downstream analyses. 
 
Anticipated results 
The final product of the ePRO-seq is genome-wide map of RNA polymerase 
active sites. In general, ePRO-seq and PRO-seq profile of a gene exhibits 
several features such as: a) higher read density at the promoter-proximal 
pause site compared to the gene body representing paused Pol IIs, b) uniform 
read density across exons and introns, c) reads beyond the polyadenylation 
site, and d) divergent PRO-seq reads at the promoter of genes in mammals 
indicating divergent transcription. The enhancer regions, which are present in 
intergenic and intragenic regions, are also characterized by divergent PRO-
seq reads. Spiky PRO-seq read coverage along the gene body indicates lower 
complexity of the library, which may arise from use of fewer nuclei or 
permeabilized. 
 ePRO-seq enables pooling of differentially barcoded libraries during or 
after the second biotin RNA enrichment. This ability to pool libraries earlier 
during the library preparation simplifies handling and allows for multiplexing. In 
addition to these advantages, we noticed that the pooled libraries have lower 
variance in sequencing depth compared to PRO-seq libraries that are pooled 
just prior to sequencing (Figure B.2 A). The relative standard deviation of 
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sequencing depth of pooled libraries is lower in ePRO-seq compared to PRO-
seq (Figure B.2B). However, the library quality and the transcription profile of 
genes are very similar between the two assays (Figure B.2C), suggesting the 
ePRO-seq library quality is just as good as PRO-seq. The similarity in library 
quality between ePRO-seq and PRO-seq is also evident at genome-wide level 
as shown be high correlation of gene-body reads (Figure B.2D) and promoter-
proximal paused peaks (Figure B.2E). Overall, these preliminary analyses 
indicate that library generated using ePRO-seq is just as good as PRO-seq 
library, despite the shorter and easier library preparation procedures. The 
elimination of PCR- amplification of library and size-selection should remove 
the biases associated with them, at least in theory. Nevertheless, we did not 
observe change in library quality between ePRO-seq and PRO-seq, at least at 
the global level. This lack of difference could be explained either by the lack of 
such PCR and size-selection biases in PRO-seq or perhaps is more 
pronounced in high-depth libraries. 
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Figure B.2. Comparison of ePRO-seq with PRO-seq 
(A) Sequencing depth variation among pooled libraries in PRO-seq 
(individually prepared and pooled prior to submission for sequencing in 
Illumina NextSeq500 lane) and ePRO-seq (pooled during the second biotin 
RNA enrichment step on the 2nd day of library preparation and sequenced in 
Illumina NextSeq500 lane). 
(B) Relative standard deviation of sequencing depth of pooled libraries in 
PRO-seq and ePRO-seq. 
(C) Screenshot of two representative genes (Samd4 is in sense strand and 
Fbn1 is in anti-sense strand) showing PRO-seq and ePRO-seq profiles. 
(D) Correlation of gene body reads between PRO-seq and ePRO-seq. 
(E) Metagene profiles of PRO-seq and ePRO-seq reads 500 bp around the 
transcription start sites (TSS). 
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Timing 
Cell culture: 24 h 
Sample preparation (nuclei isolation/cell permeabilization): 1 h 
Nuclear Run-On: 1.5 h 
RNA extraction: 1 h 
RNA fragmentation by base hydrolysis: 0.5 h 
Biotin RNA enrichment: 3 h 
3’ RNA adaptor ligation: 0.5 h hands-on and 4 h incubation; can be stored 
overnight (suggested end of the first day) 
Second biotin RNA enrichment: 3 h 
Enzymatic modification of the RNA 5′ ends: 3.5–4 h   
5’ RNA adaptor ligation: 0.5 h hands-on and 4 h incubation; can be stored 
overnight (suggested end of the second day) 
Third biotin RNA enrichment: 3 h 
Reverse transcription: 2 h 
RNA degradation and cDNA purification: 2 h 
High-throughput sequencing, 24 h 
Data analysis: variable 
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APPENDIX Cf 
 
CBP FACILITATES TRANSCRIPTION ELONGATION BY ENABLING RNA 
POLYMERASE TO TRAVERSE +1 NUCLEOSOME BARRIER 
 
Summary 
 Transcription activation involves RNA polymerase II (Pol II) recruitment 
and release from the promoter into productive elongation, but how specific 
chromatin regulators control these steps is not fully understood. Here we 
identify a novel activity of the co-regulator and histone acetyltransferase 
p300/CBP in controlling promoter-proximal paused Pol II. Inhibition of CBP 
acetyl-transferase activity rapidly reduces Pol II recruitment to the highly 
paused promoters. CBP inhibition impedes transcription through the +1 
nucleosome causing Pol II to accumulate at this position on highly or 
moderately paused promoters. Overall, we uncover two key roles of CBP in 
directly stimulating Pol II recruitment and enabling Pol II to traverse the first 
nucleosome. 
  
 
																																																						
f Adapted from Boija, A.*, Mahat, D. B.*, Zare, A., Holmqvist, P.H., Philip, P., 
Meyers, D.J., Cole, P.A., Lis, J.T., Stenberg, P., & Mannervik, M. (2016). CBP 
regulates promoter-proximal RNA polymerase II. In review. *denotes equal 
contribution. Contributions are shown in each figure. 
		
	
	
373	
Introduction 
 Regulation of transcription occurs at two major steps in metazoans 
(reviewed by Core and Lis, 2008). The first step is the recruitment of RNA 
Polymerase II (Pol II) to the promoter, which is orchestrated by sequence-
specific transcription factors that enable formation of a pre-initiation complex 
(PIC), consisting of Pol II and general transcription factors (GTFs). A 
successful formation of the PIC leads to rapid initiation and transcription of 20 
to 60 nucleotides (Core et al., 2012; Venters and Pugh, 2016). This brings Pol 
II to the second step of regulation where it pauses on many genes, an event 
mediated by the action of NELF and DSIF. The release of paused Pol II into 
productive elongation requires recruitment of P-TEFb kinase, which 
phosphorylates these pausing factors and the Pol II C-terminal domain (CTD) 
(reviewed in Zhou et al., 2012). Although pausing temporarily restrains Pol II 
from entering elongation, a majority of paused genes are highly expressed 
(reviewed in Adelman and Lis, 2012). In most instances, pausing may 
therefore be a mechanism to maintain or tune expression rather than to 
function as an on-off switch. 
Our understanding of how specific chromatin regulators are recruited to 
promoters and how they regulate the two major steps in transcription is 
incomplete. CREB-binding protein (CBP) and its paralog p300 are widely used 
transcriptional co-regulators with over 400 interaction partners (reviewed in 
Bedford et al., 2010). p300/CBP has a histone acetyltransferase (HAT) activity 
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and is known to acetylate lysine 18 and 27 of histone H3 and lysine 8 of 
histone H4, establishing an active chromatin state (Feller et al., 2015; Jin et 
al., 2011; Tie et al., 2009). However, the mechanisms by which p300/CBP 
regulates transcription are not fully understood.  
Herein, we analyzed the functions of the sole p300/CBP homolog 
(nejire) at gene promoters in Drosophila S2 cells. Run-on (PRO-seq) 
experiments following CBP inhibition demonstrated that CBP functions to 
position Pol II at the pause site, and facilitates efficient release of paused Pol II 
into productive elongation by overcoming the transcriptional barrier caused by 
the +1 nucleosome. CBP is also important for efficient Pol II recruitment to 
promoters. We suggest that CBP activity is rate-limiting for Pol II release from 
weakly-paused genes, and rate-limiting for recruitment to the highly-paused 
promoters.  
 
Materials and methods 
Drug treatment and nuclei isolation of S2 cells 
 Nuclei were isolated as described previously (Core et al., 2013). In 
brief, 10 ml of 2 x 106 cells/ml of S2 cells were treated with CBP inhibitor 
(C646) or control drug (C37) in DMSO for 10 min followed by a PBS wash. 
Cells were resuspended in buffer L (10 mM Tris-HCl pH 7.5, 300mM sucrose, 
10mM NaCl, 3 mM CaCl2, 2 mM MgCl2 , 0.1% Triton X, 0.5 mM DTT, protease 
inhibitors cocktail (Roche), 4 u/ml RNase inhibitor (SUPERaseIN, Ambion) and 
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immediately dounced 25 strokes with a tight fitting pestle. Lysed cells were 
mixed with an equal amount of buffer B (10 mM Tris-HCl pH 8, 2M sucrose, 
10mM NaCl2, 2 mM MgCl2, 0.5 mM DTT, protease inhibitors cocktail (Roche), 
4 u/ml RNase inhibitor (SUPERaseIN, Ambion) and loaded onto a buffer B 
sucrose pillow. The sample was spun at 23000g on a SW-41 rotor, the 
supernatant was removed, and the nuclei were washed once in storage buffer 
(50 mM Tris-HCl pH 8, 25% glycerol, 5mM MgAc2, 0.1mM EDTA, 5mM DTT) 
and recovered by centrifuging at 1000g for 5 minutes. Isolated nuclei were 
resuspended in storage buffer and kept at -800C. Nuclei from two biological 
replicates were prepared for each condition. 
 
Nuclear run-on and PRO-seq library preparation 
 Nuclear run-on was carried out as described previously with some 
modifications (Kwak et al., 2013). Briefly, 10 million nuclei in 100 μl of storage 
buffer were mixed with 100 μl of 2x nuclear run-on buffer (10 mM Tris-HCl pH 
8.0, 5 mM MgCl2, 1 mM DTT, 300 mM KCl, 1% Sarkosyl, 50 uM biotin-11-
A/C/G/UTP, 0.2 units/μl RNase inhibitor) and incubated at 300C for three 
minutes. RNAs were isolated using TRIZOL LS and base-hydrolyzed with 200 
nM final concentration of NaOH, generating an average size of RNA between 
100-150 nucleotides. Nascent RNAs from run-on reactions, characterized by 
the addition of biotinylated nucleotide, were isolated with magnetic beads 
coated with streptavidin. After the ligation of 3’ adapter and a second biotin 
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streptavidin affinity purification, the mRNA cap was removed and the 5’ 
adapter was ligated. Then a third biotin streptavidin affinity purification was 
carried out and cDNA was generated by reverse transcription. The generated 
cDNA was amplified with 9 cycles of PCR using Illumina TruSeq small-RNA 
adaptors for sequencing. 
  
Normalization 
 To normalize the datasets from the two treatments we could not apply 
standard normalization techniques as they assume that only a minority of the 
data are changed between treatments (Landfors et al., 2011). Since CBP 
occupancy is higher than the genomic mean at virtually all expressed 
promoters (data not shown), we expect it to affect expression of a large 
number of genes. We therefore normalized the PRO-seq datasets using the 
TSS proximal signal (TSS +100 bp) of the 5% (n=270) expressed genes with 
the least CBP signal. At these genes, we expect the smallest changes after 
CBP inhibition. After this normalization, we quantified the change in PRO-seq 
density upon CBP inhibition at all expressed genes. 
 
Differential expression analyses of pause region and gene body 
 Significant change in PRO-seq density in the pause region and the 
body of gene was calculated using DESeq2 (Love et al., 2014) by analyzing 
the two biological replicates separately. PRO-seq count reads were calculated 
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from the 100 bp pause region or gene body (500 bp downstream of TSS to 
100 bp upstream of poly A site). Adjusted p-value cutoff of 0.001 and fold 
change of at least 1.25 was used in DESeq2. For all other analyzes of the 
PRO-seq data the reads from the two biological replicates were merged. 
 
Results 
CBP is required for transcription of thousands of genes 
 To investigate CBP’s functions in transcription, we used a previously 
described inhibitor C646 that selectively inhibits the catalytic activity of CBP 
(Bowers et al., 2010). As a control, we used C37, a compound very similar in 
structure to C646 but that shows no effect on CBP HAT activity (Bowers et al., 
2010). C646 and related inhibitors have previously been shown to affect 
histone acetylation in Drosophila and mammalian cells within minutes (Crump 
et al., 2011; Dancy et al., 2012). To assess the immediate transcriptional 
response to CBP inhibition genome-wide, we performed precision run-on 
sequencing (PRO-seq) on S2 cells treated with C37 (control) or C646 for 10 
min (Figure C.1A). This genomic assay maps transcriptionally engaged Pol II 
with single nucleotide resolution (Kwak et al., 2013). The biological replicates 
of PRO-seq showed strong correlation at both pause region and gene body 
(Figure C.1B). After normalization, we quantified the change in PRO-seq 
density upon CBP inhibition at all expressed genes. We found 3790 genes 
with significant (p < 0.001) down-regulation but only 42 genes with significant 
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upregulation in gene-body PRO-seq density in C646-treated cells (Figure 
C.1C). However, all 42 up-regulated genes are false-positives – because the 
genes are very short (Figure C.1D), the PRO-seq density increase in the 
promoter-proximal region was attributed to the gene-body. We therefore 
conclude that the only direct effect of CBP inhibition is transcription down-
regulation, and a large fraction of expressed genes in S2 cells require CBP for 
their transcription. 
 
CBP inhibition reduces Pol II occupancy at highly-paused promoters 
 Global change in gene-body PRO-seq density prompted us to look at 
change in Pol II occupancy at promoters genome-wide. We measured PRO-
seq density in the promoter-proximal region (TSS to 300 bp downstream of 
TSS) of all genes that showed significant down-regulation in gene-body 
(n=3790). This analysis identified two different responses to CBP inhibition - 
an increase in promoter-proximal Pol II at 2529 genes and a decrease in Pol II 
at 1243 genes (Figure C.2A). Interestingly, genes with increased promoter-
proximal Pol II upon CBP inhibition have lower Pol II occupancy (weakly 
paused) in control cells than genes with decreased promoter-proximal Pol II 
(highly paused) (compare Figures C.2B with C.2C). This result indicates that 
genes with weakly paused promoters accumulate Pol II in the promoter-
proximal region after CBP inhibition indicating that CBP has a function in  
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Figure C.1. CBP inhibition affects global transcription 
(A) Schematics of PRO-seq experiment with CBP-inhibitor (C646) and control 
drug (C37). 
(B) Correlation between biological replicates of PRO-seq reads in pause 
region (+1-100 bp) (left panel) and gene body region (500 bp from TSS to 100 
bp upstream of poly A site) (right panel) in C646-treated S2 cells. 
(C) Difference in gene-body precision run-on sequencing (PRO-seq) reads 
between 10 min CBP-inhibitor (C646) and control drug (C37)-treated S2 cells 
after normalization. Significantly up-regulated genes are indicated in green and 
significantly down-regulated genes are indicated in blue. 
(D) Box plot of gene length for up-regulated with high confidence (Upreg), 
down-regulated with high confidence (Downreg), and genes without a 
significant change (Unreg) in gene body PRO-seq reads after CBP inhibition. 
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Figure C.2. CBP regulates Pol II positioning at promoter-proximal region 
(A) Heatmap of PRO-seq fold change (FC) after 10 min CBP inhibition in the 
promoter-proximal region (TSS-300 bp) of genes (n=3790) with reduced gene 
body PRO-seq reads after 10 min of CBP inhibition (C646). 2529 genes had 
more PRO-seq reads in this region (shown in orange) and 1243 genes had 
less PRO-seq reads (shown in purple).  
(B) PRO-seq metagene profiles for genes with decreased gene-body 
transcription after CBP inhibition but with increased (orange) promoter-
proximal PRO-seq reads.  
(C) PRO-seq metagene profiles for genes with decreased gene-body 
transcription after CBP inhibition but with decreased (purple) promoter-
proximal PRO-seq reads. 
(D) Screenshot of a gene showing PRO-seq density across the gene body in 
control drug and CBP-inhibitor treated cells. The inset elaborates the effect of 
CBP-inhibition in dribbling of promoter-proximal paused Pol II. 
(E) Metagene profiles of PRO-seq reads in all expressed genes from TSS to 
500 bp downstream in control or CBP-inhibited S2 cells for 10 min. 
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releasing Pol II into productive elongation. At highly paused genes, Pol II 
levels are decreased both in the promoter-proximal region and in the gene 
body, indicating that CBP has a crucial role in recruiting Pol II to these 
promoters. 
 
CBP positions paused Pol II at the promoter-proximal site 
 CBP inhibition not only affects the amount of Pol II at the promoter-
proximal pause region but also alters the positioning of paused Pol II. We 
noted a shift in the position of transcriptionally engaged Pol II at both weakly-
paused and highly-paused promoters upon CBP inhibition (see Figures C.2B 
and C.2C). Upon closer inspection at paused sites, we observed an 
accumulation of Pol II downstream of the canonical pause site in CBP-
inhibited condition (Figure C.2D). A metagene profile of PRO-seq reads in the 
promoter-proximal region showed reduced level of Pol II at the canonical 
pause site, but Pol II “dribbles” downstream of the pause site after CBP 
inhibition (Figure C.2E). This observation indicates that CBP is important for 
proper positioning of Pol II at the canonical promote-proximal paused site. 
 
CBP facilitates Pol II elongation by overcoming the +1 nucleosome 
barrier 
 To examine the scope of CBP in genome-wide positioning of paused 
Pol II, we measured the change in PRO-seq reads in 60 bp windows from the  
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TSS to 600 bp downstream in all expressed genes and ordered them by 
pausing index (Figure C.3A). The highly paused genes show a decrease in 
PRO-seq signal at the canonical pause site (0-60bp downstream of the TSS), 
whereas the less paused genes do not change as much. However, essentially 
all genes exhibit Pol II dribbling into the +60-180 bp region from TSS. Since 
this effect is observed after just 10 min of inhibitor treatment, it likely is a direct 
effect of CBP inhibition. The +60-180 bp region downstream of TSS where 
dribbled Pol II accumulate coincide with the position of first nucleosome. In 
order to examine the role of nucleosome in Pol II dribbling upon CBP 
inhibition, we plotted nucleosome density map from a previously published 
MNase-seq data (Gilchrist et al., 2010). The resolution of PRO-seq density 
change after CBP inhibition was increased to 5 bp bins, and the genes were 
ordered by the level of gene-body down-regulation. Interestingly, the increased 
PRO-seq density upon CBP inhibition correlates well with the position of the 
+1 nucleosome (Figures C.3B and C.3C), indicating that Pol II dribbles from 
the pause site but has difficulty overcoming the transcriptional barrier caused 
by the first nucleosome when CBP is inhibited. We then plotted the PRO-seq 
ratio in CBP inhibited versus control cells as a function of distance from the 
center of first nucleosome in control cells (Figure C.3D). This shows that the 
PRO-seq density in CBP inhibited cells is lower than in control cells in the 
pause region (around 100-250 bp upstream of the +1 nucleosome), but then 
increases until it reaches a maximum just upstream of the dyad axis of the +1  
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Figure C.3. Promoter-proximal Pol II dribbles to more downstream 
positions after CBP inhibition but is retarded at the +1 nucleosome  
(A) Heatmap of log2 fold change in PRO-seq reads in 60bp bins from the TSS 
to +600bp sorted on pausing index. The genes are ordered by their pausing 
index from top to bottom in decreasing order. 
(B) Heatmap of log2 fold change in PRO-seq reads in 5bp bins from the TSS to 
+600bp sorted on level of down-regulation in gene-body after CBP inhibition. 
(C) Heatmap of MNase-seq data (Gilchrist et al., 2010) in 5bp bins from the 
TSS to +600bp sorted on level of down-regulation in gene-body PRO-seq 
desity.  
(D) The ratio of PRO-seq change in CBP inhibited versus control cells and 
average profile of nucleosome position in control cells plotted as distance from 
the dyad axis of the +1 nucleosome.  
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nucleosome, from where it decreases again. These results further indicate that 
the Pol II is released from the canonical pause site, but cannot efficiently 
traverse the +1 nucleosome in absence of CBP.  
 
CBP-mediated nucleosome modification facilitates Pol II elongation 
 Since CBP is a HAT that targets H4K8, H3K18 and H3K27 (Feller et al., 
2015; Jin et al., 2011; Tie et al., 2009), we investigated if the inhibition of CBP 
affects the modifying marks and occupancy of +1 nucleosome. The level of 
H3K27ac in the promoter-proximal region, normalized by total H3 occupancy, 
was decreased upon CBP inhibition at both highly-paused and other 
promoters (Figure C.4A). In the first minute of treatment, the change in 
H3K27ac mark is very subtle if any, but a substantial reduction in H3K27ac is 
observed after 10 min of CBP inhibition. However, total H3 ChIP showed an 
opposite trend at all tested promoters - the overall nucleosome occupancy 
increased upon CBP drug treatment (Figure C.4B), suggesting a compaction 
of the chromatin. These results show that the chromatin compaction in the 
promoter-proximal paused region coincides with accumulation of Pol II 
upstream of the +1 nucleosome. Together, these observations are consistent 
with CBP’s role in histone acetylation to facilitate paused Pol II release into 
transcription elongation. 
Furthermore, the high-resolution heatmap (Figure C.3B) revealed that 
the PRO-seq density after CBP inhibition decreases in the first 60 bp for  
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Figure C.4. CBP facilitates productive elongation of Pol II by acetylating 
nucleosomes 
(A) ChIP-qPCR of H3K27ac after CBP inhibitor treatment for the indicated time 
points (n=2-4). Occupancy at paused and highly-paused promoters are plotted 
relative to control-treated cells. Error bars represent S.E.M., two-tailed paired 
t-test, *p<0.05.  
(B) ChIP-qPCR of H3 after CBP inhibitor treatment for the indicated time 
points (n=2-4). Occupancy at paused and highly-paused promoters are plotted 
relative to control-treated cells. Error bars represent S.E.M., two-tailed paired 
t-test, *p<0.05.  
The data and figure was generated by Ann Boija. 
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almost all genes, suggesting that CBP is also important for Pol II recruitment 
at the majority of expressed genes. Taken together, our results reveal that 
CBP is required for recruitment of Pol II and to allow Pol II to overcome 
transcriptional barrier caused by +1 nucleosome that resides downstream of 
the pause region. 
 
Discussion 
 Elucidating transcriptional regulatory mechanisms is of fundamental 
importance for understanding cell behavior in both normal and pathological 
conditions. In metazoan genomes, pausing of Pol II at a position close to the 
transcription start site is prevalent, occurring on a majority of active genes in a 
given cell type (Core et al., 2012). How Pol II pausing is regulated is not fully 
understood. Here we show that only 10 min of CBP inhibition results in 
dribbling of Pol II from the canonical pause site to positions further 
downstream. We propose that this effect can be explained by the combination 
of two different CBP activities, recruitment of Pol II to the promoter and 
facilitation of transcription elongation beyond the first nucleosome. In this 
scenario, CBP inhibition causes less Pol II recruitment, resulting in diminished 
Pol II amounts at the canonical pause site. The Pol II that has initiated 
transcription is released normally from the canonical pause, but accumulates 
upstream of the +1 nucleosome. Due to different rate-limiting steps at different 
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types of promoters, the final outcome of CBP inhibition is either a decrease or 
an accumulation of Pol II in the promoter-proximal region.  
At weakly-paused promoters, most Pol IIs that are recruited are 
efficiently released into productive elongation. Upon CBP inhibition, paused 
Pol II dribbles to more downstream positions, accumulates upstream of +1 
nucleosome, and fails to effectively enter productive elongation, causing an 
increase in total Pol II occupancy around the pause region. Thus, CBP is rate-
limiting for transcription of these genes at a post-recruitment step, likely by 
acetylation of the +1 nucleosome. This is consistent with single-cell analyses 
of transcription induction of a tandem gene array in mouse cells, where 
H3K27ac and p300/CBP were shown to be required for accumulation of 
elongating S2P Pol II (Stasevich et al., 2014). Together, these results 
demonstrate a critical function for CBP in efficient release of Pol II from the 
promoter-proximal pause into productive elongation. Furthermore, our data 
suggest that CBP is involved in Pol II recruitment at weakly-paused genes, 
and therefore stimulates transcription by both Pol II recruitment and release at 
virtually all promoters. This indicates that CBP activity has its effect at most 
expressed genes, including those that fall below our cut-off for high confidence 
CBP ChIP-seq peaks.  
Another explanation for the altered positioning of Pol II at the pause site 
upstream of the first nucleosome could be the CBP-mediated acetylation of 
some other protein involved in pausing. In mammalian cells, CBP can 
		
	
	
389	
acetylate many proteins including the non-consensus lysines in the Pol II CTD 
(Schroder et al., 2013). Inefficient positioning of paused Pol II upon CBP 
inhibition could result in insufficient modification of the Pol II CTD for efficient 
elongation. Yet another possibility is the targeting of pausing factor (e.g. NELF 
or DSIF) or core promoter factors by CBP. 
C646 is the most potent inhibitor of lysine acetyltransferases described, 
and selectively inhibits p300/CBP over other acetyltransferases (Bowers et al., 
2010). Although it is a competitive inhibitor that does not covalently modify 
p300/CBP (Bowers et al., 2010), covalent off-target reactivity with abundant 
cellular proteins has also been described (Shrimp et al., 2016). The short 
exposure (10 min) of the treated cells in our experiments, the use of the 
similarly reactive compound C37 as a control, and the significant correlation 
between CBP occupancy and the effects of C646, argue that on-target CBP 
inhibition accounts for the transcriptional changes observed. Although C646 
inhibits CBP’s catalytic activity (Bowers et al., 2010), we discovered that 
occupancy of CBP itself is rapidly affected by the CBP inhibitor, consistent 
with in vitro data showing that a p300/CBP inhibitor causes a conformational 
change that dissociates p300/CBP from a chromatin template (Black et al., 
2006). CBP is also a large protein with many interacting domains and binding 
partners (reviewed in Bedford et al., 2010).  For this reason, we cannot 
distinguish between CBP-mediated acetylation of a substrate that is required 
for transcription and a non-enzymatic CBP function.  
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  Our results demonstrate that CBP controls positioning of promoter-
proximal paused Pol II at a large fraction of Drosophila genes by facilitating 
transcription through the first nucleosome and by stimulating Pol II recruitment. 
This global activator function for CBP is consistent with tethering experiments 
where a Gal4-CBP fusion protein strongly activated transcription from 24 
different enhancer contexts (Stampfel et al., 2015). This suggests that CBP 
has critical roles not only in the previously described control of enhancer 
activity by H3K27 acetylation (reviewed in Holmqvist and Mannervik, 2013), 
but also in regulation of Pol II activity at the promoter.  
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